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The Burden of Disease and Injury in Aboriginal and 
Torres Strait Islander peoples 2003 provides the first 
comprehensive assessment of the burden of disease 
of Indigenous Australians. 
Burden of disease analysis gives a unique 
perspective on health. Fatal and non-fatal outcomes 
are combined, but can be examined separately as 
well. This report provides details of the extent of 
premature mortality and disability estimated for 
over 170 disease and injury categories and for 
Indigenous people living in remote and non-remote 
areas of Australia. It also presents estimates of the 
amount of disease and injury caused by 11 major 
risk factors. More importantly, it measures the 
Indigenous Health Gap, which is the difference 
between the observed burden of disease in 
Indigenous Australians and what it would have been 
if the same rates of burden of disease as in the total 
Australian population would have applied. This is of 
major policy interest. The diseases and risk factors 
that contribute most to the Indigenous Health Gap 
are identified as health areas where appropriately 
resourced health services, combined with 
interventions to address the social and economic 
disadvantages faced by Indigenous Australians, are 
likely to have the greatest impact on reducing the 
burden of disease in Aboriginal and Torres Strait 
Islander peoples.
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Foreword 
Policies and programs to improve health rely heavily on valid and timely information about 
the major causes of disease and injury in a population, and how these are changing. 
Typically, government policy is informed by a variety of data sources about the state of 
population health, many of them fragmentary and of uncertain quality, and none of them 
completely capturing the spectrum of diseases and injuries of interest, or indeed the 
consequences of disease and injury in terms of premature mortality and disability. More than 
a decade ago, a single summary measure of population health, the Disability-Adjusted Life 
Year, or DALY, was developed and has been widely applied since to measure disease 
burden by age, sex, cause and risk factor in numerous populations across the globe, as well 
as for the world and its major regions. DALYs are now the accepted unit for health 
accounting worldwide, and the Burden of Disease framework has become the global 
standard for integrating, adjusting and using available health information to produce policy-
relevant and comparable evidence about a population’s health.  
While there have been numerous burden of disease studies over the past decade in 
developed countries, including several in Australia, the framework and tools have never 
before been applied to measure disease burden in Indigenous populations apart from a pilot 
study in the Northern Territory, although the need for such evidence to guide policies and 
programs is clear. Given the uncertain quality of many data sources on Indigenous health, 
and the lack of comprehensive information about the comparative importance of various 
diseases and injuries, it has been difficult to appreciate the complete set of priorities for 
Indigenous health development. This report responds to that need by providing the first ever 
burden of disease and injury estimates for the Aboriginal and Torres Strait Islander 
population of Australia by leading experts in the field. Detailed estimates are provided of the 
comparative importance of over 170 diseases and injuries for the health of Indigenous 
Australians, and in doing so, this report fills an important gap in the evidence base for 
Indigenous Australian health policy. 
By highlighting the main causes of disease burden – and there are many – the report 
provides clear guidance for intervention strategies, particularly to reduce the unacceptably 
high risks of death in young adulthood that are still prevalent today. For example, on current 
rates, one-third of young indigenous men aged 15 will be dead before age 60, compared to 
8% in the Australian population. This four-fold increase in risk of death, comparable to parts 
of Africa today, is largely due to excess mortality from such causes as ischaemic heart 
disease, suicide and Type 2 diabetes, and its reduction must be a priority for Indigenous 
health services. 
With the publication of this report, a critical gap in the information base for health 
development for Indigenous Australians has been filled. I strongly urge all health 
jurisdictions throughout Australia to consider its findings carefully in developing policies for 
better health of Indigenous Australians.  
 
Alan D Lopez 
Chair – Steering Committee 
Aboriginal and Torres Strait Islander Peoples Burden of Disease Study 
School of Population Health  
The University of Queensland 
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Executive summary 
This study is the first complete assessment of the burden of disease and injury for Aboriginal 
and Torres Strait Islander peoples. It identifies the extent and causes of Indigenous health 
problems and quantifies the contribution of key health risk factors to these problems. 
Levels of death and disability from a comprehensive set of diseases, injuries and risks to 
health are combined to measure the total health ‘burden’ in disability-adjusted life years 
(DALYs). The DALY is a health gap measure that compares the current health status of a 
population against an ‘ideal’ in which everyone lives into old age free from disease. Similar 
estimates for the total Australian population for the same baseline year, 2003, have been 
published separately in The Burden of Disease and Injury in Australia, 2003 report (Begg et al. 
2007). Results from both studies are quantified in the same measure with comparable 
methods.  
The health problems facing Indigenous Australians are best illustrated as the ’Indigenous 
health gap’, which we calculated as the difference between the burden of disease estimates 
for Indigenous Australians in 2003 and what these estimates would have been if Indigenous 
Australians had experienced mortality and disability at the level of the total Australian 
population. The Indigenous health gap reflects the potential for health gain; in other words, 
it answers the question ‘For which health problem, addressing which age group, in males or 
females, is a concerted effort most likely to lead to an improvement in the health status of the 
Indigenous population?’ This makes the Indigenous health gap the most useful finding for 
health policy makers.  
The assessment of the health status of Indigenous Australians is not easy. The main 
challenge is the inaccurate and incomplete identification of who is, and who is not, 
Indigenous in population health and census data collections. For instance, in order to 
estimate more accurate rates of mortality for Indigenous Australians we had to use an 
indirect demographic method which in turn introduces uncertainty. Estimating the cause of 
death was deemed more accurate because the quality of certification of cause of death for 
Indigenous people was similar to that for the rest of the population when comparing the 
proportions of deaths coded to ill-defined codes. We therefore assumed that the cause of 
death pattern in deaths recorded as Indigenous reflected the pattern of all Indigenous deaths. 
Estimates of disability for more than 170 disease and injury categories that were included in 
this study depended on a combination of methods. If available, data on directly observed 
Indigenous health events in routine health statistics databases, health surveys or 
epidemiological studies were included. For many diseases, such information did not exist. 
Instead, ratios of the differences between Indigenous and total population rates were sought 
for proxy measures of disease occurrence, such as hospital admissions or mortality records. 
Consequently, the accuracy of the estimates included in this study vary. The study provides 
transparency on the data sources consulted, and all the assumptions and judgments on 
which the results depend. 
Key findings 
The Indigenous Australian population is younger than the total Australian population, 
therefore where overall rates are presented and comparisons are made with rates in the total 
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Australian population these are age-standardised to the 2003 Indigenous Australian 
population. 
Indigenous health gap 
• If Indigenous Australians had the same level of mortality and disability as the total 
Australian population, the total burden of disease would have been 59% lower (39,522 
compared with 95,976 DALYs); this indicates a very large potential for health gain. 
• Non-communicable diseases explained 70% of the health gap, with cardiovascular 
disease the leading cause group (23%) followed by diabetes (12%), mental disorders 
(12%) and chronic respiratory diseases (9%) (Figure i). 
• Ischaemic heart disease (14%), Type 2 diabetes (12%) and substance use disorders (6%) 
were the main non-communicable disease categories that contributed to the health gap. 
• Injuries and group I conditions (communicable disease, maternal and neonatal 
conditions) were each responsible for 15% of the gap. 
• Communicable diseases (9%) and neonatal conditions (4%) explained almost all of the 
gap for group I conditions. 
• Suicide (4%), road traffic accidents (RTAs) (3%), and homicide & violence (3%) were the 
major causes responsible for the injury gap. 
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Diabetes
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Mental disorders
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* Communicable diseases, maternal and neonatal conditions 
** Other non-communicable diseases 
Figure i: Indigenous health gap (DALYs) by selected causes, 2003 
• The overall Indigenous health gap was similar in males and females; the gap for injuries 
was much greater in males while that for diabetes and cancers was greater in females 
(Figure ii). 
• Compared to the total burden of disease estimates for Indigenous Australians, where 
54% of burden was due to mortality, two-thirds of the Indigenous health gap was due to 
mortality (Figure iii). This means that the mortality gap was considerably greater than 
the disability gap, and reflects in part a higher case fatality: when sick, Indigenous 
Australians are more likely to die.  
Executive summary 
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• Mortality dominated the gap for cancer, injuries and cardiovascular disease; cancer was 
the only disease category that had a lower rate of disability (by 14%) than the total 
population (hence the 114% for fatal cancer in Figure ii). 
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Figure ii: Indigenous health gap (DALYs) by selected causes expressed as proportions by sex, and 
proportions due to fatal and non-fatal outcomes, 2003 
• The largest proportion of Indigenous health gap occurred in the age group of 35–54 years 
(35%) followed by the 15–34-year age group (25%), the 55-year and older age group 
(23%) and then children under 15 years (17%).  
• Cardiovascular disease, particularly ischaemic heart disease and diabetes, were the main 
contributors to the health gap at ages 35 years and over. 
• Injuries and mental disorders were the main contributors to the health gap in young 
adults aged 15–34 years; notably at these young ages, cardiovascular disease and 
diabetes were already responsible for one-fifth of the health gap. 
• Suicide explained almost half of the health gap from injuries in young males. In young 
females, injuries contributed a lesser proportion to the gap but there was still 
considerable excess health loss from RTAs, suicide and violence. 
• Substance use disorders explained most of the gap from mental disorders in young 
adults. 
• Indigenous Australians residing in remote areas represented 26% of the total Indigenous 
Australian population but contributed 35% of the overall Indigenous disease and injury 
burden and experienced 40% of the Indigenous health gap (Figure iii). Thus, despite the 
higher disease rates experienced by Indigenous Australians in remote areas, the majority 
of burden still occurred in non-remote areas. This indicates that policies need to address 
the health problems of Indigenous Australians in both non-remote and remote areas. 
• Relative to population size Indigenous Australians residing in remote areas experienced 
a disproportionate amount of the health gap for all major disease areas apart from mental 
disorders (Figure iii). This latter finding may be an artefact of the methods. For example, 
the disease models for alcohol dependence & harmful use, and anxiety & depression 
were derived from the 2004-05 National Aboriginal and Torres Strait Islander Health 
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Survey Social and Emotional Well-being module which gave proxies rather than 
diagnostic indicators for ICD-10 defined mental disorders. 
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Figure iii: Indigenous health gap (DALYs) by selected causes expressed as proportions by 
remoteness, 2003 
Disease and injury burden in DALYs 
• The disease burden occurred at a considerably higher rate at each age for Indigenous 
Australians compared with the total Australian population. In 2003, the Indigenous 
Australian population made up 2.4% of the total Australian population; however, despite 
its much younger age structure, the Indigenous Australian population carried 3.6% of the 
total disease burden. 
• Cardiovascular disease and mental disorders were the leading causes of disease burden 
in the Indigenous Australian population in 2003 (Figure iv). These two broad cause 
groups together accounted for 32% of the disease burden. Chronic respiratory disease, 
diabetes mellitus and cancers were the next three leading causes, accounting for an 
approximately equal proportion of the total Indigenous Australian disease burden at 8% 
each.  
• Cancer was responsible for a much greater proportion of the burden in the total 
Australian population (19%) than the Indigenous population (8%). Diabetes, and 
unintentional and intentional injuries were each responsible for a larger proportion of the 
total burden in Indigenous Australians than in the total Australian population 
(Figure iv). 
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Figure iv: DALYs by broad cause group, Indigenous and total Australian population, 2003 
• Among the top seven broad cause categories, the largest differentials in rate of burden 
between the Indigenous and total Australian population were seen in cardiovascular 
disease, diabetes mellitus and intentional injuries for both males and females (Figure v). 
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Figure v: DALY rate per 1,000 for the leading broad cause groups by sex, Indigenous and total 
Australian population, 2003 
• Ischaemic heart disease was the largest single contributor to the disease burden 
experienced by Indigenous Australian males, accounting for 12% of the total burden. 
Type 2 diabetes, anxiety & depression, suicide, and RTAs were the next four leading 
causes of male burden, together accounting for 22% of the male burden.  
• For females, the leading cause was anxiety & depression, causing 10% of the total 
burden. Type 2 diabetes, ischaemic heart disease, asthma and chronic obstructive 
pulmonary disease (COPD) were the following four leading causes, accounting for 26% 
of the total burden for females. 
• Among the 20 conditions that caused the greatest burden, the largest differentials in 
burden rate between the Indigenous and total Australian male population were for 
homicide & violence (rate ratio, RR 6.8), inflammatory heart disease (RR 6.3), and lower 
respiratory tract infection (RR 6.1) .For females, the largest differentials were for 
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rheumatic heart disease (RR 26.4), homicide & violence (RR 11.0), and alcohol 
dependence & harmful use (RR 7.9).  
Health risks 
• The 11 risk factors considered (tobacco, alcohol, illicit drugs, high body mass, inadequate 
physical activity, low intake of fruit and vegetables, high blood pressure, high 
cholesterol, unsafe sex, child sexual abuse and intimate partner violence) together 
explained 37% of the total burden of disease experienced by Indigenous Australians.  
• If Indigenous Australians experienced the same burden rates as the total Australian 
population due to these 11 selected risk factors, 29% of the total Indigenous Australian 
burden of disease could be avoided (Table i). This is half of the overall Indigenous health 
gap of 59%. This indicates that there is potential to considerably reduce the disease and 
injury experience of all Indigenous Australians with interventions targeted at these risk 
factors. 
Table i: Indigenous health gap (DALYs) due to selected risk factors, expressed as a proportion of 
excess burden from each risk factor, 2003 
  Total (%) 
Risk factor 0–14 15–34 35–54 55+ Total
  
Health gap 
(DALYs) 
 % of total 
Indigenous 
burden
Tobacco 6 0 47 47 100 9,816 10
High body mass 0 9 57 34 100 8,953 9
Physical inactivity 0 13 48 39 100 6,554 7
High blood cholesterol 0 10 64 26 100 3,994 4
Alcohol 2 45 40 13 100 3,820 4
High blood pressure 0 5 45 50 100 3,215 3
Low fruit and vegetable intake 0 10 52 37 100 2,873 3
Illicit drugs 4 63 28 5 100 2,150 2
Intimate partner violence 0 48 42 11 100 1,836 2
Child sexual abuse 0 67 28 5 100 869 1
Unsafe sex 4 40 43 12 100 926 1
11 risk factors combined(a) 3 21 45 32 100 27,383 29
(a) Joint effect of 11 risk factors in Indigenous analysis, and 14 in National Study (Begg et al. 2007) minus the burden from osteoporosis, 
occupation, and air pollution 
• Indigenous Australians residing in remote areas experienced a disproportionate amount 
of the health gap due to all selected risk factors excluding illicit drugs (Figure vi). The 
distribution of the gap due to child sexual assault is likely to be an artefact of our 
methods where, due to limited information, we assumed the same prevalence of child 
sexual abuse in remote and non-remote areas. 
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Figure vi: Indigenous health gap (DALYs) by selected risk factors expressed as proportions by 
remoteness, 2003 
• For the total Indigenous population, the 10 risk factors associated with cardiovascular 
disease together explained 69% of the cardiovascular disease burden. Tobacco 
contributed most to this cause, followed closely by high body mass, high blood 
cholesterol, physical inactivity and high blood pressure. 
• Eight of the risk factors were associated with cancer and together explained 49% of the 
total burden from this cause. In contrast, for the burden of disease and injury study in the 
total Australian population, the 14 risk factors considered explained 33% of the cancer 
burden. The major difference between the distribution of cancer burden among these risk 
factors was that a greater proportion of cancer was explained by tobacco in the 
Indigenous Australian population compared with the total Australian population (35% 
compared with 21%). 
• More than one-third of the mental disorder burden was attributable to four of the risk 
factors. Alcohol contributed the most to this burden followed by illicit drugs, child sexual 
abuse and intimate partner violence. 
• Five of the risk factors were associated with injury burden and together explained 33% of 
the burden from this cause. This was similar to the proportion of injury burden explained 
by these risk factors in the total Australian population (32%) in relative terms, but as the 
burden of injuries in Indigenous Australians was much larger, it meant that the average 
risk of an injury due to these risk factors was also much higher. Alcohol was by far the 
leading risk factor for injury burden in Indigenous Australians, followed by intimate 
partner violence, illicit drugs and child sexual abuse. 
• Indigenous Australians experienced a higher rate of disease burden due to each of the 
11 risk factors considered compared with the total Australian population. This resulted 
from a combination of higher prevalence of exposure to the risk factors, and higher 
disease levels in the population. The largest relative differences in rates of burden were 
for low fruit and vegetable consumption, tobacco, and high body mass.  
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Mortality and health-adjusted life expectancy 
• Mortality in young and middle-aged Indigenous adults was particularly high (33% and 
23% probability of dying between ages 15 and 60 years in males and females, 
respectively, compared with 10% and 6% in the total Australian population). A 
comparable high level of adult mortality was found in only a few countries in the world 
that are not severely affected by HIV/AIDS mortality. The probability of dying between 
ages 15 and 60 years was higher still in Indigenous Australians residing remotely: 46% 
and 31% for males and females, respectively. 
• Under-five mortality in Indigenous Australians was also greater than that of the total 
Australian population but differences were less extreme than they were for adult 
mortality. The probability of dying before age 5 was 1.6% and 1.4% for males and 
females, respectively (compared with national figures of 0.7% and 0.6%). 
• Using the general growth balance (GGB) methodology and assuming no trend in life 
expectancy since the 1996 to 2001 intercensal period, health-adjusted life expectancy 
(HALE) for Indigenous males was 56 years in 2003 (compared with 71 years for males in 
the total population), and for Indigenous females was 60 years (compared with 75 years 
for females in the total population); a gap of about 15 years respectively compared with 
the total population by sex. 
• Indigenous Australians not only have a much shorter life span, but the proportion of 
time lived with disability is greater than that in the total population (13% compared with 
10%). 
Key implications 
It has been known for a long time that Indigenous Australians experience much higher 
mortality rates and have worse life expectancy than the total Australian population. 
However, this study is the first comprehensive description of the Indigenous population that 
takes fatal and non-fatal health outcomes into account and details which conditions at which 
ages by sex contribute most to the observed enormous health gap. This study provides 
health policy makers with a wealth of information to identify the greatest potential for health 
gain by addressing particular diseases and risk factors; by targeting the most affected age 
groups in males and/or females; and by providing effective interventions to Indigenous 
people residing in cities, regional towns and remote areas. 
To set priorities to achieve these health gains, complementary information is needed on the 
cost-effectiveness of specific interventions for each of the health problems. The details 
provided in this study on each disease and risk factor are essential for these economic 
analyses. 
There is great potential to reduce the Indigenous health gap by addressing the 11 risk factors 
identified in this study as being responsible for half of the total health gap. There is growing 
evidence to guide choices on what preventive interventions for which risk factors are most 
likely to be effective and cost-effective in the total Australian population but not yet what the 
implications are for the Indigenous population. The much higher disease burden makes it 
more likely that interventions can achieve large health gain in Indigenous Australians. In 
economic evaluations this needs to be taken into account together with the different costs of 
interventions that are culturally appropriate and the different challenges that will arise by 
delivering interventions to Indigenous people residing in non-remote versus remote areas. 
Executive summary 
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In this study, certain diseases and risk factors contributed more to the overall burden of 
disease in Indigenous Australians, and particularly to the Indigenous health gap. 
Cardiovascular disease, diabetes and other tobacco-related conditions (e.g. lung cancer and 
chronic respiratory disease) explained half the gap. Apart from tobacco, these conditions 
have many lifestyle risk factors in common, including high body mass, physical inactivity, 
raised blood pressure and cholesterol. These health problems largely affect middle-aged and 
older Indigenous Australians; however, they start at young ages, and there is already a 
sizeable burden in the 15–34-year age group. This means that prevention efforts should be 
targeted at a much younger Indigenous population than would be the case in the rest of the 
population. 
Further health gain (up to 15% of the health gap) can be expected if the excess burden from 
infectious disease and neonatal conditions can be addressed. We also note that suicide, 
RTAs, and homicide & violence were the main injuries that explained 15% of the health gap. 
Most of this excess in injuries occurred at young adult ages. Mental disorders, including 
substance use disorders and particularly alcohol, also contributed significantly (10%) to the 
health gap. 
When addressing the Indigenous health gap, it is important to note that the focus should not 
just be on prevention. The higher proportion of the health gap that was due to mortality 
reflected the greater chance of dying if Indigenous Australians fall sick. Each disease may 
have specific problems to be addressed; however, it is likely that the higher case fatality for 
most diseases was influenced by a combination of late presentations, shortcomings in acute 
surgical and medical management, and poor follow-up during the course of disease. 
Therefore, reducing the incidence and effects of these diseases requires a multi-pronged 
approach. 
Addressing the multitude of health problems facing Indigenous Australians is complex and 
will require a wide range of initiatives to increase preventive and curative efforts from 
mainstream and particularly Indigenous health services. The National Aboriginal 
Community Controlled Health Organisation (NACCHO) states that:  
It is widely recognised that health solutions lie in assisting Aboriginal people being 
able to enjoy their right to self-determination. All relevant inquiries and studies have 
shown conclusively that culturally appropriate, comprehensive primary health care 
(such as Aboriginal community controlled health services), based on maximum 
community participation, is the best way of addressing Aboriginal health (NACCHO 
2001).  
It would be more effective to combine this with approaches outside the health sector to 
address the social and economic disadvantages that contribute to the poor health status of 
Indigenous Australians. This is in keeping with the Indigenous concept of health which 
acknowledges that: 
Improving Aboriginal health is not just about improving the physical well-being of 
an individual. It is about working towards the social, emotional, and cultural well-
being of the whole community in which each individual is able to achieve their full 
potential as a human being (NACCHO 2001).  
However these requirements should not lead to inaction by health policy makers arguing 
that the social and economic problems should be tackled first. It is within the reach of 
appropriately resourced health services to reduce a sizeable proportion of the Indigenous 
health gap. 
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1 Introduction 
1.1 Purpose of the report 
In 1993, Harvard University and the World Health Organization collaborated on the World 
Development Report 1993 (The World Bank 1993). This report provided a detailed assessment of 
the global burden of disease, injuries and risk factors, to guide policies towards delivering 
more cost-effective and equitable health care to areas where achievable gains could be made. 
To help achieve this, a new summary measurement of population health (which combined 
information on mortality and non-fatal health outcomes into a single number to represent a 
population’s health status) was developed: the disability-adjusted life year (DALY) (Murray 
& Lopez 1996).  
Two Australian (Begg et al. 2007, Mathers et al. 1999), and two Victorian burden of disease 
and injury studies (Victorian Department of Human Services 1999a, 1999b, 2005) built on the 
methods outlined in the World Development Report 1993. These Australian studies provided a 
comprehensive overview of the burden of disease for 176 diseases and conditions by age 
group, sex, national health priority area, risk factors, and by area of socioeconomic 
disadvantage for all Australians and Victorians respectively. The results of these studies 
continue to be used widely in population health and health economic-related policy and 
research environments. In particular, the inclusion of the impact of morbidity has helped 
raise the profile of health conditions that do not have a significant mortality impact, such as 
mental disorders, hearing loss, vision loss and musculoskeletal disorders. In the recent 
Australian study (Begg et al. 2007) these conditions were estimated to contribute 20% to the 
overall disease burden.  
Neither of these studies, nor subsequent smaller studies in other Australian states, quantified 
the burden of disease and injury for Indigenous Australians, predominantly due to concerns 
about incomplete Indigenous identification in population datasets. A pilot study sought to 
overcome these data issues by focusing on Indigenous and non-Indigenous people in the 
Northern Territory (NT), which has well-documented Indigenous identification practices 
(Zhao et al. 2004). The NT study used a combination of observed data with relativities 
derived from health services data on which to develop the disease models that underlie 
DALYs. The study demonstrated that Indigenous people had rates of DALYs two-and-a-half 
times as high as the Australian rate, and that the non-Indigenous Northern Territory 
population was similar to the total Australian population. The pilot study also showed that 
health inequalities not only affect the length of life (three time more years of life lost due to 
premature deaths) but also the health-related quality of life (almost a doubling of disability 
experienced due to non-fatal disease). Finally, most of the extra burden experienced by 
Indigenous people was found to occur in diseases (e.g. cardiovascular and renal disease, and 
diabetes mellitus) with preventable risk factors, such as diet, lifestyle, education and physical 
activity (Zhao et al. 2004). 
In 2003, the Australian Government Department of Health and Ageing Office for Aboriginal 
and Torres Strait Islander Health (OATSIH) funded the University of Queensland to 
develop, in parallel to the national study, a separate study of the burden of disease in 
Indigenous Australians in 2003.  
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This study’s objectives were: 
• to develop internally consistent estimates of mortality for Indigenous Australians for 
more than 170 diseases and injuries for the year 2003 by age group, sex and cause 
• to develop internally consistent estimates of disease occurrence and duration for more 
than 170 diseases and injuries for the year 2003 by age group, sex and cause 
• to estimate the premature mortality (years of life lost, YLL), non-fatal disability (years of 
life lost to disability, YLD) and burden of disease and injury (DALY) for more than 
170 diseases and injuries for the year 2003 by age group, sex and cause 
• to estimate the attributable burden of disease and injury to major disease risk factors for 
the year 2003 by age group, sex and cause. 
Importantly, the Indigenous burden of disease study has been guided by a steering 
committee of experts and representatives of Indigenous community organisations to ensure 
the study provides relevant information for policymaking and advocacy. We thank Professor 
Cindy Shannon and OATSIH for their advice with the selection of this committee. A 
representative technical subcommittee was also formed to discuss methodological issues. It 
is also noteworthy that the study operated under the umbrella of the Cooperative Research 
Centre for Aboriginal Health as an ’in-kind project’.  
1.2 Background to the report 
Indigenous Australians continue to suffer disproportionately from the consequences of 
European settlement (AIHW & ABS 2005). The colonisation of Australia was characterised 
by a legacy of unjust and misguided policies (Steering Committee for the Review of 
Government Service Provision 2005) that lead to the ‘dispossession, physical ill-treatment, 
social disruption, population decline, economic exploitation, codified discrimination, and 
cultural devastation’ of Indigenous Australians (Gardiner-Garden 1998-99, Gray et al. 2004). 
Today, the majority of Indigenous Australians live in conditions of clear social and economic 
disadvantage in terms of poor education, employment and housing outcomes (AIHW & ABS 
2005). Many indicators are reported to show ‘little or no movement’ (Steering Committee for 
the Review of Government Service Provision 2005:xx) and that ‘in some important respects 
the circumstances of Indigenous people appear to have deteriorated or regressed’ (Banks 
2003:9). In 2005, worsening indicators included child protection notifications rates, 
imprisonment rates and victim crime rates (Steering Committee for the Review of 
Government Service Provision 2005). All the aforementioned factors interact to contribute to 
the extremely poor health of Indigenous people in Australia. According to the Australian 
Bureau of Statistics (ABS) and the AIHW, ’Aboriginal and Torres Strait Islander people suffer 
greater ill-health, are more likely to experience disability and reduced quality of life and to 
die at younger ages, than other Australians’ (AIHW & ABS 2005:91). 
While it is beyond any doubt that great differentials in health status exist between 
Indigenous and non-Indigenous Australians, the evidence is generally limited to traditional 
population health indicators, such as life expectancy at birth, mortality rates, hospital 
separation data and reports on the prevalence of infectious diseases and lifestyle disorders 
(ABS & AIHW 2003, Steering Committee for the Review of Government Service Provision 
2005, Zhao et al. 2004). For policy decision making, these disparate measures inadequately 
indicate where the opportunities for health gain lie. Burden of disease estimates for 
Indigenous Australians, on the other hand, would help to identify those diseases and risk 
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factors that are most responsible for the gap in health status between Indigenous Australians 
and the Australian population overall. The existence of a large gap is indicative of the 
potential to improve health status. 
In addition, there is considerable uncertainty about the correct level of mortality, as well as 
disease occurrence, among Indigenous Australians. This is because routine data collection 
systems systematically underestimate true rates due to inadequate identification of 
Indigenous status, and also because population denominators are rising due to a greater 
propensity to identify as an Indigenous Australian. There is a lack of comprehensive, 
Indigenous-specific epidemiological data and little is known about non-fatal health states 
affecting Indigenous people. 
OATSIH recognised the value of funding a study that would improve the evidence base for 
determining the size and impact of health problems in the Indigenous population, using a 
‘burden of disease’ methodology, which is increasingly being used in Australia and 
internationally to assess population health outcomes and to evaluate the cost-effectiveness of 
health interventions. Burden of disease methodology is distinct from other methods of 
summarising population health in policy-settings, because it incorporates fatal and non-fatal 
conditions in assessments of health status; it separates epidemiology from advocacy to 
produce objective, independent and demographically plausible assessments of the burdens 
of particular conditions and diseases; and it can be used to assess the cost per unit of disease 
burden averted using a specific health intervention (Murray & Lopez 1996).  
This study contributes to the development of such an agenda for Indigenous Australians by 
providing a detailed and internally consistent assessment of the incidence, prevalence, 
duration, mortality and burden for an exhaustive and mutually exclusive set of major 
diseases and injuries experienced in Australia, as well as the contribution of major risk 
factors to health. By doing so, this study also provides an unprecedented, comprehensive 
summary of the magnitude and distribution of health problems for Indigenous Australians. 
The study is an important foundation for further work on developing the evidence base for 
improving health outcomes in Indigenous Australians. 
It is important to note that the burden of disease and injury method measures health status 
in terms of disease and infirmity. This method is not capable of incorporating the nuances 
inherent in the broader definition of health and wellbeing preferred by Indigenous 
Australians:  
Health does not simply mean the physical well being of an individual but refers to 
the social, emotional and cultural well being of the whole community. For Aboriginal 
people this is seen in terms of the whole of life view incorporating the cyclical 
concept of life – death – and the relationship to the land. Health care services should 
strive to achieve the state where every individual is able to achieve their full potential 
as a human being of their community. (NACCHO 2003:11).  
Although the World Health Organization advocates a similar, broad definition of health, the 
whole-of-life view is difficult to quantify. In this study, we have opted to use the same 
definition of health that has been used in previous burden of disease studies in Australia 
(Begg et al. 2007, Mathers et al. 1999, Victorian Department of Human Services 1999a, 1999b, 
2005), arguing that comparisons of health status between the Indigenous population and the 
total Australian population are paramount when arguing for investment in Indigenous 
health. Such comparisons are only valid the methods of assessment are the same.  
Further, work is currently being undertaken as part of the ACE-Prevention study to define 
and quantify a broader concept of Indigenous Australian health benefit. The ACE-Prevention 
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study is a collaborative effort by the University of Queensland and Deakin University, 
funded by the National Health and Medical Research Council (NHMRC), and aims to 
evaluate the cost effectiveness of preventive health interventions for non-communicable 
disease. An important component of the study focuses on the cost and benefit implications of 
these intervention options for the health of Indigenous Australians. ACE-Prevention 
researchers are also collaborating with the Cooperative Research Centre for Aboriginal 
Health to consider important Indigenous values that extend beyond the traditional notion of 
health gain to individuals, including community health gain, equity and cultural security.  
1.3 Unique features of the Indigenous population 
In 2001, the ABS Census of Population and Housing showed that Indigenous Australians 
represented 2.4% of the total Australian population. The vast majority of Indigenous 
Australians identified as being ‘only Aboriginal’ in origin (90%) with small proportions 
reporting as being of ‘only Torres Strait Islander’ origin (6%) or having ‘both Aboriginal and 
Torres Strait Islander’ origins (4%) (ABS 2003b). For ease in reading, we use the term 
‘Indigenous Australians’ to refer to the Aboriginal and Torres Strait Islander Australian 
population. Making separate estimates for Torres Strait Islanders was outside the scope of 
this study. While we recognise that Torres Strait Islander people have their own distinctive 
cultural identity, we also note that they share many of the characteristics of disadvantage 
that Indigenous Australians experience generally (AIHW & ABS 2005).  
The 2001 Census also showed that the Indigenous population had a younger age profile 
compared with the total Australian population, with a median age of 21 years compared 
with 36 years (ABS 2003b). To account for these differences in age structure we use age 
standardisation when comparing the Indigenous and total Australian populations.  
In 2001, 26% of Indigenous Australians lived in remote areas, compared with 2% of non-
Indigenous Australians. While 74% of the Indigenous population lived in major cities and 
regional areas compared to 98% of the non-Indigenous population (ABS 2003b).  
Ever since Indigenous peoples were formally counted in census and vital registration data, 
the number of people identifying as Indigenous has increased in excess of what can be 
explained by births, deaths and migration (ABS 2003b). We used specific methods to correct 
for Indigenous identification in Australian mortality and health datasets (Chapter 2, 
Appendix A and Appendix B). 
1.4 Disability-adjusted life years 
The measure of ‘burden of disease’ is the disability-adjusted life year (DALY) — the sum of 
the years of life lost (YLL), due to premature death, and the years lived with disability (YLD), 
with time as a common metric: 
DALY = YLL + YLD 
One DALY is equivalent to one year of healthy life lost (Zhao et al. 2004). Estimating YLL 
involves multiplying the number of deaths by a standard life expectancy at age of death. The 
formula for calculating the YLL is: 
YLL = number of deaths x standard life expectancy (in years) 
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The loss of healthy life due to non-fatal health conditions requires an estimate of the 
incidence of the health condition (disease or injury) in the specified time period. For each 
new case, the number of years of healthy life lost is obtained by multiplying the average 
duration of the condition (to remission or death) by a severity weight that measures the loss 
of healthy life using an average health state weight (Begg et al. 2007, Murray & Lopez 1996, 
Victorian Department of Human Services 2005). The basic formula for calculating the YLD is: 
YLD = number of incident cases x disability weight (range 0–1) x  
duration of disability (in years) 
Estimates of diseases were first made separately, disease by disease. Adjustments were then 
made to account for when two or more conditions occur simultaneously in the same person, 
either by chance or because the conditions are related. Health loss is likely to be over-
estimated without such corrections because the weights were originally derived for health 
states in isolation, without reference to co-existing conditions (Mathers et al. 2006). Due to a 
lack of appropriate data for Indigenous Australians we apply the same comorbidity 
adjustments as used in the National Study (Begg et al. 2007).  
The great advantage of a detailed burden of disease analysis is that it facilitates meaningful 
comparisons between populations and identifies the most important diseases and risk factors 
that contribute to differences in health status and hence differences in health service needs. A 
detailed burden of disease analysis also indicates areas of health with the greatest potential 
for change. It is important to realise that burden of disease estimates are calculated for the 
year of interest (2003), taking into account the impact of all existing health services on levels 
of disease and injury. 
Burden of disease analyses rely on available data sources. Even if data sources for a 
particular disease are inadequate, provisional estimates are made. To be transparent about 
these assumptions, the study results are accompanied by a detailed description of the 
underlying data sources and data manipulations. 
1.5 Structure of the report 
Chapters 2 and 3 present the methods used to estimate fatal and non-fatal health outcomes, 
respectively. Chapter 4 provides an overview of the burden of disease results for Indigenous 
Australians by cause, age and sex compared with the total Australian population. Chapter 5 
gives estimates of the burden of disease attributable to selected risk factors in Indigenous 
Australians. Chapter 6 presents the Indigenous health gap — the difference between the 
current levels of disease burden in Indigenous people and what it would be if the total 
Australian population DALY rates applied. In this chapter we also describe the differentials 
in the burden of disease for Indigenous Australians by broad remoteness areas. Chapter 7 
provides a general discussion of the major findings.  
Technical notes on the methods for adjusting recorded mortality and hospital rates for 
under-identification of who is Indigenous are presented in Appendices A and B respectively. 
Technical notes on the methods for estimating non-fatal health outcomes and attributing risk 
follow in Appendices C and D. 
Annex Table 1 summarises the primary data sources used to estimate disease occurrence. 
Annex Table 2 summarises the quality of information on disease occurrence for the main 
disabling conditions. Annex Table 3 summarises assumptions and confidence in the risk 
factor exposure estimates. Tabulations of the core results are included in Annex Tables 4–8. 
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2 Estimating fatal burden of disease  
2.1 Background 
The estimation of fatal health outcomes relies on accurate information on the population size, 
the numbers of death by age and sex — the mortality envelope — as well as details on the 
causes of death. There are problems with under-identification of Indigenous people in 
population censuses and in the death registration system. As a result mortality rates for 
Indigenous people based on recorded data suffer from bias in the numerator (number of 
deaths) and denominator (population estimates) and these biases are not necessarily of the 
same magnitude. There are indirect demographic methods to help correct for these biases. 
The ABS has used two of these methods to date to produce adjusted mortality estimates. 
However they caution readers against using their corrected mortality estimates for any 
purpose other than population projection because of concerns about judgments made in their 
application of the indirect methods (ABS 2004a). Nevertheless, the ABS life expectancy at 
birth figures for Indigenous Australians are widely quoted.  
For this study, we engaged Professor Kenneth Hill (Professor of Demography, Harvard 
University), a pioneer and world expert in indirect demographic methods, to advise on the 
most appropriate method to adjust for under-identification of Indigenous people in census 
counts and the death registration system. Details of the methods have been published 
elsewhere and are summarised in Section 2.2, below. Further details regarding adjustment of 
Australian mortality data is provided in Appendix A.  
The cause of death attribution in Australia is of good quality in those identified as 
Indigenous, as non-Indigenous or with unknown Indigenous status. Thus, the question is 
whether the cause of death structure in those erroneously not identified as Indigenous is the 
same as that for deaths identified as Indigenous. This is discussed in greater detail in 
Section 2.2.3, below. 
Once we had estimated the Indigenous mortality envelope by age, sex and cause, we were 
able to estimate the loss of health for each death, in YLL. We based this estimate on the 
concept that not all deaths are equivalent: a death at a younger age represents a greater loss 
than a death at an older age. In keeping with the National Study (Begg et al. 2007) and the 
Global Burden of Disease study (Murray & Lopez 1996), we quantified YLL as the difference 
between the age at death and the remaining life expectancy at that age derived from 
standard life tables with a corresponding life expectancy at birth of 80.0 for males and 82.5 
for females. 
2.2 Methods for correcting Indigenous mortality 
rates 
The ABS compiles information on Australian deaths from the state and territory offices of the 
Registrar of Births, Deaths and Marriages. It is considered that most deaths in Australia are 
registered and that the mortality of Indigenous Australians is substantially higher than that 
of the total Australian population (ABS & AIHW 2003). Despite this, the exact magnitude of 
the mortality difference between Indigenous Australians and the total Australian population 
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is unclear. This uncertainty about the true age- and sex-specific Indigenous mortality is due 
to: 
• failure to identify the Indigenous status of all deaths 
• changing propensity to identify as Indigenous in population counts, with errors thus 
affecting the numerators and denominators required for death and YLL rates. 
To a lesser extent, there are also some concerns about incorrect data (e.g. wrong declaration 
of age).  
2.2.1 Indirect demographic methods 
The problems in estimating Australian Indigenous mortality are similar to those faced by 
developing countries with incomplete vital registration data, for which indirect demographic 
methods were developed. One group of indirect mortality estimation methods designed for 
post-childhood mortality correction are the ‘death distribution methods’, such as methods 
developed by Brass (1975), Preston and Hill (1980), Bennett and Horiuchi (1981), Hill (1987) 
and Bhat (2002). Essentially, these methods propose that if the completeness of death 
recording relative to population recording can be estimated, the differential in completeness 
can be adjusted for. All these methods, apart from Brass (1975) , compare population counts 
from two successive censuses and subsequently compare these with the deaths recorded in 
the period between censuses. This approach is based on the principle that the population in a 
particular age group counted during the first census can either remain alive and shift to an 
older age group at the next census, or die in the period between censuses (Hill et al. 2005). 
Physical migration in and out of the population can also affect this comparison. The Bhat 
method explicitly takes physical migration into account but other methods, such as Hill’s 
(1987) GGB method, have also been adapted to consider migration (Hill & Queiroz 2004). 
It is important to note that all the indirect demographic methods rely on subjective expert 
opinion (ABS 2004a). As there is no direct way of verifying the accuracy of estimates derived 
from these methods, plausibility is the key when choosing an indirect method and assessing 
the required assumptions (Hill et al. 2007). 
2.2.2 ABS experimental population estimation 
Corrected age- and sex-specific mortality rates are an essential component of estimating and 
projecting the Indigenous population. As a result, since 1998 the ABS has tried applying the 
Preston-Hill method and more recently the Bhat method to correct for the under-
identification of Indigenous status in mortality data, at a national level and for grouped 
jurisdictions. The Bhat (2002) method reformulates the GGB (Hill 1987) method to make it 
applicable to populations that are affected by migration. Even though migration of 
Indigenous Australians in and out of the country is considered negligible, the ABS uses the 
migration corrections in the Bhat method to adjust for the unexplained growth of the 
Indigenous population between censuses, which is attributed to a changing propensity to 
identify as Indigenous. The Bhat method requires an a priori estimate of the population 
growth in the period between two censuses and this in turn requires an upfront estimate of 
mortality. This leads to circularity: an estimate of mortality is needed as an input to derive 
adjusted mortality estimates as an output. The ABS has flagged this as one of their more 
problematic assumptions (ABS 2004a) and so has an independent reviewer (Brown 2005). 
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2.2.3 General growth balance method and adult Indigenous 
mortality  
To avoid the problems with the Bhat method, Professor Hill suggested using the GGB 
method. The main difference between the GGB and Bhat methods is that the former treats 
’changing propensity to identify as Indigenous’ from one census to the next as a ’change in 
census coverage’ (with an age pattern proportional to the observed population), rather than 
‘migration’ (with an age pattern that can be approximated from prior knowledge). In other 
respects, the methods are very similar. For instance, both the Bhat and GGB methods assume 
that errors in reporting deaths are proportionately constant by age, and that errors of census 
coverage (if there are any) are also proportionately constant by age. If the changing 
propensity to declare oneself as Indigenous is approximately constant across age groups, the 
GGB method is preferred on the grounds of simplicity, because it requires no assumption 
about the rate of natural increase to arrive at an estimate of the extent of the change.  
If, on the other hand, the changing propensity to identify as Indigenous has a known age 
pattern, the Bhat method or the GGB method, adapted for migration, are preferable. Since we 
do not have data about this age pattern, and migration of the Indigenous population at the 
national level is thought to be negligible, the GGB method was selected by Professor Hill.  
Application of the GGB method requires three data inputs: the initial and final population 
age distribution from two successive censuses, and an age pattern of deaths for the 
intervening period from vital registration data. To avoid incorporating the assumptions of 
other analysts, we opted to use the actual census counts of the 1996 and 2001 censuses 
(Source: ABS 2005. ABS data available on request) rather than the experimental estimated 
resident population (EERP). We demonstrated that this choice had little bearing on the 
results (Hill et al. 2007), which is not surprising because the differences between actual 
census counts and EERP estimates are of the same magnitude for the 1996 and 2001 censuses, 
with few differences for age or sex.  
The second choice was to use the age structure of mortality rates for the years 2000–02 rather 
than rates based on recorded deaths in the five-year period between the 1996 and 2001 
censuses. The reasons for this were that Queensland only started recording Indigenous 
status in 1996 and the number of recorded Indigenous deaths in other jurisdictions only 
stabilised towards the end of the 1990s. The implication of our choice to use the age structure 
of mortality rates for 2000–02 is that our mortality estimates reflect the mortality experience 
of the proportion of the population who identified themselves as Indigenous in the 2001 
census. It is important to choose a particular year of reference for mortality estimates because 
of the phenomenon of unexplained growth in population, where more people are inclined to 
identify as Indigenous over time. 
Third, we assumed that the difference in census coverage as estimated in the GGB method 
(by the intercept of the regression line) is a measure of the unexplained growth. Two 
assumptions in the baseline application of the GGB method are that the change in census 
coverage and the under-identification of deaths were the same for all age groups. In a 
sensitivity analysis, we demonstrated that the results were not influenced much by altering 
these two assumptions to reflect that both the unexplained population growth and the 
under-identification of deaths affects young adults more than older adults, and males more 
than females (Hill et al. 2007). However, it can be argued that change in census coverage and 
under-identification of deaths may have varied in other age groups than in our sensitivity 
analysis, and differentially between census and deaths. Additional sensitivity analyses could 
be undertaken to test the effects of such changes. 
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2.2.4 GGB method and adult Indigenous mortality by remoteness 
We applied the GGB method (Hill 1987) separately to four groupings jurisdictions (a -
Northern Territory; b - Western Australia and South Australia; c - Queensland; d – New 
South Wales, Victoria, Australian Capital Territory and Tasmania) and by broad remoteness 
areas. Results for the four regional groupings showed rather large differentials and we 
hypothesised that this was due to different proportions of Indigenous people in these 
jurisdictions residing in major cities, regional and remote areas as determined by the ARIA+ 
remoteness classification of usual residence (AIHW 2004b). This classification system is a 
geographic approach to remoteness based on road distance to five categories of service 
centre (a surrogate for remoteness) and on the population size of a service centre (a surrogate 
for the availability of services). When we compared the results from the GGB models by 
remoteness, we found similar mortality estimates for major cities and regional areas but 
much higher mortality for Indigenous Australians residing in remote areas. In consultation 
with this study’s steering committee, we decided to restrict our burden of disease 
calculations to non-remote and remote groupings. 
We obtained customised data from the ABS on the migration patterns between remote and 
non-remote areas between the 1996 and 2001 censuses. We first calculated the net migration 
from remote to non-remote areas by sex and five-year age group for people with a stated 
remote or non-remote residence in both censuses. We then scaled the figures by the ratio of 
the total 2001 population and those with stated area of residence in both censuses. 
Application of these net migration figures caused an upward adjustment of remote life 
expectancy by 0.6 years and a downward adjustment of non-remote life expectancy of 
0.2 years. 
We multiplied the GGB derived non-remote and remote life expectancy estimates by the 
proportions of the Indigenous population in the four regional groupings of jurisdiction 
mentioned above (Table 2.1). This gave life expectancy at birth estimates for the grouped 
jurisdictions within two years of those estimated separately by the GGB method. This 
supported our hypothesis that differences in life expectancy between jurisdictions were 
largely explained by the proportion of the population in remote areas. 
Table 2.1: Proportion of Indigenous population by broad remoteness areas and grouped 
jurisdictions, 2001  
Grouped jurisdictions Non-remote (%) Remote (%) 
NSW, Vic, Tas, ACT 95 5 
Qld 76 24 
SA, WA 61 39 
NT 19 81 
Source: AIHW (2005b) 
2.2.5 Correcting under-five mortality  
Death distribution methods, such as the GGB method, do not provide information about the 
under-identification of deaths in young children. Therefore, different adjustments need to be 
made. For the life tables for the total Indigenous population, we used infant mortality rates 
(IMR) based on observed deaths and births, after finding that the IMR in Western Australia 
(Freemantle et al. 2006), estimated using linked birth and death data, was similar to that 
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calculated from ABS recorded deaths and births. Furthermore, the neonatal mortality rate 
from the AIHW perinatal data collection did not suggest that the observed IMR was an 
underestimate. We adjusted the observed mortality in 1 to 4 year old Indigenous children by 
the same GGB correction factor used for adults.  
In the absence of published information on births for Indigenous children by remoteness, we 
assumed that IMRs for Indigenous infants residing in non-remote and remote areas for 1998–
2001 from Western Australia’s linked database held for all Indigenous infants in Australia by 
remoteness (Freemantle et al. 2006). As these IMR estimates for 1998–2001 were for males 
and females combined, we applied the published sex ratio from the 1980–2001 period. We 
adjusted the observed mortality in 1 to 4 year old Indigenous children by the increased 
likelihood of mortality for 1 to 7 year old Indigenous children by remoteness from Western 
Australia’s linked database for the 1980–1997 period (Freemantle 2003).  
2.3 Cause of death data for Indigenous Australians 
We examined the ABS death information for Indigenous Australians in four ways. First, 
plots of the age-and-sex distribution of observed deaths by Indigenous status (i.e. 
Indigenous, non-Indigenous and not stated groups) showed an almost complete overlap 
between the non-Indigenous and not-stated proportions, and a very different age pattern for 
those identified as Indigenous. This indicated to us that the unknown number of 
unidentified Indigenous deaths could have been coded to either the not-stated or non-
Indigenous category. Second, age- and sex-specific mortality rates based on recorded 
Indigenous deaths showed an expected exponential increase from age 35 onwards. This 
suggested that there was no obvious underreporting of Indigenous deaths by age. Third, 
age-standardised proportions of deaths according to burden of disease broad cause groups 
(group I: communicable disease, maternal and neonatal causes; group II: non-communicable 
disease; and group III: injuries) were similar by Indigenous status indicating that the broad 
cause of death structure was similar for Indigenous and non-Indigenous Australians. Fourth, 
the proportions of ill-defined and residual categories contributing to overall mortality were 
similar for Indigenous and non-Indigenous deaths.  
We concluded that the recording of mortality by age, sex and cause for Indigenous 
Australians was plausible and of good quality. Thus, we assumed that the cause of death 
pattern for deaths recorded as Indigenous reflected the cause of death pattern of all 
Indigenous deaths (including the unknown number of unidentified Indigenous deaths). As 
numbers of deaths by age, sex and cause can fluctuate from year to year, we assessed the 
cause of death pattern for the 2001 to 2003 period. In consultation with the study’s steering 
committee and technical advisory panel, we fixed the mortality envelope for Indigenous 
Australians as the mortality rates predicted from the GGB exercise for the 1996–2001 period 
multiplied by the 2003 Indigenous population estimates. We then multiplied the resulting 
numbers of age- and sex-specific deaths by the proportions of deaths for each cause to obtain 
our final estimates of corrected Indigenous deaths by age, sex and cause. 
These calculations assumed no changes in mortality from the 1996 to 2001 period to 2003. 
This decision was based on consultation with the steering committee, due to the paucity of 
available trend data. However, recent evidence suggests that this may not be the case, at least 
for the Northern Territory (Wilson et al. 2007) . Between 1967 and 2004, the life expectancy at 
birth increased by 8.0 years for Indigenous men and 14.2 years for Indigenous women in the 
Northern Territory (Wilson et al. 2007). These findings were derived from what is considered 
to be the most complete and internally consistent database of deaths by Indigenous status 
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and population counts in Australia for the period 1967–2004 (Wilson et al. 2007). On average, 
and assuming a stable mortality decline over time, this translates to an increase of 0.22 and 
0.38 years per year for males and females respectively, over the 38-year period. This is within 
the same range of the increase that has been observed for the total Australian population 
(although with a different sex ratio), which was 0.33 and 0.22 years per year for males and 
females respectively over the past 10 years (Begg et al. 2007). It is worthwhile noting that 
despite this increase in life expectancy at birth over time for Indigenous people residing in 
the Northern Territory, the disparity in life expectancy compared with the total Australian 
population remained substantial: 15.2 years for females, and 17.7 years for males (Wilson et 
al. 2007).  
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3 Estimating non-fatal burden of disease 
3.1 Background 
The disease and injury models for Indigenous Australians are based on the models 
developed for the National Study (Begg et al. 2007). This ensures consistent and meaningful 
comparisons between the Indigenous and the total Australian population. The Indigenous-
specific epidemiological information required to complete the disease models were derived 
using similar methods to the pilot Northern Territory study (Zhao et al. 2004). 
3.1.1 The burden of disease and injury in Australia, 2003 
The National Study developed internally consistent measures of incidence, prevalence, 
remission, mortality and duration for more than 170 diseases and injuries that describe the 
health status of the total Australian population, 2003 (Begg et al. 2007).. These models were 
based on a critical examination of Australian data sources, including disease registers, 
surveillance systems, notification systems, vital registration systems, health service use data, 
population health surveys and epidemiological studies. If Australian data sources were few 
or absent, international epidemiological studies were used to inform estimates (e.g. 
dementia) and expert opinion was sought to validate assumptions. A small number of ‘other’ 
categories were estimated indirectly based on the YLL to YLD ratio from the rest of the 
disease category. For further explanation, we encourage readers to refer to Annex Table 2 
(which summarises the primary data sources for incidence and prevalence) and Appendix 1 
(which discusses each of the models in detail) in the National Study (Begg et al. 2007).  
3.1.2 Burden of disease and injury in the Northern Territory 
The Northern Territory study estimated disease and injury models for Indigenous and non-
Indigenous populations using multiple sources. These sources included observed events 
based on Northern Territory surveillance systems, disease registries and local 
epidemiological studies (for 36% of YLD), relativities based on Northern Territory hospital 
data (29% of YLD), and by assuming the national ‘average’ when there was no available 
evidence to suggest otherwise (36% of YLD) (Zhao et al. 2004).  
3.2 Methods for calculating YLD 
We undertook a comprehensive literature review to identify all potential data sources for 
calculating YLD for Indigenous Australians. Due to the lack of available data, for the 
majority of disease models we concentrated on estimating incidence or prevalence and 
defaulted to using the same assumptions for remission, relative risk of mortality and the 
proportion of time symptomatic. We estimated the disease occurrence for Indigenous 
Australians by using observed health events (rates or proportions) and/or applying 
differentials (rate ratios) in health events to the disease models developed for the National 
Study (Begg et al. 2007). Data sources for disease occurrence included routine data 
collections (such as Australian perinatal collection data, notification data, mortality data and 
hospital data) (covering 53% of YLD); self-report and measured population health surveys 
(28% of YLD), and epidemiological studies that identified Indigenous Australians (3% of 
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YLD) (Table 3.1). For a number of conditions, we assumed the same disease occurrence as 
the National Study because of the lack of data to suggest otherwise (concerning 10% of YLD). 
Finally, in keeping with the National Study, to estimate rest categories (such as ‘other 
cancers’), we applied a ratio of YLL to YLD from the rest of the disease category to the YLL 
for the disease in question (6% of YLD). We encourage readers to refer to Annex Table 1 for a 
summary of the primary data sources for incidence and prevalence; and Appendix C for a 
summary of each of the explicit disease models. 
Table 3.1: Principal source of YLD estimates by percent of total YLD 
Source YLD 
Per cent of 
total YLD 
Disease registers, surveillance, notification & vital registration systems 1,880 4 
Health service utilisation data 21,895 49 
Population health surveys 12,510 28 
Epidemiological studies 1,362 3 
Indirect estimation 2,477 6 
Assume same incidence as the total Australian population 4,378 10 
 
3.3 Precision of estimates  
The precision of the YLD estimates is not quantifiable in the usual statistical sense of 
deriving a confidence interval, because of the diversity of the data sources and the methods 
used (Zhao et al. 2004).  
There are a number of areas of uncertainty in YLD estimation for Indigenous Australians. As 
already mentioned, the accurate identification of Indigenous people in health data collections 
is a challenging issue. In the previous chapter, we highlighted the use of an indirect 
demographic method to adjust the observed mortality rates to give more plausible mortality 
rates for Indigenous Australians for the purpose of this study. Similarly, we adjusted the 
Australian hospital data (AIHW 2003b) for under-identification of Indigenous people by 
state and remoteness using a method developed by the AIHW for their Expenditures on health 
for Aboriginal and Torres Strait Islander peoples, 2001–02 report (AIHW 2005b). Broadly, this 
approach involves applying correction factors by jurisdiction and remoteness across 
diseases, age and sex. These correction factors were derived by the AIHW, in part, from 
jurisdictional studies on the quality of Indigenous identification in hospitals. For more 
information on this method, see Appendix B.  
The epidemiological information available for Indigenous Australians is limited (see Annex 
Table 2). Specifically, data sources allowing direct measurement of disease parameters for 
Indigenous Australians are few; often not representative for all Indigenous Australians; 
and/or for a different time period.  
In addition to data identification issues and gaps in the literature, when judging the quality 
of the burden of disease estimates for Indigenous Australians, it is also important to note that 
the quality of the data sources not only differ from each other but within the source by 
disease. For example, hospital data can be used reliably for estimating health events, such as 
injuries and maternal conditions, where hospital admission is an important part of managing 
these conditions. However, less confidence can be placed in using relativities based on 
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hospital data for conditions for which hospitalisation is only a small part of management 
(e.g. asthma, depression and anxiety, osteoarthritis).  
This brings us to the underlying assumption of the majority of the disease models: 
relativities based on health events and self-report population health surveys between the 
Indigenous population and the non-Indigenous or total Australian populations reflect actual 
differentials in disease occurrence. The consistency we observed in gradients of several 
indirect sources for non-fatal outcomes with those found in mortality and population health 
survey data added credibility to use of relativities. However, for a number of conditions we 
were unable to triangulate data sources (e.g. Alzheimer and other dementias, Parkinson’s 
disease and migraine). For these conditions, we assumed the same disease occurrence as the 
total Australian population. For conditions such as adult-onset hearing loss, for which there 
is considerable uncertainty around the national estimates, the accuracy of the Indigenous-
specific estimates will be affected even more. We encourage the reader to refer to Annex 
Table 2 (‘Assessment of quality of disease occurrence information for the main disabling 
conditions in the Indigenous population’) and Section 7.3 (‘Precision of estimates’) in the 
National Study for a discussion of these issues (Begg et al. 2007).  
Petrol sniffing is a substance use disorder that causes devastating health and social 
consequences for Indigenous Australian young people and their communities. 
Unfortunately, we were unable to model the disability related to petrol sniffing as a distinct 
substance disorder category because of the problems estimating the prevalence of this 
condition and the uncertainty about the exact nature of long-term harms. According to the 
literature, the number of Indigenous people who sniff petrol in Australia and in individual 
communities has fluctuated considerably over time; petrol sniffing does not occur in all 
Indigenous communities, and occurs in ‘waves’ in some regions, depending on the time of 
year (Gray et al. 2004). Furthermore, the increasing uptake of non-sniffable petrols, such as 
‘Avgas’ and ‘Opal’ in remote areas in recent years also hinders the use of estimates from 
older studies.  
It is clear from the considerations above that there is great scope for refining the models as 
appropriate data becomes available. Notwithstanding these qualifications, we consider this 
study to make the most comprehensive and critical use of health information for Indigenous 
Australians to date. Furthermore, we anticipate that the data gaps and deficiencies identified 
in this study will contribute to setting priorities for improving health information.  
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4 Burden of disease and injury in 
Indigenous Australians 
4.1 Overview 
This chapter presents the 2003 burden of disease and injury in Indigenous Australians, with 
comparisons to the results for the total Australian population. This chapter discusses the 
overall burden, fatal and non-fatal burden, and burden by the six leading broad cause 
categories: cardiovascular disease, mental disorders, intentional and unintentional injuries 
combined, chronic respiratory disease, diabetes mellitus, and cancers. Because the 
Indigenous Australian population is younger than the total Australian population overall 
rates comparing these groups are age standardised.  
4.2 Disability-adjusted life years 
In 2003, the Indigenous Australian population made up 2.4% of the total Australian 
population but, despite its much younger structure, carried 3.6% of the total Australian 
population disease burden.  
The majority of the absolute burden (number of DALYs) for Indigenous Australians occurred 
in the middle-aged population with a significant peak also occurring in the very young 
(Figure 4.1). In the total Australian population, the absolute burden continued to increase 
into old age for females, while for males there was a steady increase peaking at age 70–
74 years. 
The rate of burden, in DALYs, peaked in both Indigenous Australians and the total 
Australian population in the very young, followed by a sharp drop then a steady rise to old 
age (Figure 4.1). In the Indigenous Australian population, the rate of burden increased at a 
much younger age than for the total Australian population. The rate of burden also occurred 
at a considerably higher rate at each age for Indigenous Australians compared with the total 
Australian population.  
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Figure 4.1: DALYs by age and sex expressed as rates and numbers, Indigenous Australian and total 
Australian populations, 2003 
Cardiovascular disease and mental disorders were the leading causes of burden in the 
Indigenous Australian population in 2003 (Figure 4.2). These two broad cause groups 
together accounted for 32% of the Indigenous disease burden. Chronic respiratory disease, 
diabetes mellitus, and cancers were the next three leading causes, accounting for an 
approximately equal proportion of the disease burden at 8% each.  
Cancer was responsible for a greater proportion of the burden in the total Australian 
population (19%) than the Indigenous population (8%) (Figure 4.2). Diabetes, and 
unintentional and intentional injuries were each responsible for a larger proportion of the 
burden in Indigenous Australians than in the total Australian population. 
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Figure 4.2: DALY by broad cause group, Indigenous Australian and total Australian populations, 
2003 
There was a reversal in the sex ratios of the burden due to diabetes mellitus and cancers 
between the total Australian and Indigenous Australian populations, with the majority of the 
experienced by females in the Indigenous population (Figure 4.3).  
A greater proportion of the Indigenous burden was due to premature mortality compared 
with the total Australian population (Figure 4.3). For five of the seven leading disease 
groups, the share of the burden caused by mortality was higher in Indigenous people. 
Meanwhile a greater proportion of the burden from intentional injuries was due to non-fatal 
disability whereas the proportion of non-fatal disability for cardiovascular disease was 
similar for the two populations.  
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Figure 4.3: DALYs by broad cause group expressed as proportions by sex, and proportions due to 
fatal and non-fatal outcomes, Indigenous Australian and total Australian populations, 2003 
Among the top seven broad cause categories contributing to Indigenous burden, the largest 
differentials in disease burden rates for the Indigenous and total Australian population were 
for cardiovascular disease, diabetes mellitus, and intentional injuries in both males and 
females (Figure 4.4).  
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Figure 4.4: DALY rate per 1,000 and rate ratios for the leading broad cause groups by sex, 
Indigenous Australian and total Australian populations, 2003 
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Ischaemic heart disease was the largest single contributor to the disease burden experienced 
by Indigenous males, accounting for 11.8% of the total Indigenous male burden (Table 4.1). 
Type 2 diabetes, anxiety & depression, suicide, and RTAs were the next four leading causes 
of male burden, together accounting for 21.9% of the male Indigenous burden. For females, 
the leading cause of burden was anxiety & depression, causing 10.0% of the total Indigenous 
female burden. Type 2 diabetes, ischaemic heart disease, asthma, and COPD were the next 
four leading causes, accounting for 26.2% of the female Indigenous burden. 
Table 4.1: Leading causes of DALYs by sex, Indigenous Australians, 2003 
 Males Females 
Rank Condition DALY
Per cent 
of total Condition DALY 
Per cent 
of total
 All causes 50,107 100.0  All causes 45,869 100.0
1 Ischaemic heart disease 5,899 11.8  Anxiety & depression 4,582 10.0
2 Type 2 diabetes 3,520 7.0  Type 2 diabetes 4,361 9.5
3 Anxiety & depression 2,864 5.7  Ischaemic heart disease 4,074 8.9
4 Suicide 2,644 5.3  Asthma 1,907 4.2
5 Road traffic accidents 1,955 3.9  COPD 1,678 3.7
6 COPD 1,941 3.9  Stroke 1,413 3.1
7 Alcohol dependence & harmful use 1,797 3.6  Road traffic accidents 1,074 2.3
8 Asthma 1,396 2.8  Alcohol dependence & harmful use 1,008 2.2
9 Stroke 1,293 2.6  Lung cancer 945 2.1
10 Homicide & violence 1,102 2.2  Homicide & violence 854 1.9
11 Low birth weight 1,001 2.0  Low birth weight 808 1.8
12 Lung cancer 995 2.0  Pneumonia 798 1.7
13 Pneumonia 878 1.8  Suicide 795 1.7
14 Inflammatory heart disease 799 1.6  Breast cancer 719 1.6
15 Heroin or polydrug dependence 771 1.5  Rheumatic heart disease 660 1.4
16 Schizophrenia 695 1.4  Deficiency anaemia 626 1.4
17 Epilepsy 616 1.2  Schizophrenia 558 1.2
18 Hepatitis 590 1.2  Otitis media 505 1.1
19 Birth trauma & asphyxia 538 1.1  Heroin or polydrug dependence 453 1.0
20 Otitis media 516 1.0  STDs (not HIV/AIDS) 450 1.0
 
The top 20 causes of burden in Indigenous Australians, and the corresponding ranks for the 
total Australian population, revealed differences in the distribution of cause of burden in the 
two populations (Table 4.2). For Indigenous Australian males, otitis media, homicide & 
violence, birth trauma & asphyxia, and low birth weight were ranked at least 20 places 
higher than in the total Australian population. For females, sexually transmitted diseases, 
homicide & violence, otitis media, and rheumatic heart disease showed the largest shift in 
rank. 
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Table 4.2: Rank of leading causes of DALYs, Indigenous Australian and total Australian 
populations, 2003  
Males  Females 
Condition 
Indigenous 
Australian 
Total 
Australian  Condition 
Indigenous 
Australian 
Total 
Australian 
Ischaemic heart disease 1 1  Anxiety & depression 1 1 
Type 2 diabetes 2 2  Type 2 diabetes 2 4 
Anxiety & depression 3 3  Ischaemic heart disease 3 2 
Suicide 4 8  Asthma 4 9 
Road traffic accidents 5 12  COPD 5 7 
COPD 6 6  Stroke 6 3 
Alcohol dependence & harmful 
use 7 14  Road traffic accidents 7 22 
Asthma 8 13  
Alcohol dependence & harmful 
use 8 34 
Stroke 9 5  Lung cancer 9 8 
Homicide & violence 10 46  Homicide & violence 10 75 
Low birth weight 11 37  Low birth weight 11 33 
Lung cancer 12 4  Pneumonia 12 16 
Pneumonia 13 21  Suicide 13 24 
Inflammatory heart disease 14 32  Breast cancer 14 6 
Heroin or polydrug dependence 15 24  Rheumatic heart disease 15 74 
Schizophrenia 16 16  Deficiency anaemia 16 52 
Epilepsy 17 36  Schizophrenia 17 19 
Hepatitis 18 23  Otitis media 18 81 
Birth trauma & asphyxia 19 54  Heroin or polydrug dependence 19 55 
Otitis media 20 81  STDs (not HIV/AIDS) 20 86 
 
Among the 20 conditions that caused the greatest burden in Indigenous Australians, the 
largest differentials in burden rate between Indigenous and total Australian population 
males were for homicide & violence, inflammatory heart disease, and lower respiratory tract 
infection (Table 4.3). For females, the largest differentials were for rheumatic heart disease, 
homicide & violence, and alcohol dependence & harmful use. 
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Table 4.3: Rate per 1,000 and rate ratio of top 20 leading causes of DALYs, Indigenous Australian 
and total Australian populations, 2003 
 Males Females 
Rank Condition 
Indigenous 
Australian 
Total 
Australian(a) RR(b)  Condition 
Indigenous 
Australian 
Total 
Australian(a) RR(b)
 All causes  212.4 87.6 2.4  All causes  191.5 78.0 2.5
1 
Ischaemic heart 
disease 25.0 4.9 5.1  Anxiety & depression 19.1 13.9 1.4
2 Type 2 diabetes 14.9 3.2 4.6  Type 2 diabetes 18.2 2.9 6.3
3 Anxiety & depression 12.1 7.3 1.7  
Ischaemic heart 
disease 17.0 2.6 6.6
4 Suicide 11.2 3.4 3.3  Asthma 8.0 4.8 1.7
5 Road traffic accidents 8.3 3.3 2.5  COPD 7.0 1.4 4.9
6 COPD 8.2 1.9 4.3  Stroke 5.9 1.9 3.1
7 
Alcohol dependence 
& harmful use 7.6 2.1 3.7  Road traffic accidents 4.5 1.2 3.7
8 Asthma 5.9 4.8 1.2  
Alcohol dependence & 
harmful use 4.2 0.5 7.9
9 Stroke 5.5 2.1 2.7  Lung cancer 3.9 1.2 3.3
10 Homicide & violence 4.7 0.7 6.8  Homicide & violence 3.6 0.3 11.0
11 Low birth weight 4.2 1.7 2.5  Low birth weight 3.4 1.5 2.3
12 Lung cancer 4.2 1.7 2.4  Pneumonia 3.3 0.5 6.8
13 Pneumonia 3.7 0.6 6.1  Suicide 3.3 1.0 3.3
14 
Inflammatory heart 
disease 3.4 0.5 6.3  Breast cancer 3.0 2.9 1.0
15 
Heroin or polydrug 
dependence 3.3 1.4 2.3  
Rheumatic heart 
disease 2.8 0.1 26.4
16 Schizophrenia 2.9 1.8 1.6  Deficiency anaemia 2.6 0.4 6.2
17 Epilepsy 2.6 1.1 2.4  Schizophrenia 2.3 1.3 1.7
18 Hepatitis 2.5 0.6 4.0  Otitis media 2.1 0.3 6.2
19 
Birth trauma & 
asphyxia 2.3 1.1 2.2  
Heroin or polydrug 
dependence 1.9 0.5 3.7
20 Otitis media 2.2 0.4 5.4  STDs (not HIV/AIDS) 1.9 0.2 9.2
(a) Age standardised to the total Indigenous Australian population, 2003  
(b) Indigenous Australian to total Australian rate ratio 
Other conditions that occur at a much higher rate in the Indigenous Australian population, 
but are not among the leading contributors to Indigenous burden of disease include: 
trachoma, which we assume only occurs in Indigenous Australians residing in remote areas; 
rheumatic heart disease (Indigenous to total Australian RR 23.2 in males and 26.4 in females); 
sexually transmitted diseases (male RR 11.6, female RR 9.2); non-hepatitis liver cancer (male 
RR 5.5, female RR 6.7); septicaemia (male RR 7.3, female RR 7.9); sudden infant death 
syndrome (male RR 5.7, female RR 7.3); deficiency anaemia (male RR 7.5, female RR 6.2); and 
pancreatitis (male RR 11.4, female RR 4.7). 
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4.3 Years of life lost 
Years of life lost (YLL), or fatal burden, accounted for 54% of the total Indigenous Australian 
disease burden in 2003 (Figure 4.3). This was higher than the total Australian population 
where 49% of total burden was due to mortality. The bulk of the absolute fatal burden 
occurred in the very young and middle ages for Indigenous Australians (Figure 4.5), in part 
reflecting the younger age structure of the population. At every age, the Indigenous 
Australian rate of fatal burden was higher than that of the total Australian population.  
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Figure 4.5: YLL by age and sex expressed as rates, and numbers, Indigenous Australian and total 
Australian populations, 2003 
Ischaemic heart disease was the largest disease or injury category contributing to Indigenous 
Australian fatal burden (Table 4.4). The second leading cause was suicide for males and Type 
2 diabetes for females. Road traffic injury was the third leading cause of fatal burden for 
males and females. 
The ranking of suicide in Indigenous males and females (second and seventh respectively) 
was considerably higher than that for Australian males and females (seventh and twenty-
third, respectively). This was partly due to the younger age structure of the Indigenous 
Australian population, but particularly due to the increased incidence of suicide in the 
Indigenous Australian population, where it occurred at around three times the total 
Australian rate. 
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Table 4.4: Leading causes of YLL by sex, Indigenous Australians, 2003 
  Males  Females 
Rank Condition YLL
Per cent 
of total  Condition YLL
Per cent 
of total
 All Causes 28,904 100.0  All Causes 22,571 100.0
1 Ischaemic heart disease 5,026 17.4  Ischaemic heart disease 2,995 13.3
2 Suicide 2,628 9.1  Type 2 diabetes 1,735 7.7
3 Road traffic accidents 1,786 6.2  Road traffic accidents 1,008 4.5
4 Type 2 diabetes 1,336 4.6  Stroke 932 4.1
5 Alcohol dependence & harmful use 1,125 3.9  Lung cancer 923 4.1
6 Lung cancer 971 3.4  COPD 807 3.6
7 Stroke 899 3.1  Suicide 783 3.5
8 COPD 864 3.0  Alcohol dependence & harmful use 758 3.4
9 Homicide & violence 802 2.8  Breast cancer 641 2.8
10 Pneumonia 711 2.5  Pneumonia 618 2.7
11 Inflammatory heart disease 584 2.0  Homicide & violence 561 2.5
12 Low birth weight 584 2.0  Low birth weight 509 2.3
13 Hepatitis 546 1.9  Rheumatic heart disease 455 2.0
14 Epilepsy 469 1.6  Hepatitis 389 1.7
15 SIDS 413 1.4  SIDS 342 1.5
16 Suffocation & foreign bodies 402 1.4  Nephritis & nephrosis 333 1.5
17 Nephritis & nephrosis 297 1.0  Cervical cancer 323 1.4
18 Drowning 290 1.0  Colorectal cancer 290 1.3
19 Poisoning 280 1.0  Inflammatory heart disease 271 1.2
20 Oesophagus cancer 277 1.0  Poisoning 250 1.1
 
Indigenous Australians experienced a higher rate of fatal burden for all 20 leading conditions 
compared with the total Australian population (Table 4.5). The Indigenous fatal burden rate 
was at least double that seen in the total Australian population for all 20 leading fatal 
conditions in males, and 18 of the top 20 conditions in females. The ratio of the Indigenous 
population to the total Australian population rates was largest for Type 2 diabetes for both 
males and females (RR 12.8 males; RR 24.5 females). Indigenous females also experienced a 
much higher rate of fatal burden from rheumatic heart disease, and alcohol dependence & 
harmful use compared with the total Australian female population.  
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Table 4.5: Rate per 1,000 and rate ratio of top 20 leading causes of YLL, Indigenous Australian and 
total Australian populations, 2003 
  Males  Females 
Rank Condition 
Indigenous 
Australian 
Total 
Australian(a) RR(b)  Condition 
Indigenous 
Australian 
Total 
Australian(a) RR(b)
 All causes  122.5 34.9 3.5  All causes  94.3 23.3 4.1
1 
Ischaemic heart 
disease 21.3 4.1 5.2  
Ischaemic heart 
disease 12.5 1.8 6.8
2 Suicide 11.1 3.4 3.3  Type 2 diabetes 7.2 0.3 24.5
3 Road traffic accidents 7.6 2.8 2.7  Road traffic accidents 4.2 1.0 4.2
4 Type 2 diabetes 5.7 0.4 12.8  Stroke 3.9 1.1 3.7
5 
Alcohol dependence & 
harmful use 4.8 0.6 8.4  Lung cancer 3.9 1.1 3.5
6 Lung cancer 4.1 1.6 2.5  COPD 3.4 0.6 6.0
7 Stroke 3.8 1.0 3.7  Suicide  3.3 1.0 3.4
8 COPD 3.7 0.7 5.3  
Alcohol dependence & 
harmful use 3.2 0.2 20.7
9 Homicide & violence 3.4 0.5 7.1  Breast cancer 2.7 1.8 1.5
10 Pneumonia 3.0 0.4 7.0  Pneumonia 2.6 0.3 8.0
11 
Inflammatory heart 
disease 2.5 0.4 5.8  Homicide & violence 2.3 0.2 9.6
12 Low birth weight 2.5 1.0 2.5  Low birth weight 2.1 0.8 2.8
13 Hepatitis 2.3 0.6 3.9  
Rheumatic heart 
disease 1.9 0.1 24.4
14 Epilepsy 2.0 0.3 5.8  Hepatitis 1.6 0.3 5.4
15 SIDS 1.8 0.3 5.7  SIDS 1.4 0.2 7.3
16 
Suffocation & foreign 
bodies 1.7 0.3 5.0  Nephritis & nephrosis 1.4 0.2 6.5
17 Nephritis & nephrosis 1.3 0.3 4.9  Cervical cancer 1.3 0.2 5.7
18 Drowning 1.2 0.4 3.3  Colorectal cancer 1.2 0.8 1.5
19 Poisoning 1.2 0.6 2.0  
Inflammatory heart 
disease 1.1 0.2 5.4
20 Oesophagus cancer 1.2 0.3 3.5  Poisoning 1.0 0.3 3.3
(a) Age standardised to the total Indigenous Australian population, 2003 
(b) Indigenous Australian to total Australian rate ratio 
The leading causes of death were similar to the leading causes of fatal burden (Table 4.6). 
However, where the condition was dominated by mortality in the younger ages, the YLL per 
death was higher than for a condition that primarily affects older people (i.e. a death at a 
young age is more heavily weighted than a death in old age). For example, the YLL rate was 
higher in Indigenous males for RTAs than for Type 2 diabetes (Table 4.65) despite there 
being more deaths due to Type 2 diabetes (Table 4.6). 
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Table 4.6: Leading causes of death by sex, Indigenous Australians, 2003 
  Males   Females 
Rank Condition Deaths
Per cent of 
total   Condition Deaths 
Per cent of 
total
 All Causes 1,574 100.0  All Causes 1,296 100.0
1 Ischaemic heart disease 314 20.0   Ischaemic heart disease 213 16.4
2 Suicide 104 6.6   Type 2 diabetes 115 8.8
3 Type 2 diabetes 85 5.4   Stroke 77 6.0
4 Road traffic accidents 72 4.6   Lung cancer 58 4.5
5 COPD 71 4.5   COPD 57 4.4
6 Stroke 71 4.5   Road traffic accidents 39 3.0
7 Lung cancer 68 4.3   Breast cancer 37 2.9
8 
Alcohol dependence & harmful 
use 59 3.7   Pneumonia 37 2.8
9 Pneumonia 40 2.5   
Alcohol dependence & 
harmful use 35 2.7
10 Homicide & violence 32 2.0   Suicide 29 2.2
11 Inflammatory heart disease 29 1.8   Nephritis & nephrosis 25 1.9
12 Hepatitis 28 1.8   Homicide & violence 21 1.6
13 Epilepsy 21 1.3   Rheumatic heart disease 21 1.6
14 Nephritis & nephrosis 20 1.3   Dementia 20 1.6
15 Low birth weight 19 1.2   Hepatitis 19 1.5
16 Oesophagus cancer 19 1.2   Cervical cancer 18 1.4
17 Colorectal cancer 17 1.1   Colorectal cancer 17 1.3
18 Mouth cancers 17 1.1   Low birth weight 17 1.3
19 Prostate cancer 16 1.0   Type 1 diabetes 15 1.2
20 Suffocation & foreign bodies 16 1.0   Inflammatory heart disease 14 1.1
 
A comparison of the mortality rates between the Indigenous and total Australian 
populations for the top 20 leading conditions showed a similar pattern as that described 
above for YLL rates (Table 4.7). 
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Table 4.7: Mortality rate per 10,000 and rate ratio of top 20 leading causes, Indigenous Australian 
and total Australian populations, 2003  
  Males  Females 
Rank Condition 
Indigenous 
Australian 
Total 
Australian(a) RR(b)  Condition 
Indigenous 
Australian 
Total 
Australian(a) RR(b)
 All causes  66.7 21.5 3.1  All causes  54.1 14.2 3.8
1 Ischaemic heart disease 13.3 3.6 3.7  Ischaemic heart disease 8.9 1.8 5.0
2 Suicide 4.4 1.4 3.1  Type 2 diabetes 4.8 0.3 18.9
3 Type 2 diabetes 3.6 0.4 9.2  Stroke 3.2 1.0 3.3
4 Road traffic accidents 3.0 1.1 2.8  Lung cancer 2.4 0.7 3.2
5 COPD 3.0 0.7 4.4  COPD 2.4 0.5 5.2
6 Stroke 3.0 1.0 2.9  Road traffic accidents 1.6 0.4 4.2
7 Lung cancer 2.9 1.3 2.3  Breast cancer 1.6 1.0 1.5
8 
Alcohol dependence & 
harmful use 2.5 0.3 8.0  Pneumonia 1.5 0.2 6.1
9 Pneumonia 1.7 0.4 4.5  
Alcohol dependence & 
harmful use 1.5 0.1 18.7
10 Homicide & violence 1.3 0.2 7.2  Suicide 1.2 0.4 3.1
11 
Inflammatory heart 
disease 1.2 0.2 5.1  Nephritis & nephrosis 1.0 0.2 5.4
12 Hepatitis 1.2 0.3 3.4  Homicide & violence 0.9 0.1 10.0
13 Epilepsy 0.9 0.1 6.3  
Rheumatic heart 
disease 0.9 0.0 18.3
14 Nephritis & nephrosis 0.9 0.3 3.1  Dementia 0.8 0.3 3.0
15 Low birth weight 0.8 0.3 2.5  Hepatitis 0.8 0.2 4.7
16 Oesophagus cancer 0.8 0.2 3.4  Cervical cancer 0.7 0.1 6.1
17 Colorectal cancer 0.7 0.7 1.0  Colorectal cancer 0.7 0.6 1.3
18 Mouth cancers 0.7 0.2 4.1  Low birth weight 0.7 0.2 2.8
19 Prostate cancer 0.7 0.6 1.1  Type 1 diabetes 0.6 0.1 10.2
20 
Suffocation & foreign 
bodies 0.7 0.1 4.7  
Inflammatory heart 
disease 0.6 0.1 5.1
(a) Age standardised to the total Indigenous Australian population, 2003  
(b) Indigenous Australian to total Australian rate ratio 
4.4 Years lived with disability 
Years lived with disability (YLD), or non-fatal burden, is typically the number of years of 
healthy life lost due to disability accrued into the future from incident cases of disease in the 
base year. An alternative method uses prevalent cases. Prevalent non-fatal burden (PYLD) is 
interpreted as the number of years of life lost due to disability currently experienced by a 
population. This cannot be added to fatal burden to derive total burden in the same way as 
incident non-fatal burden. Both methods of calculating non-fatal burden are presented 
below. For all the other sections of this study, references to non-fatal burden reflect incident 
non-fatal burden unless otherwise specified. 
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4.4.1 Incident YLD 
Incident YLD accounted for 46% of total Indigenous Australian disease burden (Figure 4.3). 
The absolute non-fatal burden peaked in young adulthood for Indigenous Australians, 
dropping off considerably after 40 years of age (Figure 4.6). For Australian females, absolute 
non-fatal burden peaked in young adulthood and was reasonably steady to old age. For 
males, there were peaks in young adulthood, then a decline and steady rise through the 
middle ages, before the absolute non-fatal burden decreased in the oldest ages. Again, while 
the absolute number of YLD was considerably smaller for Indigenous Australians compared 
with the total Australian population, the DALY rate was higher at every age. 
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Figure 4.6: Incident YLD by age and sex expressed as rates, and numbers, Indigenous Australian 
and total Australian populations, 2003 
Anxiety & depression, Type 2 diabetes, and asthma were the leading causes of incident non-
fatal burden for male and female Indigenous Australians (Table 4.8). The top five conditions 
accounted for 38.9% and 46.7% of male and female non-fatal burden respectively. 
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Table 4.8: Leading causes of incident YLD by sex, Indigenous Australians, 2003  
 Males  Females 
Rank Condition YLD
Per cent 
of total  Condition YLD 
Per cent 
of total
 All Causes 2,1202 100.0  All Causes 23,299 100.0
1 Anxiety & depression 2,855 13.5  Anxiety & depression 4,582 19.7
2 Type 2 diabetes 2,183 10.3  Type 2 diabetes 2,626 11.3
3 Asthma 1,262 6.0  Asthma 1,718 7.4
4 COPD 1,077 5.1  Ischaemic heart disease 1,080 4.6
5 Ischaemic heart disease 872 4.1  COPD 872 3.7
6 Schizophrenia 695 3.3  Deficiency anaemia 619 2.7
7 Alcohol dependence & harmful use 672 3.2  Schizophrenia 558 2.4
8 Otitis media 515 2.4  Otitis media 493 2.1
9 Heroin or polydrug dependence 512 2.4  Stroke 481 2.1
10 Low birth weight 417 2.0  Migraine 426 1.8
11 Stroke 394 1.9  Dental caries 405 1.7
12 Dental caries 388 1.8  STDs (not HIV/AIDS) 373 1.6
13 Adult-onset hearing loss 370 1.7  Personality disorders 309 1.3
14 ADHD 324 1.5  Low birth weight 299 1.3
15 Birth trauma & asphyxia 316 1.5  Homicide & violence 293 1.3
16 Personality disorders 307 1.4  Heroin or polydrug dependence  264 1.1
17 Homicide & violence 300 1.4  Peripheral vascular disease 263 1.1
18 Neonatal infections 285 1.3  Alcohol dependence & harmful use 250 1.1
19 Peripheral vascular disease 280 1.3  Infertility 211 0.9
20 Cannabis dependence  243 1.1  Back pain 210 0.9
 
For most of the top 20 leading causes of the Indigenous Australian non-fatal burden, 
Indigenous Australians experienced a higher rate than the total Australian population (Table 
4.9). Both male and female Indigenous Australians experienced a much higher rate of non-
fatal burden from homicide & violence (RR 6.1 males; RR 15.5 females), and ischaemic heart 
disease (RR 5.0 males; RR 6.2 females) compared with the total Australian population.  
Burden of disease and injury in Indigenous Australians 
41 
Table 4.9: Rate per 1,000 and rate ratio of top 20 leading causes of incident YLD, Indigenous 
Australian and total Australian populations, 2003 
  Males  Females 
Rank Condition 
Indigenous 
Australian 
Total 
Australian(a) RR(b)  Condition 
Indigenous 
Australian 
Total 
Australian(a) RR(b)
 All causes  89.9 52.7 1.7  All causes  97.3 54.7 1.8
1 Anxiety & depression 12.1 7.3 1.7  Anxiety & depression 19.1 13.9 1.4
2 Type 2 diabetes 9.3 2.8 3.3  Type 2 diabetes 11.0 2.6 4.2
3 Asthma 5.4 4.7 1.1  Asthma 7.2 4.7 1.5
4 COPD 4.6 1.2 3.7  
Ischaemic heart 
disease 4.5 0.7 6.2
5 
Ischaemic heart 
disease 3.7 0.7 5.0  COPD 3.6 0.9 4.1
6 Schizophrenia 2.9 1.8 1.6  Deficiency anaemia 2.6 0.4 6.2
7 
Alcohol dependence & 
harmful use 2.8 1.5 1.9  Schizophrenia 2.3 1.3 1.7
8 Otitis media 2.2 0.4 5.5  Otitis media 2.1 0.3 6.1
9 
Heroin or polydrug 
dependence  2.2 0.9 2.4  Stroke 2.0 0.9 2.3
10 Low birth weight 1.8 0.7 2.5  Migraine 1.8 1.9 0.9
11 Stroke 1.7 1.0 1.6  Dental caries 1.7 0.5 3.1
12 Dental caries 1.6 0.5 3.1  STDs (not HIV/AIDS) 1.6 0.2 8.2
13 
Adult-onset hearing 
loss 1.6 1.7 0.9  Personality disorders 1.3 1.3 1.0
14 ADHD 1.4 1.4 1.0  Low birth weight 1.2 0.7 1.8
15 
Birth trauma & 
asphyxia 1.3 0.6 2.1  Homicide & violence 1.2 0.1 15.5
16 Personality disorders 1.3 1.4 1.0  
Heroin or polydrug 
dependence  1.1 0.3 3.2
17 Homicide & violence 1.3 0.2 6.1  
Peripheral vascular 
disease 1.1 0.2 5.6
18 Neonatal infections 1.2 0.3 4.8  
Alcohol dependence 
& harmful use 1.0 0.4 2.7
19 
Peripheral vascular 
disease 1.2 0.3 3.9  Infertility 0.9 0.9 1.0
20 Cannabis dependence  1.0 0.5 1.9  Back pain 0.9 0.9 0.9
(a) Age standardised to the total Indigenous Australian population, 2003 
(b) Indigenous Australian to total Australian rate ratio 
4.4.2 Prevalent YLD 
The difference between prevalent and incident non-fatal burden was most apparent for 
childhood conditions (e.g. asthma and congenital disorders), and for chronic mental 
disorders (the incidence of which peaks in childhood and early adulthood). Incident non-
fatal burden at these life stages was much larger compared with prevalent non-fatal burden, 
because most incident cases of chronic conditions at young ages were expected to remain 
prevalent cases at older ages. This explained the shift to the right in the figures of prevalent 
non-fatal burden (Figure 4.7) compared with incident non-fatal burden (Figure 4.6). 
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Figure 4.7: Prevalent YLD by age and sex expressed as rates, and numbers, Indigenous Australian 
and total Australian populations, 2003 
4.5 Mortality and life expectancy 
Mortality in young and middle-aged Indigenous adults was particularly high (33% and 23% 
probability of dying between ages 15 and 60 years in males and females, respectively, 
compared with 10% and 6% in the total Australian population). A comparable high level of 
adult mortality is found in only a few countries in the world that are not severely affected by 
HIV/AIDS mortality. Under-five mortality in Indigenous Australians was also greater than 
that of the total Australian population but differences were less extreme than they were for 
adult mortality. The probability of dying before age 5 was 1.6% and 1.4% for males and 
females, respectively (compared with national figures of 0.7% and 0.6%). 
For the purpose of this report we estimated the life expectancy at birth in Indigenous 
Australians for the period 1996 to 2001 to be 64 years for males and 69 years for females, a 
gap of 12.5 and 13.5 years with life expectancy of the total Australian population, 
respectively. These life expectancy figures are higher than those reported by the ABS for the 
same period. There is a scientific debate about the validity of either set of estimates that can 
only be resolved when new and better data and methods become available. We have 
endeavoured to make our estimation process as available, transparent and as scientifically 
rigorous as possible, including having our work peer-reviewed internationally (Hill et al. 
2007), to help advance this very important area of Indigenous health. If the ABS mortality 
figures had been adopted, the total Indigenous population burden of disease estimates 
would have been greater (since the ABS estimates a larger gap in life expectancy for the total 
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Indigenous Australian population), with DALY rates comparable to those presented in 
chapter six for Indigenous people residing in remote areas. 
Table 4.10: Life expectancy at birth and probability of dying before age 5 and between ages 15 and 
60, Indigenous Australian and total Australian populations, 1996–2001  
  Life expectancy (years)  
Probability of dying 
before age 5  
Probability of dying 
between ages 15 and 60
Area Males Females  Males Females   Males Females
Indigenous Australian population 64 69  0.016 0.014   0.326 0.231
Total Australian population 77 82  0.007 0.006   0.101 0.057
4.6 Specific disease and injury categories 
This section discusses the seven leading broad cause categories in greater detail. These 
categories together accounted for more than 70% of the total disease burden, three-quarters 
of the fatal burden, and two-thirds of the non-fatal burden in Indigenous Australians (Table 
4.11). In this section, we discuss broad cause categories intentional and unintentional injuries 
together. 
Table 4.11: YLD, YLL and DALYs for top ten broad cause groups, Indigenous Australian 
population, 2003 
Rank Cause YLD 
Per cent 
of total 
 
YLL 
Per cent 
of total 
 
DALY 
Per cent 
of total 
  All causes 44,501 100.0  51,475 100.0  95,976 100.0 
1 Cardiovascular disease 4,214 9.5  12,573 24.4  16,786 17.5 
2 Mental disorders 12,335 27.7  2,525 4.9  14,860 15.5 
3 Chronic respiratory disease 5,816 13.1  2,771 5.4  8,587 8.9 
4 Diabetes 4,946 11.1  3,552 6.9  8,498 8.9 
5 Cancers 466 1.0  7,351 14.3  7,817 8.1 
6 Unintentional injuries 1,464 3.3  5,524 10.7  6,989 7.3 
7 Intentional injuries 622 1.4  4,774 9.3  5,395 5.6 
8 
Nervous system and sense organ 
disorders 2,629 5.9 
 
1,485 2.9 
 
4,114 4.3 
9 Neonatal causes 1,668 3.7  2,379 4.6  4,047 4.2 
10 Infectious and parasitic diseases 1,682 3.8  2,114 4.1  3,796 4.0 
  Other 8,660 19.5  6,427 12.5  15,087 15.7 
4.6.1 Cardiovascular disease 
Cardiovascular disease was the leading broad cause category, responsible for 17.5% of 
disease burden in Indigenous Australians in 2003 (Table 4.11). This was a similar proportion 
to that seen in the total Australian population (18.0%). Ischaemic heart disease and stroke 
dominated the cause group, accounting for more than three-quarters of the cardiovascular 
burden. Cardiovascular burden was largely fatal, with premature mortality causing 75% of 
the total burden (Figure 4.8). Males contributed to 55% of the total cardiovascular burden. 
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However, of the top four specific cardiovascular diseases, the burden of rheumatic heart 
disease is higher in females. 
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Figure 4.8: Cardiovascular disease DALYs by specific cause expressed as (a) proportions of total; (b) 
proportions by sex; (c) proportions due to fatal and non-fatal outcomes, Indigenous Australian 
population, 2003 
Ischaemic heart disease alone contributed to 10.4% of the total disease burden (Table 4.12). 
The cardiovascular burden was 4.6 times higher among Indigenous Australians than the 
total Australian population. At the disease level, the rate ratio was lowest for stroke, and 
highest for rheumatic heart disease. 
Table 4.12: Cardiovascular disease DALYs by specific cause, Indigenous Australian and total 
Australian populations, 2003 
  Indigenous Australian  Total Australian   
Cause DALY 
Per cent of 
total DALY
DALY rate 
per 1,000  DALY
Per cent of 
total DALY 
DALY rate 
per 1,000(a) RR(b)
Ischaemic heart disease 9,973 10.4 21.0  263,497 10.0 3.9 5.4
Stroke 2,706 2.8 5.7  118,462 4.5 2.1 2.8
Inflammatory heart disease 1,193 1.2 2.5  15,904 0.6 0.4 5.9
Rheumatic heart disease 984 1.0 2.1  4 ,091 0.2 0.1 25.1
Other 1,931 2.0 4.1  71,840 2.7 1.2 3.4
Total cardiovascular burden 16,786 17.5 35.3  473,794 18.0 7.6 4.6
(a) Age standardised to the total Indigenous Australian population, 2003  
(b) Indigenous Australian to total Australian rate ratio 
4.6.2 Mental disorders 
Mental disorders caused 15.5% of the total disease burden experienced by Indigenous 
Australians in 2003 (Table 4.11); with anxiety & depression, alcohol dependence & harmful 
use, and schizophrenia contributing more than three-quarters to this burden (Figure 4.9). 
Overall, the burden of mental disorders was equally distributed between males and females; 
however, anxiety & depression was more common in females, while males experienced more 
substance use and schizophrenia. More than 80% of the mental disorder burden was non-
(a) (b) (c) 
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fatal; although, the burden from alcohol dependence & harmful use had a large fatal 
component.  
The fatal component of the substance use categories only included those deaths directly 
coded to that use, thereby excluding, for example, injury deaths where alcohol was a 
contributing factor. In the risk factor analysis, we included all alcohol- and illicit drug-related 
deaths (see Chapter 5). 
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Figure 4.9: Mental disorder DALYs by specific cause expressed as (a) proportions of total; (b) 
proportions by sex; (c) proportions due to fatal and non-fatal outcomes, Indigenous Australian 
population, 2003 
The burden due to mental disorders occurred in Indigenous Australians at 1.6 times the rate 
of the total Australian population (Table 4.13); with alcohol dependence & harmful use 4.5 
times the total Australian population rate.  
Table 4.13: Mental disorder DALYs by specific cause, Indigenous Australian and total Australian 
populations, 2003 
  Indigenous Australian  Total Australian   
Cause DALY 
Per cent of 
total DALY
DALY rate 
per 1,000  DALY
Per cent of 
total DALY 
DALY rate 
per 1,000(a) RR(b)
Anxiety & depression 7,446 7.8 15.7  191,786 7.3 10.5 1.5
Alcohol abuse 2,805 2.9 5.9  34,116 1.3 1.3 4.5
Schizophrenia 1,253 1.3 2.6  27,502 1.0 1.6 1.7
Heroin or polydrug dependence 1,223 1.3 2.6  16,839 0.6 1.0 2.7
Other 2,133 2.2 4.5  80,303 3.1 5.2 0.9
Total mental disorder burden 14,860 15.5 31.3  350,545 13.3 19.6 1.6
(a) Age standardised to the total Indigenous Australian population, 2003  
(b) Indigenous Australian to total Australian rate ratio 
4.6.3 Injuries 
Together, intentional and unintentional injuries were the third leading broad cause of 
Indigenous Australian disease burden, causing 12.9% of total burden (5.6% and 7.3% 
respectively) (Table 4.11). In comparison, injuries were responsible for 7.0% of the disease 
burden in the total Australian population. Suicide, RTAs, and homicide & violence 
contributed to more than two-thirds of the Indigenous Australian injury burden (Figure 
(a) (b) (c) 
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4.10). Overall, injuries were much more common in males. However, homicide & violence 
had an almost equal distribution between the sexes. Among the top six specific injury 
categories, falls was the only category dominated by non-fatal burden, while 83% of the 
overall injury burden was due to mortality.  
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Figure 4.10: Injury DALYs by specific cause expressed as (a) proportions of total; (b) proportions by 
sex; (c) proportions due to fatal and non-fatal outcomes, Indigenous Australian population, 2003 
Overall, the injury burden rate was three times higher in Indigenous Australians compared 
with the total Australian population (Table 4.14); with homicide & violence 8.6 times the 
total Australian rate.  
Table 4.14: Injury DALYs by specific cause, Indigenous Australian and total Australian 
populations, 2003 
  Indigenous Australian Total Australian   
Cause DALY 
Per cent of 
total DALY
DALY rate 
per 1,000  DALY
Per cent of 
total DALY 
DALY rate 
per 1,000(a) RR(b)
Suicide 3,439 3.6 7.2  49,916 1.9 2.2 3.2
RTAs 3,030 3.2 6.4  42,425 1.6 2.3 2.8
Homicide & violence 1,956 2.0 4.1  9,221 0.4 0.5 8.1
Falls 655 0.7 1.4  26,386 1.0 0.8 1.7
Other 3,304 3.4 7.0  57,101 2.2 2.8 2.4
Total injury burden 12,384 12.9 26.1  185,050 7.0 8.6 3.0
(a) Age standardised to the total Indigenous Australian population, 2003  
(b) Indigenous Australian to total Australian rate ratio 
4.6.4 Chronic respiratory diseases 
Chronic respiratory diseases were responsible for 8.9% of the total disease burden in 
Indigenous Australians in 2003 (Table 4.11). Chronic obstructive pulmonary disease and 
asthma caused 43% and 38% of this burden respectively (Figure 4.11). Males experienced the 
majority of burden due to COPD, while females experienced the majority of asthma burden. 
The burden due to asthma was largely non-fatal, with mortality only contributing 10%. 
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Figure 4.11: Chronic respiratory disease DALYs by specific cause expressed as (a) proportions of 
total; (b) proportions by sex; (c) proportions due to fatal and non-fatal outcomes, Indigenous 
Australian population, 2003 
The burden from COPD and other chronic respiratory diseases occurred at a higher rate in 
Indigenous Australians than in the total Australian population (Table 4.15). The largest 
differentials occurred in COPD and other chronic respiratory diseases. 
Table 4.15: Chronic respiratory disease DALYs by specific cause, Indigenous Australian and total 
Australian populations, 2003 
  Indigenous Australian  Total Australian   
Cause DALY 
Per cent of 
total DALY
DALY rate 
per 1,000  DALY
Per cent of 
total DALY 
DALY rate 
per 1,000(a) RR(b)
COPD 3,619 3.8 7.6  86,751 3.3 1.7 4.5
Asthma 3,303 3.4 6.9  63,100 2.4 4.8 1.4
Other 1,664 1.7 3.5  36,887 1.4 0.6 5.8
Total chronic respiratory 
disease burden 8,587 8.9 18.1  186,737 7.1 7.1 2.5
(a) Age standardised to the total Indigenous Australian population, 2003  
(b) Indigenous Australian to total Australian rate ratio 
4.6.5 Diabetes 
Diabetes was responsible for 8.9% of the disease burden in Indigenous Australians in 2003 
(Table 4.11); with Type 2 diabetes accounting for 93% (Figure 4.12). Females experienced the 
majority of burden due to diabetes, and 58% of the burden was non-fatal. 
(a) (b) (c) 
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Figure 4.12: Diabetes DALYs by specific cause expressed as (a) proportions of total; (b) proportions 
by sex; (c) proportions due to fatal and non-fatal outcomes, Indigenous Australian population, 2003 
Overall, the burden due to diabetes occurred in Indigenous Australians at 5.1 times the rate 
experienced by the total Australian population (Table 4.16). While we have assumed a 
similar incidence of Type 1 diabetes in Indigenous and total Australian populations, the rate 
of burden is elevated by a factor three due to differences in YLL. This may reflect a higher 
case fatality of Type 1 diabetes in Indigenous Australians but may also be due to coding 
errors of Type 1 diabetes deaths. 
Table 4.16: Diabetes DALYs by specific cause, Indigenous Australian and total Australian 
populations, 2003 
  Indigenous Australian  Total Australian  
Cause DALY 
Per cent of 
total DALY
DALY rate 
per 1,000  DALY
Per cent of 
total DALY 
DALY rate 
per 1,000(a) RR(b)
Type 2 diabetes 7,880 8.2 16.6  132,940 5.0 3.1 5.4
Type 1 diabetes 618 0.6 1.3  10,891 0.4 0.4 3.0
Total diabetes burden 8,498 8.9 17.9  143,831 5.5 3.5 5.1
(a) Age standardised to the total Indigenous Australian population, 2003  
(b) Indigenous Australian to total Australian rate ratio 
4.5.6 Cancers 
Cancer was responsible for 8.1% of the total disease burden in Indigenous Australians in 
2003 (Table 4.11). This was considerably lower than the 19.7% seen in the total Australian 
population. Despite this, the rate of burden due to cancer was 1.7 times higher in the 
Indigenous population compared to the total Australian population (Table 4.17). Lung 
cancer, followed by breast cancer, contributed the most (Figure 4.13). Females experienced 
54% of the cancer burden; however, in the total Australian population, females experienced 
47% of the cancer burden. Almost 94% of the burden due to cancer in Indigenous Australians 
was due to mortality. 
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Figure 4.13: Cancer DALYs by specific cause expressed as (a) proportions of total; (b) proportions 
by sex; (c) proportions due to fatal and non-fatal outcomes, Indigenous Australian population, 2003 
The burden due to mouth & oropharynx cancer, and lung cancer among Indigenous 
Australians was 3.8 and 2.7 times as high as the total Australian population (Table 4.17).  
Table 4.17: Cancer DALYs by specific cause, Indigenous Australian and total Australian 
populations, 2003 
  Indigenous Australian  Total Australian   
Cause DALY 
Per cent of 
total DALY
DALY rate 
per 1,000  DALY
Per cent of 
total DALY 
DALY rate 
per 1,000(a) RR(b)
Lung cancer 1,940 2.0 4.1  88,904 3.4 1.5 2.7
Breast cancer 725 0.8 1.5  60,654 2.3 1.4 1.1
Colorectal cancer 601 0.6 1.3  63,605 2.4 1.1 1.1
Mouth & oropharynx cancers 530 0.6 1.1  13,464 0.5 0.3 3.8
Leukaemia 358 0.4 0.8  19,956 0.8 0.5 1.4
Other 3,663 3.8 7.7  252,833 9.6 5.0 1.5
Total cancer burden 7,817 8.1 16.4  499,416 19.0 9.8 1.7
(a) Age standardised to the total Indigenous Australian population, 2003 
(b) Indigenous Australian to total Australian rate ratio 
4.5.7 Alternative categories 
The burden from intellectual disability, renal failure and vision disorders was attributed to 
multiple underlying causes in the primary listing of diseases and injuries and is therefore not 
discussed explicitly in the above sections. The burden from intellectual disability was 
divided amongst other chromosomal disorders, Down syndrome, low birth weight, 
infection, epilepsy, other perinatal conditions, autism and foetal alcohol syndrome. The 
burden from renal failure was divided among diabetic nephropathy, the injury category of 
medical misadventure (analgesic nephropathy), and congenital conditions (dysplasia, 
polycystic kidneys). The burden from total vision loss was divided among diabetic 
retinopathy, glaucoma, cataract, refraction errors, age-related macular degeneration, 
trachoma, and other causes of vision loss.  
Indigenous Australian males experienced the majority of the intellectual disability burden, 
while females experienced the majority of vision loss burden (Figure 4.14). The burden from 
(a) (b) (c) 
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renal failure is overwhelmingly from years of life lost, while vision loss resulted mainly in 
non-fatal burden.  
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Figure 4.14: Alternative category DALYs by specific cause expressed as (a) proportions by sex; (b) 
proportions due to fatal and non-fatal outcomes, Indigenous Australian population, 2003 
Indigenous Australians experienced renal failure at a much higher rate (7.6 times) than the 
total Australian population (Table 4.18). 
Table 4.18: Alternative category DALYs, Indigenous Australian and total Australian populations, 
2003 
  Indigenous Australian  Total Australian   
Cause DALY 
Per cent of 
total DALY
DALY rate 
per 1,000  DALY
Per cent of 
total DALY 
DALY rate 
per 1,000(a) RR(b)
Intellectual disability 5,261 5.5% 11.1  44,187 1.7% 4.1 2.7
Renal failure 4,923 5.1% 10.4  68,721 2.6% 1.4 7.6
Vision loss 859 0.9% 1.8  55,661 2.1% 1.3 1.3
(a) Age standardised to the total Indigenous Australian population, 2003 
(b) Indigenous Australian to total Australian rate ratio 
 
(a) (b) 
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5 Risks to health in Indigenous 
Australians 
5.1 Overview 
This chapter discusses the contribution of a number of important health risks to the burden 
of disease and injury in Indigenous Australians in 2003. The choice of which risks to include 
was based on the following: 
1. Good evidence of a causal association between the exposure to the risk and the health 
outcomes and available relative risk estimates from reputable epidemiological 
studies. 
2. Reliable estimates of exposure to the risk factor for the Indigenous Australian 
population. 
3. Importance of the risk factor to Indigenous health policy making as informed by this 
study’s advisory committees. 
The outcome of these considerations was a set of 11 selected health risks (Table 5.1). Lack of 
data on prevalence and/or outcome prevented the estimation of the burden of intimate 
partner violence in males, osteoporosis and occupation. Urban air pollution was excluded 
because of data uncertainty and the expectation that it would not be a very large contributor 
to the Indigenous burden of disease. 
Table 5.1: Eleven selected risks to health discussed in this study 
Lifestyle behaviours Physiological states Social and environmental factors 
1. Tobacco 7. High body mass 10. Intimate partner violence 
2. Alcohol 8. High blood pressure 11. Child sexual abuse 
3. Physical inactivity 9. High blood cholesterol  
4. Illicit drugs   
5. Low fruit and vegetable consumption   
6. Unsafe sex   
 
It is important to remember several points when interpreting the results in the following 
sections.  
First, health risks tend to cluster around ‘high-risk’ individuals who experience more than 
one exposure (e.g. smokers tend to be drinkers). This combination of exposures may produce 
higher or lower levels of the combined risk as a result of complex interaction effects. The 
analyses presented in this chapter for individual factors do not explicitly account for these 
interactions, except to the extent to which confounding was controlled for in the studies from 
which the exposure–outcome relationships were derived.  
Second, the causal paths between a number of related health risks and their eventual health 
outcomes are complicated. For example, physical inactivity can lead to obesity, which can 
cause high blood pressure or high blood cholesterol, which can ultimately lead to 
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cardiovascular disease. Most of the analyses presented in this chapter only measure the effect 
of a risk independent of the other exposures, irrespective of the risk’s place in a causal path. 
The important implication here is that such analyses are not additive. Using the example 
above, the burden attributable to physical inactivity was estimated to be 29.9% of total 
cardiovascular disease burden, while that for high body mass, high blood cholesterol and 
high blood pressure was 31.3%, 31.3% and 26.3% of cardiovascular disease, respectively 
(Table 5.1). The burden attributable to these health risks in combination, however, was not 
the sum of burden from each risk (that is, the combined burden was not an implausible 
118.8%). This is because the combined effect of these risks must be expressly calculated, 
rather than derived from the addition of their individual effects. Ignoring shared causal 
paths in this example leads to obvious over-estimation of the combined effect. 
To illustrate the total ‘explanatory’ power of the 11 risk factors, this chapter begins with an 
analysis that accounts for many of the overlaps between risks that share causal paths. This is 
done using the ‘joint effects’ method developed for the World Health Organization 
Comparative Risk Assessment project (Ezzati et al. 2004). Sensitivity analyses indicated that 
overall results based on this approach were relatively robust to the underlying assumptions; 
however, apportioning the combined overall risk back to each contributing risk factor was 
more difficult and was much more sensitive to assumptions. Therefore, only the former 
analyses are presented in this report. Further details on the methods used for estimating joint 
effects are provided in the Australian Burden of Disease and Injury 2003 study (Begg et al. 
2007). 
5.2 Combined effect of 11 selected risks to health 
The 11 risk factors considered in this chapter together explained 37.4% of the total burden of 
disease experience of Indigenous Australians (Table 5.2). This indicates the potential to 
considerably reduce the disease and injury experience of Indigenous Australians with 
interventions targeted at these risk factors. 
Eight of the risk factors were associated with cancer and together explained 48.5% of the total 
burden from this cause. In the total Australian population, the 14 risk factors considered 
(including air pollution, osteoporosis and occupational causes, which are risk factors that are 
not included in this study) explained 32.9% of the cancer burden. The major difference 
between the distribution of cancer burden among these risk factors is that a greater 
proportion of cancer was explained by tobacco in the Indigenous Australian population 
compared with the total Australian population (34.6% versus 21.0%). 
The 10 risk factors associated with cardiovascular disease together explained 68.9% of this 
burden in Indigenous Australians. Tobacco contributed most to this cause, followed closely 
by high body mass, high blood cholesterol, physical inactivity and high blood pressure. 
More than one-third of burden due to mental disorders was attributable to four of the risk 
factors under consideration. Alcohol, followed by illicit drugs, contributed the most to this 
burden. 
Tobacco smoking was the only risk factor considered that was associated with neurological 
disorders (it has a small protective effect on Parkinson’s disease).  
Five of the risk factors were associated with injury burden and together explained 32.6% of 
the burden from this cause. This was similar to the proportion of injury burden explained by 
14 risk factors in the total Australian population (31.7%) in relative terms, but as the burden 
of injuries in Indigenous Australians was much larger, it meant that the average risk of an 
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injury due to these risk factors was also much higher. Alcohol was by far the leading cause of 
injury burden in Indigenous Australians. 
Due to the higher prevalence of tobacco smoking among Indigenous Australians, the 
proportion of burden due to cancer and cardiovascular disease explained by tobacco use was 
considerably higher in Indigenous Australians than in the total Australian population. 
Table 5.2: Individual and joint DALYs attributable to 11 selected risk factors by broad cause group, 
Indigenous Australian population, 2003 
  Broad cause group   
  Cancer CVD Mental Neurological Injury Diabetes Other
All 
causes
Total burden 7,817 16,786 14,860 4,114 12,384 8,498 31,517 95,976
Attributable burden (%)(a)   
Tobacco 34.6 33.0 –0.3 0.7  10.5 12.1
High body mass 3.2 31.3 63.2 0.1 11.4
Physical inactivity 4.7 29.9 31.2 8.4
High blood cholesterol  31.3  5.5
Alcohol   
Harmful effects 6.3 1.6 16.3 22.2  0.2 6.2
Beneficial effects  –4.8  >–0.1 –0.8
Net effects 6.3 –3.2 16.3 22.2  0.2 5.4
High blood pressure  26.3  4.6
Low fruit and vegetable intake 4.2 18.0  3.5
Illicit drugs  <0.1 12.9 3.6  2.8 3.4
Intimate partner violence 2.4 2.4 4.5 <0.1 7.5  0.9 2.6
Child sexual abuse 0.2 <0.1 6.7 2.7  0.1 1.4
Unsafe sex 4.5  2.6 1.2
11 risk factors combined(b) 48.5 68.9 37.4 –0.3 32.6 68.8 16.2 37.4
(a) Attributable burden within each column is expressed as a percentage of total burden for that column 
(b) Figures for joint effects are not column totals; see Section 5.1 for further details 
The risk factors selected for this study had a different impact by sex and age (Table 5.3). Four 
risk factors attributed to disease burden of 0–14 year-olds, and together explained around 5% 
of total burden for this age group. Tobacco was the largest contributor to disease burden in 
this age group, due to the association between smoking during pregnancy and increased risk 
of having a low-birth weight child. Just over 30% of burden among males and females aged 
15–34 years was explained by the 11 risk factors. Alcohol and illicit drugs contributed the 
most to burden among males at this age, while intimate partner violence was the largest 
contributor to female burden. More than half the burden among people aged 35 years and 
over was explained by the 11 risk factors. The leading cause of burden among males in the 
35–54-year age group was tobacco and high body mass, which had an almost equal 
contribution. For females, high body mass was the largest contributor to burden in this age 
group, followed by tobacco. Tobacco was the largest contributor in males and females aged 
55 years and over, followed by high body mass and physical inactivity. 
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Table 5.3: Individual and joint DALYs attributable to 11 selected risk factors by sex and age group, 
Indigenous Australian population, 2003 
  Males  Females 
  0–14 15–34 35–54 55+ 
All 
ages  0–14 15–34 35–54 55+
All 
ages 
Total burden 10,811 13,366 15,278 10,652 50,107 9,376 12,004 13,218 11,271 45,869
Attributable burden (%)(a)    
Tobacco 3.9 0.1 19.5 26.0 12.3 3.8 0.1 16.8 25.4 11.9
High body mass – 3.2 19.2 16.1 10.1 – 3.9 23.5 20.1 12.7
Physical inactivity – 3.5 13.4 15.4 8.3 – 3.8 12.8 15.3 8.5
High blood cholesterol – 2.4 13.3 9.0 6.6 – 1.0 7.7 7.2 4.2
Alcohol    
Harmful effects 0.8 13.8 10.9 5.7 8.4 0.2 6.4 5.7 2.2 3.9
Beneficial effects – –0.5 –1.9 –1.7 –1.1 – –0.2 –1.0 –1.1 –0.6
Net effects 0.8 13.3 8.9 4.1 7.3 0.2 6.2 4.7 1.1 3.3
High blood pressure – 1.0 7.6 12.9 5.3 – 0.3 4.2 10.4 3.8
Low fruit and vegetable 
intake – 1.6 7.3 7.6 4.3 – 1.0 4.3 4.7 2.6
Illicit drugs 0.5 11.0 3.3 1.0 4.3 0.4 5.7 2.5 0.6 2.4
Intimate partner violence – – – – – – 10.4 7.5 2.0 5.4
Child sexual abuse – 1.6 0.8 0.2 0.7 – 5.7 2.4 0.4 2.3
Unsafe sex 0.0 0.8 0.8 0.2 0.5 0.4 3.1 2.9 1.1 2.0
11 risk factors combined(b) 5.1 32.6 53.4 55.3 37.8 4.9 31.4 52.6 51.2 36.9
(a) Attributable burden within each column is expressed as a percentage of total burden for that column 
(b) Figures for joint effects are not column totals; see Section 5.1 for further details 
5.3 Individual contribution of 11 selected risks to 
health 
Indigenous Australians experienced a higher rate of burden due to each of the 11 risk factors 
considered compared with the total Australian population (Table 5.4). This resulted from a 
combination of higher prevalence of exposure to the risk factors and higher disease levels in 
the population. The largest relative differences in rates of burden were for low fruit and 
vegetable consumption, tobacco, and high body mass.  
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Table 5.4: DALYs attributable to 11 selected risk factors by proportion of total DALY and rate, 
Indigenous Australian and total Australian populations, 2003 
  Indigenous Australian  Total Australian     
Risk DALY  % of total 
Rate per 
1,000  DALY % of total 
Rate per 
1,000(a)  RR(b) 
Tobacco 11,633 12.1 24.5   204,788 7.8 3.9   6.3 
High body mass 10,919 11.4 23.0   197,632 7.5 4.2   5.5 
Physical inactivity 8,032 8.4 16.9   174,431 6.6 3.1   5.4 
High blood cholesterol 5,262 5.5 11.1   163,591 6.2 2.7   4.1 
Alcohol          
Harmful effects 5,982 6.2 12.6   87,936 3.3 3.3   3.8 
Beneficial effects –811 –0.8 –1.7   –26,845 –1.0 –0.5   3.7 
Net effects 5,171 5.4 10.9   61,091 2.3 2.9   3.8 
High blood pressure 4,417 4.6 9.3   199,315 7.6 2.6   3.6 
Low fruit & vegetable intake 3,344 3.5 7.0   55,259 2.1 1.0   7.0 
Illicit drugs 3,264 3.4 6.9   51,463 2.0 2.4   2.9 
Intimate partner violence 2,469 2.6 5.2   29,360 1.1 1.3   4.0 
Child sexual abuse 1,390 1.4 2.9   23,513 0.9 1.1   2.7 
Unsafe sex 1,174 1.2 2.5   14,897 0.6 0.5   4.7 
(a) Age standardised to the Indigenous Australian population, 2003 
(b) Indigenous Australian to total Australian rate ratio 
5.3.1 Tobacco 
Tobacco smoking was responsible for 12.1% of the total burden, and one-fifth of deaths in 
Indigenous Australians in 2003 (Table 5.5). It was the largest contributing risk factor overall 
for males, and the second largest contributor for females. Ischaemic heart disease, COPD, 
and lung cancer attributable to tobacco accounted for almost three-quarters of overall burden 
due to tobacco. Three-quarters of the burden attributed to tobacco smoking was due to 
mortality (Figure 5.1).  
Indigenous Australian males experienced 53% of the burden from tobacco smoking 
compared with around two-thirds in the total Australian population. This difference most 
likely reflects a similarly high prevalence of smoking in Indigenous males and females in 
recent decades.  
Tobacco-related illnesses with a short lag time between exposure and outcome (e.g. 
cardiovascular diseases) contributed more significantly to the burden in Indigenous 
Australians than the total Australian population. In the latter, lung cancer and COPD were 
the leading causes of tobacco burden. The recent favourable trends seen in the prevalence of 
tobacco smoking in the total Australian population have not occurred in the Indigenous 
Australian population. Unlike the total Australian population, we therefore do not expect to 
see any significant downward trend in tobacco smoking-related illnesses that have a long lag 
time (e.g. cancers and COPD) in the next few decades in Indigenous Australians, and there is 
evidence that the incidence of smoking-related cancers in Northern Territory Indigenous 
Australians is still increasing (Condon et al. 2005). However, when there is a reduction in 
prevalence of smoking, positive effects will been seen in the shorter term through a 
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reduction in the large burden of cardiovascular disease due to tobacco for which the lag time 
is a few years rather than decades. 
Table 5.5: Deaths and DALYs attributable to tobacco by specific cause, Indigenous Australian 
population, 2003 
 Deaths  DALYs 
Specific cause Number Per cent of total  Number Per cent of total 
Ischaemic heart disease 220 7.7  4,246 4.4 
COPD  99 3.5  2,430 2.5 
Lung cancer  116 4.0  1,780 1.9 
Stroke  59 2.0  1,063 1.1 
Low birth weight 13 0.4  632 0.7 
Other  68 2.4  1,482 1.5 
Total attributable  574 20.0  11,633 12.1 
 
IHD
37%
COPD
21%
Lung cancer
15%
Stroke
9%
LBW
5%
Other
13%
54%
54%
51%
41%
55%
53%
46%
46%
49%
45%
47%
59%
IHD
COPD
Lung cancer
Stroke
LBW
Total
Males Females
54%
82%
98%
69%
60%
75%
2%
18%
25%
46%
31%
40%
Fatal Non-fatal
 
Figure 5.1: DALYs attributable to tobacco by specific cause expressed as (a) proportions of total; (b) 
proportions by sex; (c) proportions due to fatal and non-fatal outcomes, Indigenous Australian 
population, 2003 
5.3.2 High body mass 
High body mass was responsible for 11.4% of the total Indigenous Australian burden of 
disease in 2003, and was the second leading cause of burden among the 11 risk factors 
examined (Table 5.6). For females aged 35–54 years, high body mass was responsible for the 
largest amount of burden among the 11 risks examined. Type 2 diabetes and ischaemic heart 
disease accounted for 89% of the total burden due to high body mass in Indigenous 
Australians. Fifty-three per cent of the burden was experienced by females, and 60% was due 
to mortality (Figure 5.2). 
(a) 
 
(b) 
 
(c) 
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Table 5.6: Deaths and DALYs attributable to high body mass by specific cause, Indigenous 
Australian population, 2003 
 Deaths  DALYs 
Specific cause Number Per cent of total  Number Per cent of total 
Type 2 diabetes  135 4.7   5,373 5.6 
Ischaemic heart disease 195 6.8  4,359 4.5 
Stroke  31 1.1  734 0.8 
Other  25 0.9  453 0.5 
Total attributable  386 13.4   10,919 11.4 
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Figure 5.2: DALYs attributable to high body mass by specific cause expressed as (a) proportions of 
total; (b) proportions by sex; (c) proportions due to fatal and non-fatal outcomes, Indigenous 
Australian population, 2003 
5.3.3 Physical inactivity 
Physical inactivity was responsible for 8.4% of the total Indigenous Australian burden in 
2003 (Table 5.7), and was the third leading cause of burden among the 11 risk factors 
considered. Ischaemic heart disease and Type 2 diabetes together accounted for 88% of the 
burden due to this cause. Two-thirds of physical inactivity burden was due to mortality; 
however, 60% of Type 2 diabetes burden was non-fatal. Overall, Indigenous Australian 
males and females experienced an equal share of the burden due to physical inactivity 
(Figure 5.3). 
Table 5.7: Deaths and DALYs attributable to physical inactivity by specific cause, Indigenous 
Australian population, 2003 
 Deaths  DALYs 
Specific cause Number Per cent of total  Number  Per cent of total 
Ischaemic heart disease 220 7.7  4,336 4.5 
Type 2 diabetes  67 2.3  2,655 2.8 
Stroke  36 1.3  675 0.7 
Colorectal cancer  10 0.4  186 0.2 
Breast cancer  9 0.3  180 0.2 
Total attributable  342 11.9  8,032 8.4 
(a) (b) (c) 
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Figure 5.3: DALYs attributable to physical inactivity by specific cause expressed as (a) proportions 
of total; (b) proportions by sex; (c) proportions due to fatal and non-fatal outcomes, Indigenous 
Australian population, 2003 
5.3.4 High blood cholesterol 
High blood cholesterol was responsible for 5.5% of the Indigenous Australian burden of 
disease in 2003 (Table 5.8). Ischaemic heart disease was responsible for 92% of the burden 
from high cholesterol, with stroke responsible for the remaining 8% of burden. The burden 
from ischaemic heart disease and stroke was largely due to mortality. Males experienced 
almost two-thirds of the burden from high blood cholesterol (Figure 5.4).  
Table 5.8: Deaths and DALYs attributable to high blood cholesterol by specific cause, Indigenous 
Australian population, 2003 
 Deaths  DALYs 
Specific cause Number Per cent of total  Number  Per cent of total 
Ischaemic heart disease 221 7.7  4,862 5.1 
Stroke  17 0.6  400 0.4 
Total attributable  238 8.3  5,262 5.5 
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Figure 5.4: DALYs attributable to high blood cholesterol by specific cause expressed as (a) 
proportions of total; (b) proportions by sex; (c) proportions due to fatal and non-fatal outcomes, 
Indigenous Australian population, 2003 
(a) 
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5.3.5 Alcohol  
Alcohol has both hazardous and protective effects on health. Among Indigenous Australian 
males aged 15–34 years, alcohol was responsible for the greatest amount of burden among 
the 11 risk factors considered (Table 5.3). For females in this age group, alcohol followed 
intimate partner violence as the second leading cause of burden. 
Alcohol harm was responsible for 6.2%, and prevented 0.8% of the total burden in 
Indigenous Australians in 2003 (Figure 5.5). At each age, alcohol harm far outweighed its 
beneficial effects. Alcohol abuse and harmful use, homicide & violence, and suicide were the 
largest contributors to the harm caused by alcohol.  
 
Homicide & violence
14%
RTA
14%
Suicide
14%
Alcohol abuse
40%
Mouth 
cancer 
3%
Stroke
2%
Other
13%
70%
94%
75%
82%
84%
56%
64%
16%
25%
6%
36%
44%
30%
18%
Alcohol abuse
Homicide & violence
Suicide
RTA
Mouth cancer
Stroke
Total
Males Females
70%
67%
77%
99%
94%
87%
83%
1%
6%
13%
17%
23%
30%
33%
Fatal Non-fatal
 
Figure 5.5: DALYs attributable to alcohol (harm) by specific cause expressed as (a) proportions of 
total; (b) proportions by sex; (c) proportions due to fatal and non-fatal outcomes, Indigenous 
Australian population, 2003 
Table 5.9: Deaths and DALYs attributable to alcohol by specific cause, Indigenous Australian 
population, 2003 
 Deaths  DALYs 
Specific cause Number Per cent of total  Number  Per cent of total 
Harm            
Alcohol abuse  93 3.3  2,419 2.5 
Homicide & violence  23 0.8  841 0.9 
Suicide  33 1.2  839 0.9 
Road traffic accidents  30 1.0  811 0.8 
Mouth & oropharynx cancers  9 0.3  168 0.2 
Stroke  8 0.3  140 0.1 
Other  37 1.3  765 0.8 
Total attributable harm  233 8.1  5,982 6.2 
Benefit       
Ischaemic heart disease –36 –1.3  –731 –0.8 
Stroke  –4 –0.1  –72 –0.1 
Other  0 0.0  -8 0.0 
Total attributable benefit  –41 –1.4  –811 –0.8 
Total attributable  192 6.7   5,171 5.4 
(a) 
 
(b) 
 
(c) 
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Figure 5.6: DALYs attributable to alcohol (benefit) by specific cause expressed as (a) proportions of 
total; (b) proportions by sex; (c) proportions due to fatal and non-fatal outcomes, Indigenous 
Australian population, 2003 
5.3.6 High blood pressure 
High blood pressure was responsible for 4.6% of the total burden of disease, and 9.5% of 
deaths in Indigenous Australians in 2003 (Table 5.10). Ischaemic heart disease and stroke 
were the primary contributors. Males experienced 60% of the high blood pressure burden 
and 82% of the burden was due to mortality (Figure 5.7). 
Table 5.10: Deaths and DALYs attributable to high blood pressure by specific cause, Indigenous 
Australian population, 2003 
 Deaths  DALYs 
Specific cause Number Per cent of total  Number  Per cent of total 
Ischaemic heart disease 184 6.4  3,040 3.2 
Stroke  64 2.2  1051 1.1 
Other  23 0.8  326 0.3 
Total attributable  272 9.5  4,417 4.6 
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Figure 5.7: DALYs attributable to high blood pressure by specific cause expressed as 
(a) proportions of total; (b) proportions by sex; (c) proportions due to fatal and non-fatal outcomes, 
Indigenous Australian population, 2003 
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5.3.7 Low fruit and vegetable consumption 
Insufficient fruit and vegetable consumption contributed to 3.5% of the total burden of 
disease in Indigenous Australians in 2003 (Table 5.11). Ischaemic heart disease was the 
largest contributor to the burden from this risk factor. Overall, 81% of the burden from 
insufficient fruit and vegetable consumption was due to mortality, and 64% was experienced 
by males (Figure 5.8). 
Table 5.11: Deaths and DALYs attributable to low fruit and vegetable consumption by specific 
cause, Indigenous Australian population, 2003 
 Deaths  DALYs 
Specific cause Number Per cent of total  Number  Per cent of total 
Ischaemic heart disease 130 4.5  2,744 2.9 
Stroke  13 0.5  270 0.3 
Lung cancer  13 0.5  214 0.2 
Other  7 0.2  116 0.1 
Total attributable  163 5.7  3,344 3.5 
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Figure 5.8: DALYs attributable to low fruit and vegetable consumption by specific cause expressed 
as (a) proportions of total; (b) proportions by sex; (c) proportions due to fatal and non-fatal 
outcomes, Indigenous Australian population, 2003 
5.3.8 Illicit drugs  
Illicit drug use was responsible for 3.4% of the total burden in Indigenous Australians in 
2003 (Table 5.12). Heroin or polydrug dependence was responsible for 37% of the burden 
due to illicit drugs. Two-thirds of the illicit drug burden was experienced by males, and 56% 
was due to mortality (Figure 5.9). 
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Table 5.12: Deaths and DALYs attributable to illicit drugs by specific cause, Indigenous Australian 
population, 2003 
 Deaths  DALYs 
Specific cause Number Per cent of total  Number  Per cent of total 
Heroin or polydrug dependence  17 0.6  1,216  1.3 
Hepatitis C  28 1.0  554  0.6 
Cannabis dependence  0 0.0  302  0.3 
Suicide  12 0.4  299  0.3 
Hepatitis B  10 0.3  215  0.2 
Other  14 0.5  677  0.7 
Total attributable  80 2.8   3,264  3.4 
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Figure 5.9: DALYs attributable to illicit drug use by specific cause expressed as (a) proportions of 
total; (b) proportions by sex; (c) proportions due to fatal and non-fatal outcomes, Indigenous 
Australian population, 2003  
5.3.9 Intimate partner violence 
Due to a lack of data regarding male experience of intimate partner violence and the related 
health effects, we only attempted to quantify the proportion of female burden due to 
intimate partner violence. 
Intimate partner violence was responsible for 2.6% of the total burden of disease in 
Indigenous Australians, and 5.4% of the burden among female Indigenous Australians in 
2003 (Table 5.13). Homicide & violence, and anxiety & depression were both responsible for 
25% of the burden from this risk factor. Just over half of the burden from intimate partner 
violence was due to mortality (53%) (Figure 5.10). 
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Table 5.13: Deaths and DALYs attributable to intimate partner violence by specific cause, female 
Indigenous Australian population, 2003 
 Deaths  DALYs 
Specific cause Number Per cent of total  Number  Per cent of total 
Homicide & violence  16 0.6  628 0.7 
Anxiety & depression  0 0.0  606 0.6 
Ischaemic heart disease 11 0.4  287 0.3 
Suicide  10 0.4  277 0.3 
Other  22 0.7  671 0.7 
Total attributable  58 2.0  2,469 2.6 
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Figure 5.10: DALYs attributable to intimate partner violence by specific cause expressed as 
(a) proportions of total; (b) proportions due to fatal and non-fatal outcomes, female Indigenous 
Australian population, 2003 
5.3.10 Child sexual abuse 
We estimated the health outcomes in adulthood due to exposure to sexual abuse in 
childhood. Past exposure to child sexual abuse was responsible for 1.4% of the total burden 
of disease in Indigenous Australians (Table 5.14). Eighty-four per cent of this burden was 
from anxiety & depression, suicide, and alcohol dependence & harmful use. The burden 
from child sexual abuse was primarily experienced by females (75%) and was non-fatal 
(65%) (Figure 5.11). Caution is warranted in interpreting these estimates of the burden 
attributable to child sexual abuse as they are based on very limited data (see Annex table 3: 
Assessment of quality of risk factor exposure estimates in the Indigenous population). 
(a) 
 
(b) 
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Table 5.14: Deaths and DALYs attributable to child sexual abuse by specific cause, Indigenous 
Australian population, 2003 
 Deaths  DALYs 
Specific cause Number Per cent of total  Number  Per cent of total 
Anxiety & depression  0 0.0  812 0.8 
Suicide  10 0.4  271 0.3 
Alcohol abuse  4 0.1  91 0.1 
Other  7 0.2  216 0.2 
Total attributable  21 0.7  1,390 1.4 
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Figure 5.11: DALYs attributable to child sexual abuse by specific cause expressed as (a) proportions 
of total; (b) proportions by sex; (c) proportions due to fatal and non-fatal outcomes, Indigenous 
Australian population, 2003 
5.3.11 Unsafe sex 
Unsafe sex was responsible for 1.2% of the total burden in Indigenous Australians in 2003 
(Table 5.15). Cervical cancer, chlamydia, and HIV/AIDS accounted for 70% of the burden 
from this risk factor. The burden from unsafe sex was primarily experienced by females 
(79%), and was evenly split between fatal and non-fatal burden (Figure 5.12).  
Table 5.15: Deaths and DALYs attributable to unsafe sex by specific cause, Indigenous Australian 
population, 2003 
 Deaths  DALYs 
Specific cause Number Per cent of total  Number  Per cent of total 
Cervical cancer  18 0.6  355 0.4 
Chlamydia  1 0.0  267 0.3 
HIV/AIDS  3 0.1  201 0.2 
Other  8 0.3  351 0.4 
Total attributable  31 1.1  1,174 1.2 
(a) 
 
(b) 
 
(c) 
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Figure 5.12: DALYs attributable to unsafe sex by specific cause expressed as (a) proportions of total; 
(b) proportions by sex; (c) proportions due to fatal and non-fatal outcomes, Indigenous Australian 
population, 2003 
(a) 
 
(b) 
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6 Indigenous health gap and differentials 
by remoteness 
6.1 Overview 
In this chapter we introduce the concept of the ‘Indigenous health gap’ — the difference 
between the current levels of disease burden in Indigenous Australians and what the disease 
burden in Indigenous Australians would be if National Study DALY rates applied. This gap 
indicates the potential for health gain. We also describe the differentials in burden of disease 
in Indigenous Australians by remoteness. We discuss these differentials in terms DALYs, 
risk factors, life expectancy, and HALE.  
Indigenous Australians make up 2.4% of the total Australian population (Table 6.1). More 
than one-quarter of the Indigenous Australian population resides in remote areas (26.5%). 
Only 2.4% of the total Australian population resides in remote areas. The age structure of the 
non-remote and remote Indigenous Australian populations is similar, but is considerably 
younger than that of the total Australian population.  
Table 6.1: Selected demographic characteristics of Indigenous Australians by remoteness and the 
total Australian population, 2003 
  Proportions 
Population group Count Total 
0–14 
years 
15–34 
years 
35–54 
years 
55+ 
years Male 
Indigenous Australians 475,395 2.4 38.1 34.4 20.5 7.0 49.6 
Non-remote  349,600 1.8 39.0 34.1 20.3 6.6 49.4 
Remote  125,795 0.6 35.7 35.5 20.9 7.9 50.3 
Total Australian population 19,881,469 100.0 20.0 28.3 28.7 23.0 49.7 
6.2 Indigenous health gap 
A useful property of the DALY is that it lends itself to the analysis of which causes and age 
groups contribute most to the burden of disease or to the difference in health status between 
populations. Measures such as life expectancy and HALE (sections 6.5 and 6.6), while 
attractive for summarising the health of a population in a single measure, are less suited for 
describing underlying causes. We define the ‘Indigenous health gap’ as the difference 
between observed and ‘achievable’ DALYs. The ‘achievable’ burden is calculated by 
applying the total Australian rates of burden by age, sex and condition to the Indigenous 
Australian population. This gap between observed and ‘achievable’ is a useful measure for 
identifying health problems at different ages and thus where the greatest potential for 
Indigenous health gain exists.  
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6.2.1 Health gap by disease 
If Indigenous Australians experienced the fatal and non-fatal burden rate of the total 
Australian population, a total of 56,455 DALYs could be avoided, equivalent to 59% of the 
burden of disease estimated for Indigenous Australians in 2003 (Table 6.2). 
Almost one-quarter of the Indigenous health gap was due to cardiovascular diseases (Figure 
6.1). Diabetes, mental disorders and chronic respiratory disease were responsible for a 
further 31% of the gap. Injuries and the group I conditions (communicable diseases, maternal 
and neonatal conditions) were each responsible for 15% of the gap. Infectious and parasitic 
diseases, acute respiratory infections and neonatal conditions contributed most to the gap in 
group I conditions (Table 6.2). The major contributors to the gap in injury burden were 
RTAs, suicide, and homicide & violence.  
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Figure 6.1: Indigenous health gap (DALYs) by selected causes, 2003 
Overall, the Indigenous health gap was equally distributed between males and females, and 
two-thirds of the gap was due to mortality (Figure 6.2). Mortality dominated the gap for 
cardiovascular disease, injuries and cancer. In fact, mortality explained more than 100% of 
the gap in cancer. This was because disability rates from cancer in Indigenous Australians 
were lower than the national rates by 14%, due to the higher case fatality rate in Indigenous 
people with cancer.  
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Figure 6.2: Indigenous health gap (DALYs) by selected causes expressed as, (a) proportions by sex, 
and (b) proportions due to fatal and non-fatal outcomes, 2003 
The largest proportion of the Indigenous health gap occurred in people aged 35–54 years 
(Table 6.2). Non-communicable diseases, particularly cardiovascular disease and diabetes, 
contributed most to the gap at these ages. The 15–34-year age group accounted for the 
second largest proportion of the gap. Even at these young adult ages, cardiovascular disease 
and diabetes contributed one-fifth to the gap although injuries and mental disorders were 
the largest contributors. Cardiovascular disease, diabetes and tobacco-related cancers and 
respiratory disease dominated the gap in the oldest age group. In children, group I 
conditions showed the greatest differences, particularly neonatal conditions — and, among 
these, low birth weight. 
(a) 
 
(b) 
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Table 6.2: Indigenous health gap (DALYs) due to selected causes, expressed as a proportion of total 
Indigenous health gap, 2003 
  Total (%) 
Cause 0–14 15–34 35–54 55+ Total
Health gap 
(DALYs) 
% of total 
Indigenous 
burden
All causes 17 25 35 23 100 56,455 59
Group I(a) 8 3 3 1 15 8,633 9
Infectious and parasitic diseases 1 1 2 1 5 3,074 3
Acute respiratory infections 2 1 1 1 4 2,358 2
Neonatal causes 4 0 0 0 4 2,354 2
Other group I 1 1 0 0 2 847 1
Non-communicable diseases 8 13 28 21 70 39,491 41
Cancers 0 0 2 3 6 3,151 3
Tobacco related cancers(b) 0 0 1 3 4 2,287 2
Other cancers 0 0 1 1 2 865 1
Diabetes 0 2 6 4 12 6,833 7
Cardiovascular disease 0 3 11 9 23 13,208 14
Ischaemic heart disease 0 2 7 6 14 8,169 9
Stroke 0 0 1 2 3 1,734 2
Other cardiovascular diseases 0 1 3 1 6 3,305 3
Mental disorders 3 4 2 1 10 5,542 6
Substance use disorders 1 2 2 1 6 3,239 3
Other mental disorders 2 2 0 0 4 2,303 2
Chronic respiratory disease 1 1 4 3 9 5,213 5
Other NCDs(c) 4 2 3 2 10 5,543 6
Injuries 2 9 3 1 15 8,331 9
Road traffic accidents 0 2 1 0 3 1,969 2
Suicide 0 3 1 0 4 2,393 2
Homicide & violence 0 2 1 0 3 1,716 2
Other injuries 1 2 1 0 4 2,252 2
(a) Communicable diseases, maternal and neonatal conditions 
(b) Mouth and oropharynx, oesophagus, lung, larynx, pancreas, bladder, kidney, stomach, and uterine cancers 
(c) Other non-communicable diseases 
While the proportion of the Indigenous health gap in the four age groups was similar 
between males and females, the causes contributing to the gap varied by sex and age group 
(Table 6.3). In the 0–14-year age group, the gap had a similar causal distribution. In young 
adult males, injuries contributed almost as much to the gap as non-communicable diseases 
and suicide explained almost half of that. In young female adults, injuries contributed a 
lesser proportion to the gap but there was excess health loss from RTAs, suicide and 
violence. In both male and female young adults, mental disorders, early-onset diabetes and 
cardiovascular disease explained most of the gap for non-communicable disease.  
Males and females aged 35 years and over experienced most excess health loss from 
cardiovascular disease, particularly ischaemic heart disease. At older ages, diabetes was 
responsible for a greater proportion of the gap in females than in males.  
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Table 6.3: Indigenous health gap (DALYs) due to selected causes by sex, expressed as a proportion 
of total Indigenous health gap, 2003 
  Males (%)  Females (%) 
Cause 0–14 15–34 35–54 55+ Total  0–14 15–34 35–54 55+ Total
All causes 17 26 36 21 100  18 23 33 26 100
Group I(a) 8 2 3 1 14  7 4 4 2 16
Infectious and parasitic diseases 1 1 2 1 5  1 2 2 1 6
Acute respiratory infections 2 1 1 1 4  2 1 1 1 4
Neonatal causes 5 0 0 0 5  4 0 0 0 4
Other group I 1 0 0 0 1  1 1 0 0 2
Non-communicable diseases 7 13 29 19 67  9 13 27 24 73
Cancers 0 0 2 3 4  0 1 2 4 7
Tobacco related cancers(b) 0 0 2 2 4  0 0 1 3 4
Other cancers 0 0 0 0 0  0 1 1 1 3
Diabetes 0 2 5 3 10  0 2 6 5 14
Cardiovascular disease 0 3 12 8 24  0 3 10 9 23
Ischaemic heart disease 0 2 9 5 16  0 1 6 6 13
Stroke 0 0 1 2 3  0 0 1 2 3
Other cardiovascular disease 1 1 3 1 5  0 2 3 2 6
Mental disorders 2 5 3 1 10  4 3 2 0 9
Substance use disorders 1 3 2 1 7  1 2 2 0 5
Other mental disorders 1 2 0 0 4  3 1 0 0 5
Chronic respiratory disease 0 1 4 3 9  2 1 4 3 10
Other NCD(c) 4 2 3 1 9  3 3 3 2 10
Injuries 2 11 5 1 18  1 6 2 1 11
Road traffic accidents 0 2 1 0 4  0 2 1 0 3
Suicide 0 5 1 0 6  0 2 0 0 2
Homicide & violence 0 2 1 0 3  0 2 1 0 3
Other injuries 1 2 1 0 5  1 1 1 0 3
(a) Communicable diseases, maternal and neonatal conditions 
(b) Mouth and oropharynx, oesophagus, lung, larynx, pancreas, bladder, kidney, stomach, and uterine cancers 
(c) Other non-communicable diseases 
Indigenous Australians residing in remote areas represented 26% of the total Indigenous 
Australian population and 35% of the total Indigenous burden; however they experienced 
40% of the Indigenous health gap (Figure 6.3). This highlights that while the rate of burden is 
higher in remote areas, the bulk of the burden of disease is experienced by Indigenous 
Australians residing in non-remote areas.  
Relative to population size Indigenous Australians residing in remote areas experienced a 
disproportionate amount of the health gap for all major disease areas apart from mental 
disorders (Figure 6.3). This latter finding may be an artefact of the methods. For example, the 
disease models for alcohol dependence & harmful use, and anxiety & depression were 
derived from the 2004-05 National Aboriginal and Torres Strait Islander Health Survey Social 
and Emotional Well-being module which gave proxies rather than diagnostic indicators for 
ICD-10 defined mental disorders. 
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Figure 6.3: Indigenous health gap (DALYs) by selected causes expressed as: proportions by 
remoteness, 2003 
Group I conditions were responsible for 20% and 12% of the health gap experienced by 
Indigenous Australians residing in remote and non-remote areas respectively (Table 6.4). 
The greater burden of infectious and parasitic diseases in remote areas was responsible for 
most of the difference in excess health loss in group I conditions. Similarly, injuries were 
responsible for a greater proportion of the gap in remote areas (18%) compared with non-
remote areas (12%). The higher proportion of the health gap that was explained by injuries 
was due to a combination of higher rates of RTA, suicide, and homicide & violence burden in 
remote areas. Mental disorders contributed 14% of total health gap in non-remote areas, but 
only 4% in remote areas. Similar proportions of the health gap in remote and non-remote 
areas were contributed by other non-communicable diseases, but as the overall gap for 
remote was greater than would be expected given the population distribution, similar 
proportions mean a greater gap in numbers of DALYs per person.  
The gap between remote and non-remote occurred at similar proportions between the four 
age groups (Table 6.4). A somewhat greater portion of the Indigenous health gap for those 
residing in non-remote areas occurred in the 0–14-year age group than in the remote gap.  
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Table 6.4: Indigenous health gap (DALYs) due to selected causes, expressed as a proportion of total 
excess burden, by remoteness, 2003 
  Non-remote (%) Remote (%) 
Cause 0–14 15–34 35–54 55+ All ages  0–14 15–34 35–54 55+ All ages
All causes 19 24 33 24 100  15 26 36 22 100
Group I(a) 6 2 3 1 12  9 4 5 2 20
Infectious & parasitic diseases 1 1 2 1 4  2 2 3 1 8
Acute respiratory infections 1 0 1 0 3  3 1 1 1 6
Neonatal causes 4 0 0 0 4  4 0 0 0 4
Other group I 0 1 0 0 1  1 1 0 0 2
Non-communicable diseases 11 15 27 23 76  4 10 28 20 62
Cancers 0 0 2 4 6  0 0 3 2 5
Tobacco related cancers(b) 0 0 1 3 5  0 0 2 2 3
Other cancers 0 0 1 1 1  0 0 1 1 2
Diabetes 0 3 6 4 12  0 2 5 4 12
Cardiovascular disease 0 3 11 9 24  1 4 11 7 23
Ischaemic heart disease 0 1 8 6 16  0 2 7 4 13
Stroke 0 0 1 2 3  0 0 1 1 3
Other cardiovascular disease 0 1 2 1 5  1 2 3 1 7
Mental disorders 4 6 3 1 14  1 1 2 0 4
Substance use disorders 1 3 2 1 7  0 1 2 0 4
Other mental disorders 3 3 1 0 7  0 0 0 0 0
Chronic respiratory disease 2 1 4 3 10  0 1 4 3 8
Other NCD(c) 4 2 2 1 10  3 2 3 2 10
Injuries 2 7 3 0 12  2 12 4 1 18
Road traffic accidents 0 1 1 0 2  1 3 2 0 5
Suicide 0 3 1 0 4  0 4 0 0 5
Homicide & violence 0 2 0 0 2  0 3 1 0 4
Other injuries 1 1 1 0 4  1 2 1 0 4
(a) Communicable diseases, maternal and neonatal conditions  
(b) Mouth and oropharynx, oesophagus, lung, larynx, pancreas, bladder, kidney, stomach, and uterine cancers 
(c) Other non-communicable diseases 
6.2.2 Health gap by risk factors 
If Indigenous Australians experienced the same burden rates due to the 11 selected risk 
factors as the total Australian population, 29% of the total Indigenous Australian burden of 
disease would be avoided (Table 6.5). 
The largest proportion of the Indigenous health gap due to risk factors occurred in the 35–54-
year age group (Table 6.5). However, the 15–34-year age group experienced the largest 
proportion of health gap due to alcohol, illicit drugs, intimate partner violence, and child 
sexual abuse.  
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Table 6.5: Indigenous health gap (DALYs) due to selected risk factors, expressed as a proportion of 
excess burden from each risk factor, 2003 
  Total (%) 
Risk factor 0–14 15–34 35–54 55+ Total
  
Health gap 
(DALYs) 
 % of total 
Indigenous 
burden
Tobacco 6 0 47 47 100 9,816 10
High body mass 0 9 57 34 100 8,953 9
Physical inactivity 0 13 48 39 100 6,554 7
High blood cholesterol 0 10 64 26 100 3,994 4
Alcohol 2 45 40 13 100 3,820 4
High blood pressure 0 5 45 50 100 3,215 3
Low fruit and vegetable intake 0 10 52 37 100 2,873 3
Illicit drugs 4 63 28 5 100 2,150 2
Intimate partner violence 0 48 42 11 100 1,836 2
Child sexual abuse 0 67 28 5 100 869 1
Unsafe sex 4 40 43 12 100 926 1
11 risk factors combined(a) 3 21 45 32 100 27,383 29
(a) Joint effect of 11 risk factors in Indigenous analysis, and 14 in national model (Begg et al. 2007) minus the burden from osteoporosis, 
occupation, and air pollution 
Males and females experienced equal proportions of the Indigenous health gap due to the 
11 risk factors together (Figure 6.4). The health gap due to unsafe sex and child sexual abuse 
was predominately experienced by females. 
15%
0%
51%
51%
45%
52%
63%
67%
60%
63%
63%
31%
100%
49%
55%
48%
37%
33%
40%
37%
37%
69%
85%
49%
Tobacco
High body mass
Physical inactivity
High blood cholesterol
Alcohol
High blood pressure
Low  fruit and vegetable intake
Illicit drugs
Intimate partner violence
Child sexual abuse
Unsafe sex
11 risk factors combined
Males Females
 
Figure 6.4: Indigenous health gap (DALYs) by selected risk factors expressed as proportions by sex, 
2003  
Indigenous Australians residing in remote areas experienced a disproportionate amount of 
the health gap due to all selected risk factors excluding illicit drugs (Figure 6.5). 
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Figure 6.5: Indigenous health gap (DALYs) by selected risk factors expressed as proportions by 
remoteness, 2003 
6.3 Differentials by remoteness 
6.3.1 Disease burden by remoteness 
Indigenous Australians experienced 3.6% of the total disease burden in Australia in 2003 
(Table 6.6). While Indigenous Australians in remote areas made up just over one-quarter of 
the Indigenous Australian population, they experienced more than one-third of the 
Indigenous Australian disease burden (35.0%). In remote areas, Indigenous Australian males 
experienced a greater proportion of the burden than their counterparts in non-remote areas. 
For Indigenous Australians, a greater proportion of burden was due to years lost from 
mortality, particularly in remote areas.  
Table 6.6: DALYs for remoteness categories by proportions of total, proportions by sex, and 
proportions due to mortality, Australia, 2003 
      Per cent of DALYs 
Population group DALYs Per cent of total Males Fatal burden 
Indigenous Australians 95,976 3.6 52.2 53.6 
Non-remote  62,357 2.4 50.9 49.2 
Remote  33,619 1.3 54.7 61.8 
Total Australian population 2,632,770 100.0 51.8 48.6 
 
Compared with Indigenous Australians residing in non-remote areas, Indigenous 
Australians residing in remote areas experienced a greater rate of burden for each of the 
10 leading cause groups except for mental disorders (Table 6.7). The greatest remote to non-
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remote differentials were for infectious and parasitic diseases (RR 2.9), intentional injuries 
(RR 2.0), and unintentional injuries (RR 2.0). 
Table 6.7: .DALY rates per 1,000 by remoteness category for the 10 leading broad cause groups, 
Australia, 2003 
Cause 
Indigenous 
Australians 
Non-remote 
Indigenous(a) 
Remote 
Indigenous(a) RR(b) 
All causes 201.9 181.1 257.9 1.4 
Cardiovascular disease 35.3 31.1 46.9 1.5 
Mental disorders 31.3 32.8 27.0 0.8 
Chronic respiratory disease 18.1 17.1 20.4 1.2 
Diabetes mellitus 17.9 15.8 23.2 1.5 
Cancers 16.4 15.8 18.4 1.2 
Unintentional injuries 14.7 11.7 22.8 2.0 
Intentional injuries 11.3 8.9 17.9 2.0 
Nervous system and sense organ disorders 8.7 8.6 8.7 1.0 
Neonatal causes 8.5 7.8 10.6 1.3 
Infectious and parasitic diseases 8.0 5.3 15.3 2.9 
Other 31.7 26.3 46.7 1.8 
(a) Age standardised to the total Indigenous Australian population, 2003  
(b) Remote to non-remote Indigenous rate ratio 
Indigenous Australians residing in remote areas experienced a higher rate of burden for 15 
of the top 20 specific causes of Indigenous Australian burden (Table 6.8). The rate of burden 
from anxiety & depression, asthma, schizophrenia, and heroin or polydrug dependence was 
lower in Indigenous Australians residing in remote areas than those residing in non-remote 
areas. For lung cancer, the rate of burden was the almost the same in both areas. For the 
remaining conditions, the largest remote to non-remote differentials were for otitis media 
(RR 6.1), and rheumatic heart disease (RR 4.4). 
Indigenous health gap and differentials by remoteness 
77 
Table 6.8: DALY rates per 1,000 by remoteness category for the 20 leading specific causes, Australia, 
2003 
Cause Indigenous 
Non-remote 
Indigenous(a) 
Remote 
Indigenous(a) RR(b) 
Ischaemic heart disease 21.0 19.3 25.5 1.3 
Type 2 diabetes 16.6 14.6 21.5 1.5 
Anxiety & depression 15.7 16.9 12.1 0.7 
Chronic obstructive pulmonary disease 7.6 7.0 9.3 1.3 
Suicide 7.2 6.1 10.2 1.7 
Asthma 6.9 7.8 4.4 0.6 
Road traffic accidents 6.4 4.4 11.6 2.6 
Alcohol dependence & harmful use 5.9 5.1 8.0 1.6 
Stroke 5.7 5.2 6.9 1.3 
Homicide & violence 4.1 2.8 7.6 2.8 
Lung cancer 4.1 4.1 4.2 1.0 
Low birth weight 3.8 3.4 4.9 1.4 
Lower respiratory tract infections 3.5 2.4 6.5 2.7 
Schizophrenia 2.6 2.9 2.0 0.7 
Heroin or polydrug dependence 2.6 3.3 0.6 0.2 
Inflammatory heart disease 2.5 1.7 4.8 2.8 
Otitis media 2.1 0.9 5.7 6.1 
Hepatitis 2.1 1.8 3.1 1.7 
Rheumatic heart disease 2.1 1.1 4.7 4.4 
Birth trauma & asphyxia 2.0 1.8 2.4 1.3 
(a) Age standardised to the total Indigenous Australian population, 2003 
(b) Remote to non-remote Indigenous rate ratio 
6.3.2 Risk factors by remoteness 
Indigenous Australians residing in remote areas experienced a greater rate of burden due to 
nine of the 11 risk factors considered in this study and due to the 11 risk factors combined 
(Table 6.9). The largest differences in rates of burden were for intimate partner violence 
(RR 2.3), alcohol (RR 2.1), and high blood pressure (RR 2.0). Indigenous Australians residing 
in remote and non-remote areas experience a similar rate of burden due to high blood 
cholesterol. 
The rate of burden from child sexual abuse was estimated to be similar in remote and non-
remote areas. This was an artefact of the methods, where — due to lack of information — we 
assumed the same prevalence of child sexual abuse among all Indigenous Australians. These 
results may therefore not be a true reflection of the differentials between these two 
populations. 
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Table 6.9: DALYs attributable to 11 selected risk factors by Indigenous status and remoteness, rate 
per 1,000, Australia 2003  
Risk factor 
Total 
Indigenous 
Non-remote 
Indigenous(a) 
Remote 
Indigenous(a) RR(b) 
Tobacco 24.5 22.8 29.1 1.3 
High body mass 23.0 20.3 30.0 1.5 
Physical inactivity 16.9 15.3 21.0 1.4 
High blood cholesterol 11.1 11.0 11.3 1.0 
Alcohol     
Harmful effects 12.6 10.1 19.2 1.9 
Beneficial effects –1.7 –1.7 –1.6 0.9 
Net effects 10.9 8.3 17.6 2.1 
High blood pressure 9.3 7.3 14.4 2.0 
Low fruit and vegetable intake 7.0 6.1 9.6 1.6 
Illicit drugs 6.9 7.1 6.2 0.9 
Intimate partner violence 5.2 3.8 8.8 2.3 
Child sexual abuse 2.9 2.9 2.9 1.0 
Unsafe sex 2.5 2.2 3.1 1.4 
11 risk factors combined(c) 75.5 68.2 95.0 1.4 
(a) Age standardised to the total Indigenous Australian population, 2003 
(b) Remote to non-remote Indigenous rate ratio 
(c) Figures for joint effects are not column totals; see Section 5.1 for further details 
6.3.3 Mortality by remoteness 
The probability of dying between ages 15 and 60 years is higher in Indigenous Australians 
residing in remote areas than in those residing in non-remote areas: 46% and 31% for males 
and females, respectively (Table 6.10). Also, the probability of dying before age 5 is higher in 
Indigenous children in remote areas compared to that of children in non-remote areas: 2.5% 
and 2.1% for males and females, respectively (compared to 1.5% and 1.3%). 
Our estimates indicate Indigenous Australians residing in remote areas have a markedly 
lower life expectancy than Indigenous people residing in non-remote areas (major cities and 
regional areas combined): 58 years vs. 66 years in males and 65 years vs. 70 years in females. 
However the extent of the differences in life expectancy for Indigenous Australians by 
residence of remoteness is a matter of ongoing controversy and debate. Some members of the 
Steering Committee consider that at least some of the differences may be due to incomplete 
identification of Indigenous deaths and population counts in non-remote areas despite our 
attempts to correct for these issues using indirect demographic methods. On the other hand, 
members of our technical advisory panel believed our findings to be plausible and data on 
non-fatal health outcomes analysed for this study also indicated substantial differences in the 
health status of Indigenous Australians by remoteness. 
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Table 6.10: Expectation of life at birth and probability of dying before age 5 and between ages 15 
and 60 for Indigenous Australians by remoteness, 1996–2001  
  
Life expectancy 
(years) 
Life expectancy gap 
with total 
population (years) 
Probability of dying 
before age 5  
Probability of 
dying between 
ages 15 and 60  
Area Males Females  Males Females  Males Females   Males Females
Indigenous Australians 64 69  13 13  0.016 0.014   0.326 0.231
Non-remote  66 70  11 12  0.015 0.013   0.272 0.199
Remote 58 65  19 17  0.025 0.021   0.460 0.314
Total Australian population 77 82     0.007 0.006   0.101 0.057
6.3.4 Healthy-adjusted life expectancy by remoteness 
Health-adjusted life expectancy (HALE) provides an estimate of the average years of 
equivalent ‘healthy’ life (without disability) that a person can expect to live at various ages. 
HALE is related to life expectancy, which provides an estimate of the average years of life 
that a person can expect to live at various ages given current risks of mortality. HALE 
extends this concept by reducing the estimated duration by the proportion of time spend at 
each age in states less than perfect health, adjusted for the relative severity of those health 
states. The sum of PYLD across all causes is used to derive this ‘severity-weighted’ 
proportion for each age. We assumed no change in life expectancy from 1996–2001 estimates 
when calculating the HALE estimate for Indigenous Australians in 2003. 
The gap in HALE between the Indigenous Australian population and total Australian 
population was approximately 15 years (Table 6.11); with Indigenous Australians losing a 
greater proportion of their shorter life expectancy due to disability.  
Table 6.11: Health-adjusted life expectancy at birth by area and sex, Indigenous Australian and 
total Australian populations, 2003 
  HALE (years)  
Life expectancy at birth 
lost due to disability (%) 
  Males Females   Males Females 
Indigenous Australians 56 60   18 13 
Non-remote  58 62   12 12 
Remote  51 56   13 13 
Total Australian population 71 75   10 9 
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7 Discussion and conclusions 
7.1 Policy implications 
A detailed description of the burden of disease and injury in a population is not sufficient for 
setting priorities in public health. It is, however, an important foundation on which to build 
assessments and evaluations that underpin health policies. This study contributes most 
obviously by identifying the magnitude of health problems in the Indigenous population 
and by quantifying the contribution of major modifiable risks to these health problems. In 
particular, the excess amount of disease burden that Indigenous Australians experience in 
comparison with the total Australian population indicates where the greatest potential for 
health gain is. The fact that much lower rates of disease burden are experienced by the 
majority of Australians means that with existing knowledge and technologies, a reduction of 
most of the Indigenous health gap is achievable. However, reducing this health gap is a 
momentous task, because the health disadvantage of Indigenous Australians is apparent in 
almost all diseases and risk factors, at all ages, in men and women, and in remote and less 
remote areas. The most important contribution of this study is to comprehensively quantify 
the health problems that Indigenous Australians face. This helps policy makers identify 
which health issues are most likely to lead to health improvements if targeted for 
intervention. 
To set priorities for interventions, complementary information is needed on the cost-
effectiveness of specific interventions for each of these health problems. The details provided 
in this study on each disease and risk factor are essential inputs to such economic analyses. 
This set of results is already being incorporated into economic models that are under 
development for the ‘Assessing Cost-Effectiveness (ACE)—Prevention’ project funded by the 
NHMRC at The University of Queensland and Deakin University. The aim of the ACE-
Prevention project is to comprehensively model the cost-effectiveness of preventive 
intervention options for non-communicable disease in Australia and, explicitly, to examine 
the implications if these interventions are delivered to Indigenous Australians. 
There is great potential to reduce the Indigenous health gap by addressing the 11 risk factors 
identified in this study. There is growing evidence to guide choices on what preventive 
interventions for which risk factors are most likely to be effective and cost-effective in the 
total Australian population but not yet for the Indigenous population. The much higher 
disease burden makes it more likely that interventions can achieve large health gain in 
Indigenous Australians. In economic evaluations this needs to be taken into account together 
with the different costs of interventions that are culturally appropriate and may need to also 
reach people in remote areas. 
In this study, we found that certain diseases and risk factors contributed more to the overall 
burden of disease in Indigenous Australians, particularly to the Indigenous health gap. 
These included cardiovascular disease, diabetes and other tobacco-related conditions, such 
as lung cancer and chronic respiratory disease. Collectively, these diseases accounted for half 
the Indigenous health gap. Apart from tobacco, these diseases shared additional lifestyle risk 
factors, including high body mass, physical inactivity, raised blood pressure and cholesterol. 
These health problems largely affect middle-aged and older Indigenous Australians; 
however, they start at young ages, and there already is a sizeable burden in the 15–34-year 
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age group. Therefore, prevention efforts should be targeted at a much younger Indigenous 
population than in the rest of the population. 
Further health gain can be expected if the excess burden from infectious disease and neonatal 
conditions is addressed. These conditions explained 15% of the Indigenous health gap. Half 
of this excess burden was experienced by children. 
Suicide, RTAs, and homicide & violence were the main injuries that explained another 15% 
of the health gap. Most of this excess in injuries occurred at young adult ages and there was a 
particularly high rate of suicide in young Indigenous males. Mental disorders, including 
substance use disorders — particularly alcohol, also contributed significantly (10%) to the 
health gap. 
When addressing the health gap, it is important to note that the focus should not just be on 
prevention. The higher proportion of the health gap that was due to mortality reflected the 
greater chance of dying if Indigenous Australians fall sick. Each disease may have specific 
problems to be addressed; however, it is likely that the higher case fatality for most diseases 
was influenced by a combination of late presentations, shortcomings in acute surgical and 
medical management, and inadequate follow-up during the course of disease. Therefore, a 
multi-pronged approach is needed. 
It is important to note that while the rate of burden of disease may be higher in remote areas, 
the bulk of the burden and the health gap for Indigenous people is in non-remote areas since 
the vast majority of Indigenous Australians reside in non-remote areas. The policy 
implication is that the focus of health service action to reduce inequalities in Indigenous 
health needs to include culturally appropriate and uniquely targeted approaches for non-
remote and remote areas. The value of this report is that it indicates to policy makers where 
the emphasis may need to vary depending on the health problem being addressed by broad 
remoteness area. 
Addressing the multitude of health problems facing Indigenous Australians is complex and 
will require a wide range of initiatives to increase preventive and curative efforts from 
mainstream and particularly Indigenous health services. NACCHO states that: 
It is widely recognised that health solutions lie in assisting Aboriginal people being 
able to enjoy their right to self-determination. All relevant inquiries and studies have 
shown conclusively that culturally appropriate, comprehensive primary health care 
(such as Aboriginal community controlled health services), based on maximum 
community participation, is the best way of addressing Aboriginal health (NACCHO 
2001).   
It would be more effective to combine this with approaches outside the health sector to 
address the social and economic disadvantages that contribute to the poor health status of 
Indigenous Australians. This is in keeping with the Indigenous concept of health which 
acknowledges that:  
Improving Aboriginal health is not just about improving the physical well-being of 
an individual. It is about working towards the social, emotional, and cultural well-
being of the whole community in which each individual is able to achieve their full 
potential as a human being (NACCHO 2001).  
However these requirements should not lead to inaction by health policy makers arguing 
that the social and economic problems should be tackled first. It is within the reach of 
appropriately resourced health services to reduce a sizeable proportion of the Indigenous 
health gap. 
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7.2 Precision of estimates 
7.2.1 Mortality estimates and years of life lost 
Assessing the health status of Indigenous Australians is not easy. The main challenge is the 
inaccurate or incomplete identification of Indigenous status in population health and census 
data collection systems. When estimating mortality in Indigenous Australians, this means 
that ascertainment of the true rate of death requires adjustments using indirect demographic 
methods, which inherently introduce an additional degree of uncertainty. We applied the 
GGB method, an indirect demographic technique frequently used in developing country 
settings to estimate under-reporting of deaths (Hill 1987). The ABS has applied a similar 
method developed by Bhat (2002) to correct for under-registration of deaths for the purpose 
of Indigenous population projections. Ken Hill, a demographer at Harvard University and 
the world expert on these indirect demographic techniques, recommended that we use the 
GGB method in preference to the Bhat method, as applied by the ABS, because it requires 
fewer assumptions. As there is no ‘gold standard’ against which to compare either method, 
plausibility is the key issue. The GGB’s main assumptions are a constant age pattern of 
under-identification of the Indigenous population counts at two successive censuses and a 
constant age pattern of under-identification of deaths in the vital registration system. This 
may not be the case.  
To test these two vital assumptions, we carried out a series of sensitivity analyses using 
advice from the steering committee members on the likely direction of departure from this 
constant age pattern by assuming greater proportions of under-identification in younger 
adults and a greater proportion of males being under-identified. None of the sensitivity 
scenarios altered our conclusion that the true level of mortality of Indigenous Australians 
was not as high as the ABS has estimated (a gap in life expectancy at birth of around 13 years 
rather than 17 years) but was still at unacceptably high levels for a high-income country.  
Uniquely, we also introduced a calculation of corrected mortality rates and life expectancy 
for Indigenous Australians residing in remote and non-remote areas. This showed, for the 
first time, that there is a considerable difference in mortality for Indigenous Australians 
residing in remote compared to non-remote areas. We were also able to correct these 
estimates for the net flow of migration of Indigenous people from remote to non-remote 
areas based on census data. However, the extent of the differences in life expectancy between 
remote and non-remote areas is a matter of ongoing controversy and debate. Some members 
of the Steering Committee consider that at least some of the differences may be due to 
incomplete identification of Indigenous deaths in non-remote areas. On the other hand, data 
on non-fatal health outcomes analysed for this study indicate that there also are substantial 
differences in health status between Indigenous people residing in remote and non-remote 
areas. 
Despite our confidence that we estimated plausible mortality rates, we cannot be certain 
about the true level of mortality in Indigenous Australians until better data becomes 
available. The ABS has commenced a project to link 2006 Census with deaths that occurred 
in the 10 months following the Census. This will greatly assist in determining the 
completeness of death registration relative to census counts. The longer-term strategy will 
have to include efforts to improve the recording of Indigenous status in the vital registration 
system. 
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Estimating the cause of death was deemed more accurate because the quality of certification 
of cause of death for Indigenous people was similar to that for the rest of the population 
when comparing the proportions of deaths coded to ill-defined codes. We therefore assumed 
that the cause of death pattern in deaths recorded as Indigenous reflected the pattern of all 
Indigenous deaths. As we discussed earlier, in the National Study (Begg et al. 2007), there are 
unresolved issues around the validity of cause of death attribution even in the high-quality 
vital registration systems that we have in Australia. That concern would also apply to cause 
of death attribution in Indigenous Australians but is unlikely to lead to different conclusions 
about the main causes of fatal disease. 
In this study, we assumed that the level of mortality estimated for the 1996–2001 period 
between censuses applied to our baseline year of 2003 for the burden of disease estimation. 
This was a decision made in consultation with our technical advisory panel because there 
was a lack of reliable information on mortality trends in Indigenous Australians. More recent 
information has indicated an improvement in life expectancy in Aboriginal people in the 
Northern Territory that are of the same magnitude as the trends in life expectancy for the 
total Australian population, although with a reversal of the sex ratio (Wilson et al. 2007). The 
annual rate of change in life expectancy in Northern Territory Indigenous men was 
0.22 years compared with 0.33 years for all Australian men; for Northern Territory 
Indigenous women it was 0.38 years compared with 0.22 years in all Australian women. If 
we applied the Northern Territory trend to adjust our mortality estimate downwards, the 
total amount of YLL in Indigenous Australians would have been lower by 7% and the total 
amount of DALYs lower by 4%. 
7.2.2 Non-fatal burden 
Estimates of disability for the more than 170 disease and injury categories included in this 
study depended on a combination of methods. When available, we included data on directly 
observed Indigenous health events in routine health statistics databases, health surveys or 
epidemiological studies. For many diseases, such information did not exist. Instead, ratios of 
the differences between Indigenous and total population rates, for hospital admissions or 
mortality, were sought as proxy measures of disease occurrence. The consequence is that 
there are varying degrees of confidence about the accuracy of these estimates. This study 
provides transparency on the data sources consulted and all the assumptions and judgments 
on which the results depend. 
Only six of the top 20 disabling conditions had good-quality estimates of their incidence. 
These conditions included ischaemic heart disease, stroke, homicide & violence, low birth 
weight, and birth trauma & asphyxia — all of which relied on hospital admission statistics. 
However, hospital data also suffers from under-reporting of admissions for Indigenous 
Australians. We made crude adjustments based on judgments by the states and territories on 
the quality of the recording of Indigenous status in their jurisdiction combined with one 
study of the quality of Indigenous status identification by remoteness from New South 
Wales. What we were not able to adjust for was the potential difference in propensity to be 
admitted for a health problem between the Indigenous and total Australian population. A 
range of factors, including care-seeking behaviour, severity of disease at presentation, 
distance to hospital and admission practices, may be different for Indigenous Australians. 
Some of these factors would lead to higher and some to lower admission rates. It is not clear 
what the net effect is and how much this varies from disease to disease. We judged that the 
estimates for cardiovascular events and more severe injuries were more likely to reasonably 
reflect true differentials in disease occurrence as they were emergency events. For maternal 
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and neonatal conditions, we also judged the accuracy of hospital-derived estimates as good 
quality, because almost all deliveries take place in hospital. 
The only other condition with good data among the top 20 disabling conditions was dental 
caries. We judged the accuracy of estimates for alcohol dependence, migraine and 
personality disorders as particularly poor. The accuracy of estimates for the remaining top 
20 conditions were only judged as fair only. This indicated that there was a large gap in 
knowledge to accurately estimate the disease occurrence of many major diseases 
contributing to the disability component of the burden of disease. Mental disorders, Type 2 
diabetes, asthma and COPD each had good-quality data to estimate the burden in the total 
Australian population but accurate data in Indigenous Australians was lacking. We resorted 
to finding differentials between Indigenous Australians and the total Australian population 
in proxy data sources, or were limited to a few isolated epidemiological studies to generalise 
to the whole population. This is a key strategy in burden of disease and injury studies. 
Instead of ignoring health problems with poor data sources, we endeavoured to approximate 
the size and extent of each health problem even if it meant using less-adequate proxy 
indicators. The argument for doing so was that this makes it more worthwhile to policy 
makers than presenting an incomplete quantification of health problems.  
A key gap in available data to estimate the large contribution of major risk factors to the 
overall Indigenous burden of disease and the Indigenous health gap was the lack of 
representative health measurement data on key risk factors, such as blood pressure, 
cholesterol and body mass. We strongly recommend that a representative Indigenous health 
measurement survey is undertaken to measure these risk factors. Such a survey could 
include also measure a number of other important health problems for which we currently 
have poor data, such as diabetes, COPD, asthma and hearing loss. 
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Appendix A Australian mortality data 
adjustment 
A.1 Mortality data  
A.1.1 Data access 
Throughout this report, we use the term ‘Australian mortality data’ as shorthand for the 
AIHW’s National Mortality Database (AIHW 2003a). We accessed Australian mortality data 
under the data sharing agreement put in place between The University of Queensland and 
the AIHW for the purposes of estimating the burden of disease and injury in Australia in 
2003. We were supplied with a unit record file of Australian deaths, which included: 
underlying and associated causes of death coded according to the 10th revision of the 
International Classification of Diseases (ICD-10), date of death registration, Indigenous status, 
usual statistical local area (SLA) of residence, age and sex. For burden of disease estimates, 
we considered all deaths of Indigenous Australians that were registered between 2000 and 
2003 (specifically 2000–02 deaths for the GGB method and 2001–03 deaths for the Indigenous 
cause of death structure).  
A.1.2 Indigenous status in mortality records 
It is important to note that while an Indigenous identifier has been progressively introduced 
since 1980, a uniform system of identifying the Indigenous status of all deaths in Australia 
was only established in the mid to late 1990s. Queensland only included a question on 
Indigenous status of the deceased person in 1996. 
When an Indigenous person dies, their death will only be classified correctly as an 
Indigenous death in the registrar’s database if the following events occur: 
• the question about Indigenous status is answered correctly on the death certification 
form completed by the funeral director (which usually requires that the question is asked 
of a relative or friend who knows what the deceased person would have answered; and 
that the answer is recorded correctly on the form) 
• the form is completed and submitted to the registrar’s office 
• the form is processed and the information about Indigenous status is correctly entered 
into the system 
• this information is retained throughout the editing and data processing stages and 
captured correctly on the file sent by the registrar to the ABS. 
A.1.3 Classification of deaths for burden of disease purposes 
Deaths were mapped into ‘burden of disease and injury’ categories and some specific and 
non-specific causes of death were redistributed. We refer the reader to the following sections 
— ‘Categorising deaths’ and ‘Redistributing non-specific causes of deaths’ (pages 18–21) — 
within the National Study for additional information on this topic area (Begg et al. 2007). 
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A.1.4 Classification of data by remoteness  
We used the 2001 Australian Standard Geographical Classification (ASGC) Remoteness 
Areas (based on ARIA+ index values) to code deaths by SLA of usual residence to broad 
remoteness areas. The ASGC is a geographic approach to remoteness based on road distance 
to five categories of service centre (as a surrogate for remoteness) and on the population size 
of a service centre (as a surrogate for the availability of services). A classification based on 
road distance implies that persons have equal access to road transport (either via car or 
public transport). However, some population groups (such as persons in less urban areas) 
have lower levels of access to car and public transport than the general population. Road 
distance classifications also do not allow for differences in terms of road quality and 
serviceability (some roads in remote Australia are inaccessible for substantial parts of the 
year due to flooding). The five categories of remoteness are (AIHW 2004b): 
• major cities of Australia 
• inner regional Australia 
• outer regional Australia 
• remote Australia 
• very remote Australia. 
We collaborated with the ABS to develop a whole-of-allocation SLA to broad remoteness 
area mapping (to account for those SLAs that are not wholly contained within one 
remoteness area) for the 1991, 1996 and 2001 census data . We then purchased these 
concordances. To take into account boundary changes in SLAs between censuses, we 
updated the mapping file using published information (ABS 2001). We initially aggregated 
the five ASGC categories into three broad remoteness areas: major cities, regional (inner 
regional and outer regional) and remote (remote and very remote) areas. In 2001, Indigenous 
Australians were fairly evenly distributed across Australia by remoteness areas with just 
over one in four Indigenous Australians residing in remote areas, compared with 2% of non-
Indigenous Australians; while the vast majority of the non-Indigenous population resided in 
Major cities (67%) (Table A.1) (ABS 2003b). 
Table A.1: Per cent of Australian population by broad remoteness areas and Indigenous status, 2001 
Indigenous status Major cities  Regional Remote 
Indigenous 31 43 26 
Non-Indigenous 67 31 2 
Source: ABS (2003b) 
The following map shows a graphical distribution of the Indigenous Australian communities 
by the broad remoteness categories of major cities, regional and remote areas (Figure A.1). 
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 Following our first application of the GGB method (see section A.2.4) we further refined the 
ASGC categories into non-remote (major cities, inner regional and outer regional) and 
remote (remote and very remote) areas. 
A.1.5 Estimating the 2003 experimental Indigenous population by 
remoteness 
Rates in this study are calculated from the low series of experimental projections for 2003 
based on the 2001 Census of Population and Housing. We extrapolated the Indigenous 
experimental population for 2003 by broad remoteness areas (non-remote and remote), sex 
and age (0,1,5–85+) in Stata v. 9.0. First we used the 2001 census data for Indigenous 
Australians by remoteness to extrapolate the appropriate percentage breakdowns for our age 
groups of interest: 0,1,5 (by 5-year age groups) to 85+. Secondly we adjusted the projections 
to give our age groups of interest. Finally we assumed that the proportionate breakdown by 
age and sex in 2001 still held in 2003 by broad remoteness areas. We used the following ABS 
files: (a) 30 June 2001 census data for Indigenous Australians by ASGC remoteness areas, sex 
and age (0,1,5–100+) — customised data request; (b) 30 June 2001 experimental Indigenous 
population estimates by states and territories, ASGC remoteness areas, sex and age (0, 5–75+) 
— customised data request; (3) 2001–2009 Experimental Projections of Aboriginal and Torres 
Strait Islander Australians by state and territory, ATSIC Regions, sex and age (0,4,5–75+) — 
available as a download (ABS 2004b); and (4) 2001–2009 Experimental Projections of 
Aboriginal and Torres Strait Islander Australians by state and territory, ATSIC Regions, sex 
and age (0,1) — customised data request. 
A.2 Method for correcting mortality rates 
A.2.1 Methods used by the ABS  
The first indirect demographic method applied by the ABS to correct for under-identification 
in Indigenous Australian mortality rates was the Preston and Hill (1980) method In a 
subsequent review, the ABS determined that the method was not appropriate because the 
ongoing unexplainable intercensal increases in people identifying as Indigenous violated the 
method’s requirement of a closed population. Following the 2001 census, the ABS utilised a 
method proposed by Bhat (2002) that allows for migration of known age pattern, but at the 
cost of requiring information about the rate of natural increase of the population. 
A.2.2 ABS results using the Bhat method 
Experimental work for the 1996–2001 period by the ABS using the Bhat method indicated a 
large difference (around 17 years) in the life expectancy at birth of Indigenous Australians at 
a national level (59.4 years for males and 64.8 years for females) relative to the total 
Australian population (76.7 years for males and 82.4 years for females) for the 1998–2000 
period (ABS 2004a). Estimates by grouped states and territories were made (Table A.2). 
There was no clear pattern across jurisdictions with Northern Territory males having the 
lowest life expectancy at birth (57.6 years) by 0.9 years whereas Northern Territory females 
had the second highest life expectancy at birth (65.2 years) after South Australia. The ABS 
assumed that the Bhat-derived correction factor, which is based on deaths at ages 5 to 64, 
applied to deaths at all ages (including under-five mortality) (ABS 2004a). 
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Table A.2: ABS life expectancy at birth estimates (years) for Indigenous Australians by sex, 1996–
2001 
Area Males Females Difference 
Australia 59.4 64.8 5.4 
NSW, Vic, ACT and Tas 60.0 65.1 5.1 
Qld 58.9 62.6 3.7 
SA and WA 58.5 67.2 8.7 
NT 57.6 65.2 7.6 
Note: Unadjusted for interstate migration 
While the ABS assessed the life-expectancy estimates based on the Bhat method as suitable 
for the purpose of producing short-range experimental estimates and projections of the 
Indigenous population, the ABS makes the following important qualifications (ABS 2004a): 
1. “There is some degree of circularity in the way the unexplained growth is 
calculated. The Bhat method is used to estimate the completeness of death 
registration data and then to produce an ’approximate’ life table for Australia. 
This ’approximate’ life table is then used to calculate unexplained growth of 
the Indigenous population. Therefore, the accuracy of the level and age 
distribution of unexplained growth obtained this way is very much 
dependent on the accuracy of the ‘approximate’ life table this method 
produced in the first place.” 
2. ”It should be noted that the correction to the registered Indigenous deaths, the 
level of the unexplained population growth and the age distribution of the 
unexplained growth are all based on subjective judgements, and any 
variations in these would influence the outcome as measured by the 
expectation of life at birth.” 
3. “Results obtained from the sensitivity analysis show that life expectancy 
estimates derived under various assumptions vary widely, suggesting that the 
life expectancy estimates in the life tables will not be robust for some forms of 
analysis.” 
4. ”Over-precise analysis of these life expectancy estimates as measures of 
Indigenous health outcomes should be avoided.” 
A.2.3 UQ results for grouped states using the GGB method  
Table A.3 shows our results of the GGB method for 1996 to 2001. The GGB method indicated 
life expectancy at birth estimates for Indigenous Australians around 13 years lower than that 
of the total Australian population. Thus, our reassessment suggested that the total 
Indigenous mortality differential, although still large, was smaller than previously estimated 
by the ABS. Further, the GGB method indicated a gradient in the mortality experience of 
grouped jurisdictions. Note, as in the ABS approach, that the life expectancy estimates for 
grouped states have not been adjusted for interstate migration. 
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Table A.3: GGB life expectancy at birth estimates (years) for Indigenous Australians by sex, 1996–
2001  
Area Males Females Difference
Australia 64 69 5
NSW, Vic, ACT and Tas 68 72 4
Qld 64 68  4
SA and WA 64 67 3
NT 56 65 9
Note: Unadjusted for interstate migration 
Interestingly, the GGB results are similar to results reported by the ABS prior to their second 
major adjustment for ‘identification migration’ (i.e. assuming a population growth rate) 
(Table A.4). This is because, up to this point, the Bhat method is essentially treating change in 
identification as change in census coverage, similar to the GGB method. Professor Hill 
argued that this is not necessary and that correcting again for migration is essentially a 
double adjustment.  
Table A.4: GGB life expectancy at birth estimates (years) for Indigenous Australians by sex versus 
ABS results with zero unexplained change, 1996–2001  
 Males Females 
Area ABS(b) GGB Difference ABS(b) GGB Difference
Australia 63 64 1 68 69 1
NSW, Vic, ACT & Tas(a) 66 68 2 71 72  1
Qld 62 64 2 68 68 –
SA & WA(b) 61 64 3 70 67 -3
NT 57 56 -1 64 65 1
(a) The ABS presented life expectancy results at birth for this stage only by individual jurisdiction the GGB New South Wales grouped states are 
compared only with ABS New South Wales and GGB South Australia/Western Australia are compared only with South Australia 
(b) Source: ABS (2004a) 
Note: Unadjusted for interstate migration 
A.2.4 UQ results by remoteness (major cities, regional and remote) 
using the GGB method 
We hypothesised that the gradient observed in our exploratory life expectancy results by 
grouped states and territories could largely be explained by the proportions of Indigenous 
people residing in major cities, regional and remote areas (Table A.5) and the level of life 
expectancy by area of remoteness. For example, the Northern Territory had the lowest life 
expectancy and the highest proportion of people residing remotely whereas New South 
Wales/Victoria had the highest life expectancy and the lowest proportion of Indigenous 
people residing remotely. 
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Table A.5: Per cent of Indigenous population by broad remoteness areas and grouped jurisdictions, 
2001 
Grouped states  Major cities   Regional  Remote 
NSW, Vic 40  55 5 
Qld 25  51 24 
SA, WA  36  25 39 
NT  0  19 81 
Source: AIHW (2005b) 
Applying the GGB method to census and mortality data for Indigenous people by 
remoteness supported this hypothesis, with remote areas experiencing the lowest life 
expectancy at birth and major cities/regional areas faring similarly (Table A.6). Note, at the 
time these estimates were made inter-regional migration was not accounted for. After 
consultation with our advisory committees it was decided to combine the estimates for major 
cities and regional areas. Thus mortality differentials and disease burden estimates in this 
report are presented for Indigenous Australians residing in non-remote and remote areas 
only.  
Table A.6: Preliminary GGB life expectancy at birth estimates (years) for Indigenous Australians 
by broad remoteness areas and sex, 1996–2001 
Area  Males  Females 
Australia 64  69 
Major cities 68  71 
Regional 67 72 
Remote 58 64 
A.2.5 Final UQ results by remoteness (non-remote and remote) 
using the GGB method 
Based on the GGB method, Indigenous people residing in remote areas experience a greater 
gap in life expectancy compared with Indigenous people in non-remote areas (Table A.7). 
Table A.7: GGB life expectancy at birth (years) for Indigenous Australians by broad remoteness 
areas and sex, 1996–2001 
 Males  Females 
Area Life 
expectancy 
Difference with 
total population 
 Life 
expectancy 
Difference with 
total population 
Australia 64 13  69 14 
Australia (fitted)(a) 64 13  69 14 
Non-remote 66 11  70 12 
Remote 58 18  65 18 
(a) Fitted life expectancies for Australia are based on corrected age- and sex-specific mortality rates for non-remote and remote areas multiplied 
by population data to give deaths, which are summed and entered into a new life table for Indigenous Australians at a national level 
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A.2.6 Consistency check  
We multiplied and summed the proportions of Indigenous people residing in non-remote 
and remote areas in each of the grouped states by the corresponding life expectancy 
estimates for non-remote and remote areas. This gave life expectancy estimates that are 
reasonably consistent with those predicted by the GGB method for the grouped states (Table 
A.8). This finding supported our hypothesis that differentials in life expectancy of 
Indigenous Australians by states and territories are largely a function of remoteness. 
Table A.8: GGB life expectancy at birth estimates (years) for Indigenous Australians by grouped 
jurisdictions and sex versus predicted results, 1996–2001  
 Males  Females 
Area Predicted  GGB Difference  Predicted  GGB Difference 
NSW, Vic, ACT and Tas 66 68 –2  70 72 –2 
Qld 64 64 –  69 68 1 
SA and WA 63 64 –1  68 67 1 
NT(a) 60 56 4  66 65 1 
(a) Compared with the 1996–2001 Northern Territory life expectancies at birth based on John Condon’s internally consistent dataset, males: 59.8; 
females: 66.0 (Wilson et al. 2007) 
Note: Predicted life expectancy at birth based on life expectancy by remoteness, age and sex and proportion of people residing by remoteness in 
each grouped jurisdiction by age and sex 
A.3 Cause of death structure 
Since the recording of mortality statistics is thought to be complete in Australia and 
Indigenous identification is incomplete, it follows that deaths in the not-stated Indigenous 
category and the non-Indigenous category include Indigenous deaths. The plotted 
proportions of deaths by age groups show that the deaths with not-stated Indigenous status 
have a very similar age distribution to that of the non-Indigenous deaths, with most of the 
deaths occurring in older age groups (Figure A.2 and Figure A.3). Conversely, the age 
distribution of Indigenous deaths shows a distinctly different pattern for both males and 
females. These graphs suggest that the deaths in the not-stated Indigenous category are 
predominantly non-Indigenous deaths. However, it is important to note that even if there is 
a small number of deaths within the not-stated Indigenous categories that are Indigenous, 
this could significantly affect Indigenous mortality rates without influencing the non-
Indigenous mortality profile. 
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Figure A.2: Proportion of male deaths by recorded Indigenous status and age, 2000–02 
0%
5%
10%
15%
20%
25%
30%
35%
40%
0 1 5 10 15 20 25 30 35 40 45 50 55 60 65 70 75 80 85 UN
Age
Indigenous Non-Indigenous Not-stated
 
Figure A.3: Proportion of female deaths by recorded Indigenous status and age, 2000–02 
Apart from childhood mortality, age-specific mortality rates are expected to increase linearly 
and exponentially. The logged age- and sex-specific mortality rates for the Indigenous 
Australian and total Australian populations followed this pattern (Figure A.4 and Figure 
A.5). This suggested that vital registration data for deaths recorded as Indigenous was not 
subject to a selection bias by age.  
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Figure A.4: Logged recorded male Indigenous and total Australian population rates, 2000–02 
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Figure A.5: Logged recorded female Indigenous and total Australian population rates, 2000–02 
A.3.1 Analysis of Indigenous cause of death structure 
Proportions of ill-defined and residual categories contributing to overall mortality are 
indicators of the quality of the cause of death coding. Ill-defined mortality as a proportion of 
overall mortality was less than 2% for both Indigenous and non-Indigenous Australians 
(Figure A.6). In addition, residual categories (e.g. other neoplasms, other cardiovascular 
conditions, etc) for Indigenous and non-Indigenous Australians contributed 10% and 8% to 
overall mortality respectively. (From experience working with mortality data, we tend to say 
that in a good-quality vital registration system, the contribution of residual categories should 
not exceed 10%.) 
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Figure A.6: Burden of disease ill-defined categories as a proportion of overall mortality by 
Indigenous status 2000–02 
Finally, the standardised proportions of deaths by broad cause clusters (group 1, 
communicable disease, neonatal and maternal causes; group 2, non-communicable diseases; 
and group 3, injuries) and Indigenous status showed how similar the cause of death 
structure is for deaths identified as Indigenous and those identified as non-Indigenous 
(Figure A.7). 
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Figure A.7: Proportion of deaths in broad cause categories by Indigenous status, 2000–02 
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Appendix B Australian hospital data 
adjustment 
Throughout this report, we use the term ‘Australian hospital data’ as shorthand for the 
AIHW’s National Hospital Morbidity Database (AIHW 2003b). This dataset is a compilation 
of episodes of care (or ‘separations’) and includes people who were admitted to a hospital in 
Australia for a particular condition or procedure at least once in 2001–02 and 2002–03. The 
following three issues must be taken into account when using Australian hospital data to 
describe and compare the health status of Indigenous Australians: 
• the under-identification of Indigenous Australians in population health datasets 
• the utility of hospital data in general as an indicator of disease occurrence 
• the plausibility of relativities by remoteness and for major diseases given adjustments for 
under-identification in Indigenous status.  
These three issues are explained in the following sections. 
B.1 Quality of Indigenous identification in 
Australian hospital data 
Australia has a universal system of access to hospital services and records all episodes of 
care in hospital. However, a number of studies have shown that Indigenous identification in 
hospitals is under-reported and as a result, true hospitalisation rates for Indigenous 
Australians are likely to be higher than what is observed (AIHW 2005d).  
The AIHW has developed correction factors for Indigenous under-identification in hospital 
data (see Table B.1). These assessments are based on consultation with state and territory 
health authorities and include a range of inputs, such as review of separation numbers, 
detailed internal data consistency checking, and formal data quality studies (AIHW 2005d). 
The Northern Territory and South Australia are thought to have complete Indigenous 
identification, with Western Australia being very close. The completion of Indigenous 
identification decreases from Queensland to Victoria to New South Wales. All together, the 
adjustment factors implied a national under-identification factor of 16% in 2001–02 (AIHW 
2005b). 
B.2 AIHW correction factors  
The AIHW has developed correction factors for Indigenous under-identification in hospital 
data for each state and territory for use in their Expenditures on health for Aboriginal and Torres 
Strait Islander peoples report (AIHW 2005b). They also have estimates by remoteness from a 
New South Wales record linkage study. The approach, recommended by the AIHW, was to 
adjust the correction factors by remoteness (Table B.2) on a pro-rata basis by state and 
territory to equal the overall state and territory correction factors (Table B.1) (John Goss, 
email, 17 January 2006).  
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Table B.1: Under-identification factors by jurisdiction used for estimating hospital expenditure for 
Indigenous patients by the AIHW (2001–02) 
State/territory Under-identification 
adjustment(a) 
Derived completeness  
(1/under-identification adjustment) (%) 
NT NIL(b) 100 
SA NIL(b) 100 
WA 1.06 94 
Qld 1.20 83 
Vic 1.25 80 
NSW 1.30 77 
ACT 1.30 77 
Tas NIL According to expenditures report, the quality is 
thought to be too poor to estimate a correction factor
(a) Source: Table A5.4 in Appendix A of the Expenditures on Health for Aboriginal and Torres Strait Islander Peoples 2001–02 report (AIHW 
2005b:42) 
(b) For those states and territories where no under-identification adjustment was made, the not stated responses were distributed between 
Indigenous and non-Indigenous patients according to the proportion of identified responses 
B.2.1 The New South Wales record linkage study 
The New South Wales Health Department assessed the under-identification of Indigenous 
status by statistically matching individual patients within annual sets of data from its 
hospital separations data collection. Linked separations were identified for all Indigenous 
patients, and an estimate of under-identification was derived from Indigenous patients with 
multiple separations by determining the number of these linked separations that had 
Indigenous status recorded as ‘other than Indigenous’. However, there are several 
limitations to this work. First, in the absence of a unique and universal patient identifier, 
comparison of data for multiple patient episodes relies on the precision of the record linkage 
methods. Second, this method assumes that no individual is incorrectly identified as 
Indigenous. A Victorian data linkage exercise found that some patients reported as 
Indigenous were probably incorrectly identified. Potentially, even very low rates of random 
recording error for non-Indigenous people could outweigh any systematic under-
identification of Indigenous patients. Third, the New South Wales methodology assumes 
that, in theory, recording Indigenous status at admissions is an independent event. However, 
in practice, this is not the case because once someone is identified as Indigenous at a hospital, 
they are more likely to have this status marked on their admission record for subsequent 
admissions (AIHW 2005b, 2005d).  
Table B.2 presents the AIHW’s unpublished work on correction factors by the ASGC 
remoteness areas. The second column shows the correction factor (from the New South 
Wales record linkage study) that is applied to the admissions data in each hospital’s remoteness 
area in New South Wales to bring Indigenous admissions up to the ‘true levels’ of Indigenous 
admissions. The fourth column shows the correction factor required to adjust for under-
identification by the patient’s usual residence of remoteness. This correction factor was 
derived by the AIHW using the 10-year-old linked New South Wales study in conjunction 
with 2003–04 New South Wales hospital separation data for Indigenous people, assuming 
that there have been no changes in Indigenous under-identification practices since the New 
South Wales study was conducted (John Goss, email, 17 January 2006).  
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Table B.2: Under-identification factors by remoteness used for estimating hospital expenditure for 
Indigenous patients by the AIHW (2001–02) 
Remoteness Under-identification 
adjustment by 
remoteness of hospital 
Derived 
completeness by 
remoteness of 
hospital (%) 
Transformed under-
identification adjustment by 
patients usual residence of 
remoteness 
Derived completeness by 
patient’s usual residence by 
remoteness (%) 
Major cities 1.83 55 1.79 56 
Inner regional 1.25 80 1.35 74 
Outer regional 1.21 83 1.27 79 
Remote 1.12 89 1.21 83 
Very remote 1.04 96 1.15 87 
 
The completeness of Indigenous identification in New South Wales is highest in remote areas 
and lowest in major cities. This is in keeping with the finding that Indigenous identification 
has been found to be more accurate in areas where Indigenous Australians make up a larger 
proportion of the population, and vice versa. The AIHW advise that only 51% of separations 
of Indigenous Australians residing in remote areas take place in remote or very remote 
hospitals. Thus the remote adjustment factor changes from 1.12 (when it is based on 
remoteness of the hospital) to 1.21 (when the additional adjustment is made for remoteness 
of the patient’s usual residence). Table B.3 shows rate ratios for the top three non-fatal 
conditions for which we use hospital relativities before and after adjustment.  
Table B.3: Rate ratios for leading three non-fatal conditions based on observed and adjusted 
hospital data 
 Observed Indigenous versus total 
Australian population 
 Adjusted Indigenous versus total 
Australian population 
Disease category All  Non-remote Remote  All Non-remote  Remote 
Type 2 diabetes        
Males 6.1 5.7 7.0  6.7 6.5 7.1 
Females 8.8 7.4 12.3  9.7 8.5 12.5 
COPD        
Males 3.6 3.1 4.6  4.1 3.8 4.7 
Females 4.9 4.2 6.6  5.6 5.1 6.7 
Ischaemic heart disease        
Males 2.1 2.1 2.1  2.4 2.6 2.1 
Females 3.7 3.7 3.8  4.3 4.8 3.8 
B.3 Plausibility of corrected hospital data  
The correction factors reflect the average level of under-identification of Indigenous patients 
across a given group of separations. Therefore, the use of these factors might be problematic 
in disease specific analyses. Annex Table 1 contains a complete list of diseases and injuries 
for which hospital relativities have been used to estimate disease occurrence (this table 
summarises the primary data sources for incidence and prevalence).  
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There is a paucity of data comparing under-identification for Indigenous status by disease. 
One disease category that has received attention is injuries. Three studies of injury 
hospitalisations for Indigenous people have highlighted the issue of under-identification of 
Indigenous status (Gladman et al. 1997, Hockey et al. 1999, Mid North Coast Aboriginal 
Health Partnership 2001). For instance, the New South Wales Mid North Coast Aboriginal 
Injury Surveillance Project found that, based on the information recorded by the accident 
and emergency department, Indigenous Australians had twice the injury rate of the non-
Indigenous population. However, after correcting for under-identification using 
independent assessors, the increase was six-fold. The Queensland Health validation study of 
the emergency department information system for injury surveillance showed that, in two 
Queensland hospitals in 1999, 3% of presentations were Indigenous compared with only 1% 
of presentations that were coded as Indigenous (Hockey et al. 1999). A 12-month case note 
audit of daily clinic register from one remote community in the 1996–97 study of injury in 
five Cape York communities found that only 0.15% of total injury events resulted in death 
and less than 8% of injury events resulted in a hospital admission. Despite this, routine 
hospital data showed that the people from Cape York Aboriginal communities were 
admitted to hospital for injury at 3–4 times the rate of other Queenslanders (Gladman et al. 
1997) . However, it is not known how the completeness of Indigenous identification for 
injuries compares with hospital admissions for other diseases. These studies are described 
below. 
B.4 Using hospital data for burden of disease 
Apart from a limited number of ‘acute’ conditions, for which, it is reasonable to assume that 
the majority of people seek treatment (such as stroke or heart attack, neonatal and maternal 
conditions, and injuries requiring immediate intervention), hospital separations say little 
about the actual incidence or prevalence of a condition in the community (AIHW 2005b). 
Moreover, hospital separations are influenced by factors such as rates of re-admission (which 
may differ across conditions, groups of people and geographical areas, depending on 
admission practices and levels and patterns of service provision), and transfers within and 
between hospitals (Victorian Department of Human Services 2005). A record is included for 
each separation, rather than for each patient, so patients who were admitted more than once 
a year have more than one record in the database. Despite this, hospital data can provide 
insights into the health of the population who use hospitals (AIHW 2005b). For this study, 
we assumed that we can use differentials in hospitalisation rates as an estimate of the relative 
difference in disease occurrence between Indigenous Australians and the total Australian 
population, even for diseases for which hospitalisation rates do not accurately represent the 
occurrence of disease within the community. Therefore, this method assumes that the 
likelihood of being hospitalised for a given disease is similar for Indigenous people and the 
total Australian population. 
The first step in our hospital analyses was to map all mentions of diseases (principal 
diagnosis and multiple secondary conditions) for an episode of care to burden of disease 
categories. After adjusting for Indigenous identification issues, decisions about using 
relativities for the Indigenous population were made on a disease-by-disease basis after 
comparing the plausibility of the age- and sex-specific graphs of hospital separations 
between the Indigenous and the total Australian population. If the age- and-sex-specific 
hospitalisation patterns were similar, an overall age-standardised rate ratio was used. If the 
patterns were different, age- and sex-specific relativities were applied to the national model 
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(Begg et al. 2007) instead. Ideally, hospital relativities were used when they appeared 
plausible or showed consistency with other data we had on these conditions.  
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Appendix C Methods for estimating non-
fatal burden 
In this section we describe our methods for calculating YLD for a number of specific diseases 
and their complications. Only those diseases for which an explicit model was developed are 
discussed (see Annex Table 1 for an outline of the data sources used for each condition, and 
whether or not an explicit model was developed). In the event an explicit disease model 
could not be developed for a condition, rate ratios were applied to the National Study as 
outlined in Annex Table 1. A more general discussion of the methods for estimating non-
fatal health outcomes is provided in Chapter 3.   
Unless otherwise specified, all the disease and injury models for Indigenous Australians 
used the same case definitions, disease stages, disability weights and complications as the 
National Study, The Burden of Disease and Injury in Australia, 2003 (Begg et al. 2007).1 Many of 
the modelled diseases have relevant information about disease occurrence (i.e. incidence or 
prevalence) in the Indigenous Australian population, but not for other disease parameters. 
For these diseases, we used the same assumptions for remission and case-fatality as the 
National Study.  
Rate ratios derived from proportions and rates using Australian hospital, mortality and 
notification data were standardised for age. Age-standardisation removes the confounding 
effects of age from comparisons of different populations. This is important because the 
Indigenous population has a much younger population age distribution than the total 
Australian population. Because of the paucity of even basic epidemiological information on 
some of the conditions that were analysed for Indigenous Australians, as new data becomes 
available the models we present can be refined. Notwithstanding this caveat, the methods 
described below make what we consider to be the most extensive and critical use of health 
information for Indigenous Australians to date. Table C.1 lists the full names of many of the 
data sources underlying our models and our abbreviations of these names, which we use in 
this section for ease of reference.  
In the following sections, broad cause groups are classified with a number to identify broad 
cluster groups (communicable diseases, maternal, neonatal and nutritional conditions; non-
communicable diseases; and injuries) and letter to identify broad cause group. The same 
classification is used in the annex tables and in The Burden of Disease and Injury in Australia, 
2003 (Begg et al. 2007). 
                                                     
 
1 For example, we model new disability weights for ‘asthma’, ‘epilepsy’ and ‘cataract’ and also include the modelling of a new 
disease ‘foetal alcohol syndrome’ 
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Table C.1: List of common name abbreviations 
Common name Full name 
1980 National Trachoma Program 1980 National Trachoma and Eye Health Program (Royal Australian College 
of Ophthalmologists 1980) 
1994–96 National Dental Telephone Survey 1994-96 National Dental Telephone Interview Survey(Brennan & Carter 
1998)  
1995–96 Adult dental survey 1995–96 Prospective Adult Dental Programs Survey (Brennan & Carter 
1998)  
2001/2004–05 National Health Survey 2001 National Health Survey — Indigenous (ABS 2006a) 
2004–05 National Aboriginal and Torres Strait Islander Health Survey 
(NATSIHS) 
2004-06 National oral health survey The National Survey of Adult Oral Health 2004–06 (Slade et al. 2007)  
Australian child wish data Fertility Decision Making Project (Weston et al. 2004) 
Australian general practitioner data  2000–01 Bettering the Evaluation and Care of Health (BEACH)  
Australian hospital data  2001–03 National Hospital Morbidity Database (AIHW 2003b) 
Australian mortality data  2001–03 Cause of Death dataset  
Australian notification data  2001–03 National Notifiable Diseases Surveillance System, age- and sex-
specific incident cases for Australians by Indigenous status and remoteness 
provided electronically by Communicable Diseases Australia except for 
HIV/AIDS, which is from the 2003 National Centre for HIV Epidemiology and 
Research (National Centre in HIV Epidemiology and Clinical Research 2004)
Disability weight regression model Regression model of Dutch disability weights which requires inputs of health 
state description based on the six domains of the Euroqol 5D+  
DisMod  DisMod version II  
GBD study  Global Burden of Disease: A Comprehensive Assessment of Mortality and 
Disability from Diseases, Injuries, and Risk Factory in 1990 and Projected to 
2020 (Murray & Lopez 1996) 
National model Disease model from The Burden of Disease and Injury in Australia, 2003 
(Begg et al. 2007) 
1A Infectious and parasitic diseases 
We use the term ‘Australian notification data’ to refer to infectious disease notifications 
from the Australian Government's Department of Health and Ageing - Communicable 
Diseases Network Australia National Notifiable Diseases Surveillance System (NNDSS) for 
2001-03. The NNDSS consists of the national surveillance of more than 50 communicable 
diseases. The Australian Government's Department of Health and Ageing website notes that: 
The quality and completeness of data compiled in the National Notifiable Diseases 
Surveillance System are influenced by various factors. Notifications may be required 
from treating clinicians, diagnostic laboratories or hospitals. In addition, the 
mechanism of notification varies between States and Territories and in some cases 
different diseases are notifiable by different mechanisms. The proportion of cases 
seen by health care providers which are the subject of notification to health 
authorities is not known with certainty for any disease, and may vary among 
diseases, between jurisdictions and over time (Australian Government Department of 
Health and Ageing 2005).  
Appendix C 
107 
For non-fatal disease modelling purposes, we calculated incidence rates for the following 
conditions: chlamydia, gonorrhoea, whooping cough, haemophilus influenzae type b, 
dengue, other arbovirus infection, hepatitis A, malaria, Ross River virus, Barmah Forest virus 
and acute hepatitis B. Missing data (such as remoteness, age, sex and Indigenous status) was 
redistributed proportionately. 
Tuberculosis 
We estimated the incidence of tuberculosis for the total Indigenous Australian population 
using published 2003 age- and sex-specific notification rates (Li et al. 2004). We estimated the 
incidence of tuberculosis for Indigenous Australians by remoteness using rate ratios based 
on admission rates from Australian hospital data (AIHW 2003b).  
Sexually transmitted diseases (excluding HIV/AIDS) 
Chlamydia and gonorrhoea 
We estimated the incidence of chlamydia and gonorrhoea for Indigenous Australians 
residing in non-remote and remote areas by applying age and sex specific rate ratios from 
Australian notification data. We adjusted the incidence of the complication infertility for ‘the 
wish to have a child’ from the Fertility Decision Making Project (Weston et al. 2004).  
HIV/AIDS 
Similar to the national model (Begg et al. 2007), we modelled HIV as a progressive condition 
with four stages: (1) asymptomatic HIV; (2) symptomatic HIV; (3) AIDS before terminal 
phase; and (4) terminal AIDS. Using Australian notification data, we assumed that the 
incidence of HIV and AIDS in the Indigenous population was the same as in the total 
Australian population (National Centre in HIV Epidemiology and Clinical Research 2004). 
We modified the incidence of HIV and AIDS to reflect the different sex distribution (HIV — 
71.4% males and AIDS — 83.4% males) reported for the Indigenous population. To estimate 
the duration of HIV and AIDS in the Indigenous population, we adjusted the durations for 
the total Australian population downwards using a ratio (of the total Australian population 
life expectancy by age to the Indigenous life expectancy by age) to account for the reduced 
life expectancy in Indigenous Australians. We assumed that the duration of terminal AIDS 
was the same as in the total Australian population.  
Tetanus 
We estimated the incidence of tetanus by applying the published age-standardised rate ratio 
for the total Indigenous population in 2000–02 to the total Australian population incidence 
(Menzies et al. 2004). We assumed the same incidence for Indigenous Australians residing in 
non-remote and remote areas.  
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Childhood immunisable diseases 
Measles 
We estimated the incidence of measles by applying the published rate ratio for the total 
Indigenous population in 2000–02 to the total Australian population incidence (Menzies et al. 
2004). We assumed the same incidence for Indigenous Australians residing in non-remote 
and remote areas. Based on published data and Australian hospital data (AIHW 2003b), we 
assumed no complications from measles occurred in the Indigenous population in 2003.  
Septicaemia 
We estimated the incidence of septicaemia for Indigenous Australians residing in non-
remote and remote areas using Australian hospital data.  
Hepatitis B 
We estimated the incidence of acute hepatitis B for Indigenous Australians residing in non-
remote and remote areas by applying age-standardised rate ratios, based on Australian 
notification data, to the total Australian population (National Centre in HIV Epidemiology 
and Clinical Research 2004). We assumed that all infections reported as incident were 
symptomatic. Notification data do not capture the proportion of infants infected in the 
perinatal period by hepatitis B-positive mothers or the larger number of children who 
become infected in childhood. Therefore, we estimated the incidence of acute hepatitis B 
infection in infants by applying published probabilities of perinatal transmission for 
Indigenous mothers to birth data (Kaldor et al. 1996). Based on the literature, we assumed a 
40% probability of transmission if exposed. Using this estimate, we calculated the number of 
infants who would be infected in the absence of vaccination (Kaldor et al. 1996). We then 
adjusted our estimates downwards on the basis that current vaccination coverage in children 
born to ‘at-risk’ mothers is 95% (Menzies et al. 2004). Similarly, we adjusted the number of 
perinatal infections downwards for the probability of symptomatic infection, which is 5%. 
Based on expert opinion, we assumed a similar number of infections by casual contact in 
childhood as from perinatal transmission.  
We based our estimates of chronic hepatitis B on a series of DisMod models. First, we 
estimated the prevalence of adults with chronic hepatitis B by adjusting the age-specific 
prevalence from the national model (Begg et al. 2007) by the crude rate ratio of Indigenous 
Australian to Australian prevalence using published figures of 2.3% and 8.2% respectively 
for Indigenous Australians residing in non-remote and remote areas (Kaldor et al. 1996) and 
the overall prevalence estimate from the Australian model. We scaled the age-specific 
estimates by a constant so that our overall prevalence estimates for Indigenous Australians 
residing in non-remote and remote areas equalled the published estimates. We assumed the 
same low spontaneous remission (0.5%) and overall relative risk of mortality (1.5) as in the 
national model (Begg et al. 2007). Then we estimated the prevalence of adults with chronic 
hepatitis B using incidence estimates from perinatal and casual childhood transmission if no 
vaccination had occurred. We again assumed the same remission and relative risk of 
mortality as the national model (Begg et al. 2007). Finally, we subtracted the prevalence of 
adult carriers from childhood infections (second model) from the prevalence of all adult 
carriers (first model) so we could use DisMod to derive the incidence of chronic hepatitis B 
infection in adults. This model assumes a steady state of hepatitis B infection in the 
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population with only recently an impact of vaccination on perinatal and childhood 
transmission rates. This is unlikely to reflect the pattern of disease over time but in the 
absence of data on the trends over time, we considered this to be the most plausible method 
of modelling the disease following expert consultation. We assumed the disability weights as 
per the national model (Begg et al. 2007). The methods we used to derive the incidence of 
hepatitis B-related cirrhosis and liver cancer are described in the respective sections for these 
diseases.  
Hepatitis C 
Due to the asymptomatic nature of hepatitis C infection, we assumed that all disability is a 
result of complications (i.e. cirrhosis and/or liver cancer). The methods we used to derive the 
incidence of hepatitis C-related cirrhosis and liver cancer are described in the respective 
sections for these diseases.  
Trachoma 
We estimated the prevalence of visual impairment resulting from trachoma infection using 
data from the 1980 National Trachoma Program (Royal Australian College of 
Ophthalmologists 1980). Based on expert advice, we assumed that trachoma infection is only 
a problem in remote Australia and we adjusted the prevalence of related visual impairment 
downwards by one third to account for observed decreases in the prevalence of the trachoma 
scarring stage since the national survey was conducted (Landers et al. 2005, Mak & Plant 
2001). In the absence of more specific information, we assumed the following: 
• trachoma proportions by age were the same as those reported for corneal disease 
• mild and moderate vision loss have the same cause distribution by age as severe vision 
loss 
•  ‘poor’ vision is equivalent to our definition of moderate vision loss 
• the difference between the pool of people without good vision and those with poor 
vision and severe vision loss is equivalent to the group of people with mild vision loss. 
We made minor adjustments to the prevalence of each stage by age to ensure plausibility and 
to reflect published estimates. We estimated the incidence and duration of trachoma-related 
visual impairment in DisMod using our derived prevalence estimates. We initially modelled 
the prevalence of severe vision loss in DisMod assuming no remission and a relative risk of 
mortality of 1. We then used the incidence of severe vision loss from the DisMod output as 
‘mortality’ in the moderate vision loss DisMod model. This takes the cases of severe vision 
loss out of the pool of susceptible cases for moderate vision loss and therefore gives more 
accurate average durations (i.e. more accurate average durations than using remission as 
remitted cases in the DisMod model, which continues to be subject to the hazard of 
incidence). Similarly, we used the incidence of moderate vision loss as ‘mortality’ in mild 
vision loss. Based on expert advice, we assumed remissions of zero for all three stages of 
trachoma-related vision loss. Based on expert advice, trachoma is only present in remote 
communities north and west of Port Augusta, South Australia, excluding coastal 
communities. We therefore may have over-estimated the overall prevalence of trachoma 
since we apply the estimated prevalence (described above) to the entire population of 
Indigenous Australians residing in remote areas. 
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1B Acute respiratory infections 
Otitis media  
We modelled the following stages of otitis media, acute infection, bilateral chronic infection 
and lifelong deafness. Indigenous general practice encounters for acute otitis media acute 
occurred at twice the rate of Australian encounters (Britt et al. 2001). Therefore, we increased 
the national model (Begg et al. 2007) incidence by a factor of 2. We assumed that Australian 
general practitioner data is not representative of Indigenous Australians residing in remote 
areas, and estimated the incidence of acute infection in Indigenous Australians residing in 
remote areas using a factor of 10, based on findings from the 1980 National Trachoma 
Program (Royal Australian College of Ophthalmologists 1980). We used the disability weight 
regression model to derive weight of 0.090 and assumed a duration of one week.  
We estimated the prevalence of chronic otitis media in Indigenous Australians residing in 
non-remote areas based on the number of Indigenous people reporting otitis media as a 
long-term health problem in the 2001 National Health Survey (ABS 2003a). We adjusted the 
prevalence of chronic infection downwards by one third to account for bilateral cases only, 
using a ratio of bilateral to unilateral cases from the 1980 National Trachoma Program (Royal 
Australian College of Ophthalmologists 1980). We estimated the prevalence of bilateral 
chronic otitis media in Indigenous Australians residing in remote areas from the 1980 
National Trachoma Program and assumed that the epidemiology of bilateral chronic otitis 
media had not changed since the survey was undertaken. We derived the incidence and 
duration of bilateral chronic otitis media in DisMod using prevalence, a relative risk of 1 and 
remission equivalent to 3 years duration for Indigenous Australians based on Australian 
data (McGilchrist & Hills 1986). For chronic infection, we applied the Dutch weight for early 
acquired mild to moderate hearing loss (0.110). 
We based our estimates for permanent hearing loss resulting from acute infections on the 
Global Burden of Disease Study (Murray & Lopez 1996), which estimated that 5 in 
100 000 cases of acute otitis media in 0–14 year-olds results in permanent hearing loss. For 
the small number of cases that experience life-long deafness, we used the Dutch weight for 
early acquired severe hearing loss (0.233).  
1C Maternal conditions 
We estimated the incidence of maternal conditions for Indigenous Australians residing in 
non-remote and remote areas by applying age- and sex-specific hospital rate ratios for the 
combined condition and complications state (e.g. rate ratios for hospital separations with a 
diagnosis of both maternal haemorrhage and acute post-haemorrhagic anaemia) to the 
national model (Begg et al. 2007). We adjusted the incidence of infertility as a complication, 
in the abortion and maternal sepsis models, for ‘the wish to have a child’ (as described above 
in section on sexually transmitted diseases).  
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1D Neonatal causes 
Low birth weight 
We estimated the incidence of low birth weight in Indigenous infants using published data 
from the National Perinatal Statistics Unit, and various state and territory perinatal 
collections. According to National Perinatal Statistics Unit (Laws & Sullivan 2005), 2.4% and 
10.6% of infants born to Aboriginal or Torres Strait Islander mothers had a birth weight 
(<1500 g and 1500–<2500 g respectively), giving an incidence of around twice the non-
Indigenous rate. To estimate the sex distribution of low birth weight Indigenous infants, we 
used Australian hospital data (AIHW 2003b). We excluded the low birth weight neonatal 
deaths, applying the same sex and birth weight distribution as the national model (Begg et 
al. 2007) to the published Indigenous neonatal mortality rate (5.6/1,000 live births) (Laws & 
Sullivan 2005). To estimate the incidence of low birth weight for Indigenous infants residing 
in non-remote and remote areas, we applied the rate ratios from Australian hospital data to 
our overall rate of Indigenous low birth weight. We estimated the incidence of low birth 
weight complications proportionate to the higher incidence of low birth weight in 
Indigenous infants compared with the total Australian population. The methods used 
assumed that the probability and distribution of low birth weight complications among low 
birth weight survivors is the same for Indigenous and non-Indigenous Australians.  
Birth trauma & asphyxia 
We estimated the incidence of birth trauma-related hearing loss, seizure and cerebral palsy 
without intellectual disability in the Indigenous population by remoteness by applying 
indirect age-standardised hospital rate ratios to the incidence of these complications in the 
total Australian population. We assumed that the remission, case-fatality and disability 
weights of severe hearing loss, seizure and cerebral palsy without intellectual disability was 
the same as those with mild intellectual disability. We used the estimates of intellectual 
disability due to birth trauma from the overall calculations for intellectual disability by all 
underlying causes (see Section 2K).  
Neonatal infections 
We estimated the incidence of acute neonatal infections and the associated complications 
(severe hearing loss and motor deficit) by applying indirect age-standardised rate ratios by 
remoteness from Australian hospital data (AIHW 2003b) to the national model (Begg et al. 
2007). We used the estimates of intellectual disability due to neonatal infections from the 
overall calculations for intellectual disability by all underlying causes (see Section 2K).  
2F Malignant neoplasms  
We modelled the incidence of all cancers using rate ratios from Australian hospital data and 
applied a 50% higher case fatality rate based on the literature. 
Previous studies used 1997–2002 Queensland cancer registry data to show that Indigenous 
people were 1.5 times more likely to die from cancer than non-Indigenous people (after 
adjusting for age, sex, year of diagnosis, remoteness index, type of cancer and stage of 
cancer) (Valery et al. 2006). This finding built on earlier studies, which found that Indigenous 
 112 
people from the Northern Territory were 1.9 times more likely to die from cancer (after 
adjusting for age at diagnosis and sex) than the total populations of Western Australia and 
Tasmania for 1991–2001 (Condon et al. 2005).  
Liver cancer 
We estimated the underlying causes of liver cancer (alcohol, other, hepatitis B and 
hepatitis C) using proportions derived in the Indigenous cirrhosis model (see Section 2N).  
2H Diabetes 
Diabetes cases 
We based the incidence of ‘all diabetes’ (Type 1 and 2 diabetes combined) in the Indigenous 
population on a DisMod model of prevalence (7.2% — males and 9.5% — females), relative 
risk of all-cause mortality of two, zero remission and a 5% annual incidence trend derived 
from a systematic review of the literature (Mott 2005). The predicted prevalence was based 
on a multiple regression analysis of pooled data from 21 studies spanning 1982–2001, after 
accounting for variance in diabetes diagnostic criteria, study size, year of study, age at study 
commencement, remoteness and ethnicity. The relative risk of all-cause mortality was based 
on a 1986–91 cohort study of Indigenous people with diabetes from central Australia 
compared with the Northern Territory Indigenous population (Phillips et al. 1995). A 
plausible age distribution of this relative risk was derived by scaling it to age-specific 
findings from an international meta-analysis (Woodward et al. 2003). 
Based on the literature, we assumed that the epidemiology of Type 1 diabetes and its 
complications for Indigenous Australians is the same as in the total Australian population 
(Office for Aboriginal & Torres Strait Islander Health Services 1998, Verge et al. 1994). In the 
absence of specific information, we also assumed that there are no differentials in the 
incidence of Type 1 diabetes and its complications for Indigenous Australians by remoteness. 
We estimated the incidence of Type 2 diabetes in Indigenous Australians by subtracting the 
incidence of Type 1 diabetes from the incidence of ‘all diabetes’ in Indigenous Australians. 
We estimated the incidence of Type 2 diabetes for Indigenous people residing in non-remote 
areas by applying rate ratios from Australian hospital data (AIHW 2003b) to the total 
Indigenous population incidence for Type 2 diabetes. We modelled the incidence of Type 2 
diabetes for Indigenous Australians residing in non-remote areas in DisMod assuming zero 
remission, the relative risk of all cause mortality output from the Type 2 diabetes DisMod 
model for all Indigenous Australians and the 5% annual incidence trend. We made separate 
estimates for the incidence of Type 2 diabetes for Indigenous people residing in remote areas 
by applying rate ratios from Australian hospital data. 
Complications 
We estimated the incidence of the following Type 2 diabetes-related complications for 
Indigenous Australians residing in non-remote areas 
• retinopathy 
• neuropathy 
• peripheral vascular disease 
• diabetic foot, amputations 
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• renal failure 
• cataract 
• glaucoma 
• ischaemic heart disease 
• stroke. 
We estimated the incidence of all Type 2 diabetes complications for Indigenous Australians 
residing in remote areas by applying rate ratios of hospital separations between remote and 
non-remote areas. 
Retinopathy, neuropathy and peripheral vascular disease 
To estimate the incidence of Type 2 diabetes-related retinopathy, neuropathy and peripheral 
vascular disease among Indigenous Australians residing in non-remote areas, we adjusted 
the total Australian population estimates using rate ratios of the incidence of Type 2 diabetes 
in the non-remote residing Indigenous population compared with the total Australian 
population.  
Amputations and diabetic foot  
We estimated the incidence of diabetes-related amputations using age- and sex-specific 
Australian hospitalisation rates, assuming all procedures represented incident cases. As per 
the total Australian model, we assumed that for every amputee there are 20 cases of diabetic 
‘foot’ (where poor circulation and neuropathy lead to gangrene). This assumption was 
supported by literature from central Australia, which showed that that 7% of separations for 
diabetic foot required amputation of at least a toe (Ewald et al. 2001). We modelled the 
incidence of toe and foot/leg amputations using zero remission and assuming a relative risk 
of all cause mortality two times the excess mortality risk of Type 2 diabetes that Indigenous 
Australians residing in non-remote areas experience to reflect the risk in the more advanced 
stages of disease. 
Renal failure  
We estimated the incidence of Type 2 diabetes-related dialysis and kidney transplants for 
Indigenous Australians using 2001–03 data from the Australian and New Zealand Register of 
Dialysis and Renal Transplants (Excell & McDonald 2005).2 To estimate the comparable 
incidence for Indigenous Australians residing in non-remote areas we applied rate ratios 
from Australian mortality data.  
For dialysis, we estimated remission as the proportion of cases that go on to receive a 
transplant: 4.5% for those younger than 65 years for Type 2 diabetes and 0% for those over 
65 years with Type 2 diabetes. We assumed that the relative risk of all causes of mortality for 
Type 2 diabetes-related dialysis was twice the excess mortality risk of Type 2 diabetes that 
Indigenous Australians residing in non-remote areas experience. For transplants, we 
estimated the case-fatality for Indigenous Australian diabetics residing in non-remote areas 
who undergo transplants using the methodology outlined in the nephritis & nephrosis 
model (see Section C12.1, below). We estimated the remission (8.6%) for cases of kidney 
transplants by applying a rate ratio for Indigenous Australians from McDonald (McDonald 
2004). Case fatality rates for kidney transplants in Indigenous Australians were also from 
                                                     
 
2 The data reported here have been supplied by the Australia and New Zealand Dialysis and Transplant Registry. The interpretation 
and reporting of these data are the responsibility of the editors and in no way should be seen as an official policy or interpretation of 
the Australia and New Zealand Dialysis and Transplant Registry. 
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published data (McDonald 2004). We used ANZDATA mortality to adjust for the differences 
in diabetics and non-diabetics and we used rate ratios from Australian mortality data to 
estimate the case-fatality rate for Indigenous people residing in non-remote areas.  
Other complications  
We estimated the proportion of cataract, glaucoma, ischaemic heart disease and stroke YLD 
respectively in the Indigenous population attributable to Type 2 diabetes using Indigenous 
prevalence figures and relative risks from the national model (Begg et al. 2007).  
2J Mental disorders  
Harmful alcohol use & dependence 
In the absence of survey data on ICD-10 or DSM-IV-defined alcohol dependence, we used 
relativities of risky/high-risk alcohol consumption from the 2004–05 National Health Survey 
as a proxy (ABS 2006a). Alcohol risk levels in this survey were derived from the average 
daily consumption of alcohol in the seven days before the interview and were grouped into 
the following levels as defined by the NHMRC: 
• low (males <4 drinks; females <2 drinks) 
• risky (males 4–5.6 drinks; females 2–4 drinks) 
• high risk (males >6 drinks; females >4 drinks). 
Risk level as defined by the NHMRC is based on regular consumption levels of alcohol, 
whereas indicators derived in the 2004–05 National Health Survey do not take into account 
whether consumption in the reference week was more, less or the same as usual (ABS 2006a).  
The 2004–05 National Health Survey shows that, after adjusting for age differences, the 
proportion of Indigenous adults who reported drinking at risky/high-risk levels (15%) was 
similar to that of non-Indigenous adults (14%), although relative risks based on age-specific 
proportions showed slightly elevated risks for Indigenous people across most of the age 
groups (ABS 2006a). This relative relationship was also observed in the 2001 National Health 
Survey, although the absolute differences were lower for the Indigenous and non-Indigenous 
population (ABS 2006a). In 2004–05, there was also no statistically significant difference in 
risky/high-risk alcohol consumption between Indigenous Australians residing in non-
remote (17%) and remote (15%) areas (ABS 2006a). This finding was the opposite of what 
was observed for the 2001 National Health Survey, which found Indigenous people residing 
in remote areas (18%) had higher levels of risky/high-risk drinking than Indigenous people 
residing in non-remote areas (10%; age-standardised RR of 1.8) (ABS 2006a).  
The age-standardised relative risks from the 2004–05 National Health Survey for risky/high-
risk alcohol consumption between Indigenous and non-Indigenous Australians, and 
Indigenous Australians residing in non-remote and remote areas differ greatly from age-
standardised rate ratios derived from Australian hospital (RR 9–10) and mortality (RR 10–13) 
datasets for alcohol use disorders. Australian general practitioner data also suggest a higher 
risk (RR 2.6) for Indigenous versus non-Indigenous Australians who drank six or more 
drinks at least weekly (Proude et al. 2006). The 2004 National Drug Strategy Household 
Survey, which also used NHMRC alcohol consumption guidelines, found that Indigenous 
Australians had elevated short-term (RR 1.9) and long-term (RR 2.3) risks for risky/high-risk 
alcohol consumption compared with the non-Indigenous population (AIHW 2005a). It is not 
clear why the results from the 2004–05 National Health Survey are so different from these 
Appendix C 
115 
other potential proxy data sources of alcohol dependence. It would be interesting to further 
stratify the 2004–05 National Health Survey results using the question, ‘Is the amount you 
drank last week more, about the same, or less compared with most weeks?’ and analyse the 
responses for the ‘about the same’ group. Conversely, the 2004–05 National Health Survey 
(ABS 2006a) interviewed nearly 10 500 Indigenous people compared with around 
500 Indigenous respondents from the survey, Statistics on Drug Use in Australia 2004 (ABS 
2006a, AIHW 2005e). In addition, the National Drug Survey asked respondents to recall their 
alcohol consumption for the previous day only. It is unknown which method would provide 
more reliable results. Some researchers prefer the 2001 or 2004–06 National Health Surveys 
to the 2004 National Drug Survey for comparative risk factor assessment models in the total 
Australian population ‘because of the more specific nature of the information collected 
(seven categories of alcoholic drinks) and the fact that adjustments were made for the alcohol 
content of a variety of brands within these categories’ (Ridolfo & Stevenson 2001). Another 
source of potential uncertainty in self-report surveys may be the sensitive nature of questions 
about alcohol consumption.  
As a compromise between the differing findings, we assumed that Indigenous Australians 
have a similar occurrence of alcohol dependence as the total Australian population but with 
different consequences by remoteness. Therefore, we estimated the prevalence of alcohol 
dependence in Indigenous Australians by applying derived age- and sex-specific rate ratios 
of risky/high-risk alcohol consumption for Indigenous Australians by remoteness from 
published 2004–05 National Health Survey data to the national model (Begg et al. 2007). It is 
likely that the large hospital and mortality rate ratios in part reflected the consequences of 
acute alcohol intoxication (such as injuries). We believe that the indirect age-standardised 
mortality rate ratios for cirrhosis are more indicative of the chronic long-term harms 
associated with alcohol dependence than the rate ratios for alcohol dependence. However, 
since the cirrhosis mortality risk also reflect hepatitis-related cirrhosis, we adjusted the 
cirrhosis relative risks downwards by one half (non-remote: male RR 2.4, female RR 4.3; 
remote: male RR 4.2, female RR 5.7). We then applied these predicted differentials by sex and 
remoteness to the total Australian population elevated mortality risks (1.8 in males and 3.8 in 
females) for alcohol dependence, to estimate the relative risk of excess mortality in 
Indigenous Australians.  
Foetal alcohol syndrome  
We used the estimates of intellectual disability by severity and underlying cause to model 
the intellectual disability related to foetal alcohol syndrome (see Section 2K). According to 
the approach outlined in Section 2K for estimating the epidemiology of intellectual disability 
in Indigenous Australians (after rescaling and assuming that all intellectual disability due to 
intoxication is alcohol), the prevalence of foetal alcohol syndrome in Indigenous infants for 
1953–2000 was 0.29% (Glasson et al. 2005). This figure is similar to other published estimates 
of foetal alcohol syndrome among Indigenous infants from Western Australia (Bower et al. 
2000, Leonard et al. 2003).  
Harmful cannabis use & dependence 
Since the hospital rate ratios for cannabis dependence did not seem plausible we derived 
relative risks based on the proportions of Indigenous people reporting cannabis use in the 
last 12 months (from the 1994 Indigenous NDSHS) compared with the proportions of the 
total population reporting cannabis use in the past 12 months from the (2001 NDSHS) by sex, 
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based on the assumption that patterns of current use have not changed markedly over time. 
This is supported in the total population with trend data over time from the 1993-2001 
National Drug Strategy Household Surveys (AIHW 2003c). For the Indigenous population, 
the 2002 NATSISS also suggests that patterns of current use have not changed over time 
since the 1994 NDSHS-ATSI; although it is important to note that the NATSISS is not 
conducted in remote areas (Gray et al. 2004, Hunter 2006). We then used hospital relativities 
to estimate the occurrence of cannabis dependence by remoteness. Because the hospital rate 
ratio of 0.5 for remote areas was not thought to be plausible we applied the hospital rate ratio 
for remote areas to the excess risk from the national drug survey results. 
Harmful other drug use & dependence 
For other drug dependence the hospital relativities did not seem plausible. Instead we used a 
relative risk of 1.6 based on current use of an illicit drug from the National Drug Strategy 
Household Survey (Gray et al. 2004). We then used hospital relativities to estimate the 
occurrence of other drug dependence by remoteness. Because the hospital rate ratio of 0.5 
for remote areas was not thought to be plausible we applied the hospital rate ratio for remote 
areas to the excess risk from the national drug survey results. 
Schizophrenia 
In the absence of survey data for schizophrenia using ICD-10 or DSM-IV-defined criteria, we 
used adjusted relativities from Australian hospital. For schizophrenia, in keeping 
with findings for New Zealand Maoris, we halved the excess risk suggested by hospital data 
by remoteness (Wheeler et al. 2005). We also assumed that the rate ratio for females was the 
same as males (as a higher risk did not appear plausible). 
Anxiety & depression 
We used indicators of psychological distress from the Western Australian Aboriginal Child 
Health Survey (Goodman’s Strengths and Difficulties Questionnaire) and the 1997–98 New 
South Wales Health Surveys (Kessler 10 questionnaire) as proxies for anxiety & depression. 
To estimate the prevalence of anxiety & depression in Indigenous Australians, we applied 
derived rate ratios of psychological distress from published data, between the Indigenous 
and non-Indigenous population, to the national model (NSW Health Department Public 
Health Division 2000, Zubrick et al. 2005). For 4–17 year-olds, the rate ratio of psychological 
distress in Indigenous children and young adults was 1.6 times that of the non-Indigenous 
population. For male and female Indigenous adults, the rate ratios of psychological distress 
were in the order of 1.9 and 1.5 respectively. We estimated the prevalence of anxiety & 
depression for Indigenous children residing in non-remote and remote areas using published 
data (odds ratio=0.7) from the Western Australian Aboriginal Child Health Survey, which 
showed that children residing in more remote areas fared better in terms of significant 
emotional difficulties. We estimated the prevalence of anxiety & depression for Indigenous 
adults residing in non-remote and remote areas using rate ratios derived from published 
data from the ‘Social and Emotional Wellbeing module’ in the 2004–05 National Health 
Survey (ABS 2006a). Averaging rate ratios based on published proportions of responses of 
‘all the time/most of the time’ for selected items in this wellbeing module indicated that 
Indigenous adults residing in non-remote areas were at slightly higher risk (RR 1.3) of 
psychological distress than Indigenous adults residing in remote areas.  
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Autism and Asperger’s syndrome 
We estimated the incidence of autism and Asperger’s syndrome by applying the published 
odds ratio of autism in Western Australian Indigenous versus non-Indigenous infants 
(OR=0.3) to the national model incidence estimates for autism and Asperger’s syndrome 
respectively (Leonard et al. 2005). This odds ratio is based on linking Western Australian 
data on people with intellectual disability from the Maternal and Child Health Research 
Database with other sources, including the Disability Services Commission, the Department 
of Education, Catholic Education and the Association of Independent Schools. In the absence 
of more detailed information, we assumed no differentials by remoteness. We assumed same 
remission, case-fatality and disability weights as the national model (Begg et al. 2007).  
2K Nervous system and sense organ disorders 
Epilepsy 
A study comparing epilepsy presentations for Indigenous and non-Indigenous people with a 
far-north Queensland specialist clinic and a local hospital concluded that the similar 
incidence of epilepsy in Indigenous and non-Indigenous people presenting to the clinic 
indicated similar incidence in the community (Archer & Bunby 2006). Furthermore, the 
study argued that the much higher hospital admission rates for epilepsy in Indigenous 
people reflected inequalities in health care use (including epilepsy management practices, 
issues relating to access in remote areas, and socioeconomic differentials) rather than 
differentials in disease occurrence. Therefore we assumed that the incidence of primary 
epilepsy in the Indigenous Australian population was the same as the total Australian 
population and that there were no differentials by remoteness. We assumed the same 
remission and case fatality as the national model (Begg et al. 2007). We accounted for the 
greater disability associated with primary epilepsy in the Indigenous population by 
estimating a new disability weight, which assumed that a greater proportion of cases are 
untreated. The GBD assumes 80% treatment coverage in industrialised countries. Instead, we 
assumed 50% of cases are treated; and to be consistent with the National Study, we applied 
the ratio of the disability weights for 50% versus 80% treatment coverage to the Dutch 
disability weight for epilepsy (0.110). This gave a new disability weight of 0.144. 
We used the estimates of intellectual disability by severity and underlying cause to model 
the epilepsy-related intellectual disability (see Section 2K).  
Glaucoma and cataract-related blindness 
There has been no systematic assessment of the prevalence of glaucoma or cataract among 
Indigenous Australians since the National Trachoma Program, which was conducted 
between 1976 and 1978 in remote Australia (Royal Australian College of Ophthalmologists 
1980).  
Primary open angle glaucoma is the most common type of glaucoma. The 1980 National 
Trachoma Program showed that ‘Aborigines when compared to non-Aborigines appear to be 
remarkably spared from primary glaucoma’ (Royal Australian College of Ophthalmologists 
1980:97). Expert advice confirms that primary open-angle glaucoma is not seen in Indigenous 
Australians who do not have non-Indigenous ancestors. We estimated the incidence of 
glaucoma-related visual impairment for Indigenous Australians residing in non-remote and 
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remote areas by applying hospital rate ratios for glaucoma surgery by sex and remoteness 
(non-remote: males RR 0.8, females RR 0.9; remote: males RR 0.4, females RR 0.4) to the 
national model (Begg et al. 2007). We assumed duration was equivalent to the expected life 
expectancy by sex, age and remoteness. We assumed the same case fatality as the national 
model.  
Expert advice indicated that Indigenous Australians residing in non-remote areas have the 
same prevalence of cataract as the total Australian population . This advice is consistent with 
the rate ratio (RR 1.0) of cataract surgeries in Indigenous Australians in non-remote areas 
and the total Australian population. We assumed that all mild and moderate bilateral vision 
loss due to cataracts is operated on, based on trends in the total Australian population. We 
estimated the incidence of mild and moderate cataract-related vision impairment in 
Indigenous Australians by remoteness using Australian hospital data (AIHW 2003b), and 
based on the following assumptions: 
• 50% of Indigenous cases that were corrected surgically had vision loss in both eyes before 
the operation for an average of one year  
• of these, 70% of cases were mild and 30% were moderate (compared with 90% and 10% 
split in the Australian model). 
In addition to increasing the proportion of cases that were moderate, we also doubled the 
national model (Begg et al. 2007) remission to account for Indigenous Australians being 
accepted for cataract surgery at a much more advanced stage of disease (Taylor 1997). We 
estimated the incidence of severe bilateral vision loss due to cataracts by applying the 
indirect age-standardised rate ratio of hospital mentions of cataracts by sex and remoteness. 
We assumed the duration of severe bilateral vision loss due to cataracts was the same as the 
life expectancy for an Indigenous Australian at that age. We also assumed the same case 
fatality for all three stages of cataract as the national model (Begg et al. 2007). 
Intellectual disability 
Similar to the national model (Begg et al. 2007), we categorised intellectual disability into the 
following levels: mild, moderate, severe and profound. Intelligence quotient ranges were 50–
69, 35–49, 20–34, and <20 respectively. To estimate the incidence of intellectual disability in 
Indigenous Australians, we applied published prevalence ratios (RR 2.4 for mild/moderate 
and RR 1.6 for severe) from a linked study of several sources3 of intellectual disability 
information in Western Australia for 1983–92 to the total Australian population incidence by 
severity (Leonard et al. 2003). We assumed that the rate ratio of mild/moderate intellectual 
disability applies to both mild and moderate categories. Likewise, we assumed that the rate 
ratio of severe intellectual disability holds for Indigenous Australians with profound 
intellectual disability too. We estimated the duration of intellectual disability by severity for 
Indigenous Australians by applying total Australian population rate ratios (life expectancy at 
birth by level of severity of intellectual disability for the total population compared with the 
total Australian population life expectancy at birth) to Indigenous life expectancy at birth.  
                                                     
 
3 The data sources included the Western Australia Disability Services Commission, the Western Australian Department of 
Education, Western Australian Catholic Education and Western Australian Association of Independent Schools. Record linkage with 
the Maternal and Child Health Research Database was used to obtain basic demographic information not available from the other 
sources and to form the denominator of the prevalence ratio. 
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In the absence of more detailed information, we assumed that the occurrence of intellectual 
disability does not differ by remoteness. As per the national model (Begg et al. 2007), we 
estimated the incidence of intellectual disability in DisMod assuming that: 
• 90% of intellectual disability starts in the first year of life and the remaining 10% starts in 
the 1–4-year age group 
• there is no remission 
• there is a relative risk of mortality that gives an average duration by severity level, as 
explained above. 
We did not include the incidence of intellectual disability as a discrete category in the main 
listings of this burden study. Instead, we attributed incident cases of intellectual disability to 
underlying causes (other chromosomal disorders, Down syndrome, low birth weight, 
infection, epilepsy, other perinatal conditions, autism and foetal alcohol syndrome) using 
findings from 1953–2000 Western Australian data on intellectual disability by cause among 
Indigenous Australians (Glasson et al. 2005). Since some Indigenous people had more than 
one underlying cause recorded, we rescaled the number of causes to reflect the number of 
cases. We also redistributed cases with unspecified underlying causes proportionately. This 
gave us the underlying cause distribution of intellectual disability for Indigenous 
Australians. However, since we had no information on the distribution of underlying causes 
by severity, we assumed that the proportionate distribution of cases by underlying cause 
was the same by severity.  
2L Cardiovascular disease  
Heart diseases resulting in heart failure 
The complete descriptive epidemiology in this group of conditions was derived in DisMod 
from prevalence and case fatality; the third parameter being zero remission. Unlike the 
national model (Begg et al. 2007), we assumed no favourable trend in case fatality or 
incidence over time. 
We estimated the prevalence of heart failure due to all causes for Indigenous Australians 
residing in remote and non-remote areas by applying the age-specific (to age 65+) rate ratios 
of heart failure, from Australian hospital data (AIHW 2003b), to the total Australian 
population prevalence. We increased the total Australian population case fatality rate for 
heart failure by 50% based on a report by the AIHW (Mathur et al. 2006). This report found 
that Indigenous case fatality for major coronary events was 50% higher than non-Indigenous. 
We assumed that all cardiovascular mortality would be similarly increased.  
Underlying cause of heart failure was derived for Indigenous Australians residing in remote 
and non-remote areas by broad age group and sex from Australian hospital data where both 
heart failure and cardiovascular disease (rheumatic, hypertensive, ischaemic, pulmonary, 
inflammatory, and non-rheumatic valvular heart diseases) were mentioned in the same 
record. Remission for rheumatic heart disease and non-rheumatic valvular disease was 
estimated as the proportion of age-specific estimated prevalent cases that underwent surgery 
for valve replacement based on two years of adjusted Australian hospital data divided by 
two (to estimate the number of replacements in one year). 
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Ischaemic heart disease  
Three health states were modelled separately for ischaemic heart disease: angina pectoris, 
acute myocardial infarction and heart failure. We estimated the incidence of angina pectoris 
and acute myocardial infarction by applying the age-specific (to age 65+) total Australian to 
remote and non-remote rate ratios of hospitalisation. We estimated remission from angina 
pectoris as the proportion of prevalent cases that underwent revascularisation surgery based 
on two years of adjusted Australian hospital data (AIHW 2003b). We increased the total 
Australian population case fatality for angina pectoris by a factor of 1.5 to reflect the 50% 
higher fatality seen for major cardio-vascular events (Mathur et al. 2006).  
Stroke  
Judy Katzenellenbogen, a PhD candidate in Perth, provided 28-day survivor stroke models, 
derived from a linked Western Australian database of hospital and mortality data and from 
the Perth community stroke data, for Indigenous Australians residing in remote and non-
remote areas of Western Australia (Judy Katzenellenbogen, email, 22 September 2006). We 
estimated the incidence for all Indigenous Australians who reside in remote and non-remote 
areas by adjusting the Western Australia incidence figures with the age-standardised 
Western Australia to Australian hospital separation rate ratio for stroke.  
Peripheral vascular diseases 
We applied the rate ratio of total Australian to Indigenous Australian remote and non-
remote peripheral vascular disease hospital separations to the national model incidence 
(Begg et al. 2007). We used this data to estimate the incidence of peripheral vascular disease 
among Indigenous Australians residing in remote and non-remote areas. We increased the 
total Australian population case fatality by 50%, reflecting the higher fatality in Indigenous 
Australians seen for major cardiovascular events (which we assumed applied to all 
cardiovascular disease case fatality) (Mathur et al. 2006). Remission for cases was determined 
as the proportion of prevalent cases (estimated in a first iteration in DisMod with input of 
incidence, case-fatality rate, and zero remission) that underwent peripheral vascular disease 
related bypass surgery. We assumed that the hospitalisation rate for peripheral vascular 
disease-related toe amputations and foot or leg amputations reflected true incidence.  
2M Chronic respiratory disease 
Chronic obstructive pulmonary disease 
We estimated the prevalence of COPD for Indigenous Australians residing in non-remote 
and remote areas by applying age-specific rate ratios (for COPD) from Australian hospital 
data (AIHW 2003b) to the total Australian population prevalence. We assumed zero 
remission and set the case fatality rate to be 30% higher than the national model (Begg et al. 
2007). YLD estimates for heart failure due to chronic lung disease and pulmonary heart 
disease were added to the COPD category (see Heart diseases resulting in heart failure, 
above). 
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Asthma 
We estimated the prevalence of asthma for Indigenous Australians residing in non-remote 
and remote areas by applying relative risks of self-reported asthma from the 2004–05 
National Health Survey (Source: ABS 2006. ABS data available on request) to the total 
Australian population prevalence. We assumed no difference in propensity to report asthma 
between Indigenous Australians and the total Australian population. We assumed remission 
was the same as in the total Australian population, and entered age- and sex-specific 
mortality due to asthma into DisMod.  
The total Australian to Indigenous Australian rate ratios for asthma-related hospital 
separations were higher than those suggested in survey and epidemiological study data 
(Blair et al. 2005, Valery et al. 2001). We assumed that the higher hospitalisation rate for 
Indigenous Australians reflected, in part, sub-optimal therapy or prevention (Correll et al. 
2007, Couzos & Davis 2005). Given this assumption, we derived a higher disability weight 
for Indigenous Australians. The national model derived a disability weight based on the 
symptomatic and asymptomatic Dutch disability weight (Begg et al. 2007). The GBD assumes 
a 95% treatment coverage for established market economies. We adjusted this downwards to 
80% treatment coverage for Indigenous Australians. We then adjusted the national model 
disability weight using the ratio of the GBD weights for 80% and 95% treatment coverage.  
2N Diseases of the digestive system  
Cirrhosis of the liver 
We estimated the incidence of cirrhosis in the Indigenous population by applying hospital 
rate ratios by remoteness to the national model (Begg et al. 2007). We distributed the 
incidence of liver cirrhosis by underlying cause for Indigenous Australians using Australian 
hospital data (AIHW 2003b), which show that alcohol is mentioned in 62% of all admissions 
for cirrhosis with an underlying cause stated as secondary diagnostic category. Similar to the 
national model (Begg et al. 2007), we attributed 5% of non-alcohol related cirrhosis to ‘other’ 
causes and the remainder to hepatitis (hepatitis b=30% and hepatitis C=70%). This translated 
to 10% and 23% of all cirrhosis for hepatitis B and C, respectively. In the absence of more 
detailed information, we assumed the same proportions for the liver cancer model. 
2O Genitourinary diseases 
Nephritis & nephrosis 
For nephritis & nephrosis, we calculated three complications: end-stage renal failure with 
dialysis, kidney transplants, and untreated end-stage renal failure. 
The Australia and New Zealand Dialysis and Transplant Registry collects information from 
all hospitals treating end-stage renal disease patients in Australia and New Zealand for all 
people under their care. Ethnicity is self-reported and is not further verified. Information is 
collected about cause of end-stage renal disease, type of renal replacement therapy, and dose 
and location, together with placement on the active transplant waiting list (McDonald & 
Russ 2003). We excluded diabetic cases from our calculations, because they were included in 
other models.  
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For end-stage renal failure with dialysis and transplant cases, we estimated the total number 
of incident cases as the mean number of new Indigenous patients over the years 2001–03 
(excluding patients with renal disease related to diabetes) (Excell & McDonald 2005). We 
distributed incident end-stage renal disease dialysis cases according to the average 2001–03 
age distribution for all new cases. Based on a study by McDonald and Russ (McDonald & 
Russ 2003), we assumed that 43% of cases at each age were male. Transplant cases were 
distributed by age according to 2001 data (McDonald & Russ 2002) and by sex according to 
the sex distribution of recipients with a functioning transplant at 31 Dec 2003 (Excell & 
McDonald 2005). We separated incident end-stage renal disease with dialysis and transplant 
cases into remote and non-remote by applying the remote to total Indigenous Australian, 
and non-remote to total Indigenous Australian mortality relative risks. We used the 
mortality data, because the hospital data may potentially reflect access issues for people 
residing in remote areas. We estimated incidence of untreated end-stage renal failure as the 
number of deaths due to nephritis & nephrosis in the mortality data minus the number of 
deaths estimated after dialysis and/or transplant from DisMod. Any negatives were set to 
zero. 
We estimated remission for end-stage renal disease with dialysis as the proportion of cases 
that go on to receive a transplant. Remission for cases of kidney transplants (i.e. graft failure) 
from the national model (Begg et al. 2007) was increased by a factor of 3.1 based on the 
hazard ratio for graft survival among Indigenous transplant recipients (McDonald 2004). We 
assumed a duration of one year for untreated end-stage renal disease. 
Indigenous-specific case fatality rates for end-stage renal disease with dialysis and kidney 
transplant are from McDonald (McDonald 2004). To adjust for the differences in diabetics 
and non-diabetics, we used adjusted case-fatality rates all Australian Australia and New 
Zealand Dialysis and Transplant Registry mortality data obtained by an all-age rate ratio of 
diabetics to non-diabetics.  
We assumed that graft failure cases become dialysis cases again, and therefore added the 
remitters from the kidney transplant DisMod model to the end-stage renal disease with 
dialysis incidence.  
2R Congenital anomalies  
We used the estimates of intellectual disability by severity, remission and case fatality to 
model the intellectual disability related to Down syndrome and other chromosomal 
disorders (see Section 2K).  
2S Oral health 
Dental caries 
We estimated the incidence of caries in Indigenous children using relative risks derived from 
published data on caries experience between Aboriginal and non-Aboriginal children (6-
year-old RR 2.4; 12-year-old RR 1.8) from the 2001 South Australian Child Dental Health 
Survey (AIHW DSRU 2003). Higher incidence of caries in Indigenous children has also been 
reported in several other studies (AIHW DSRU 2002, Davies et al. 1997, Popat & Dinnage 
2006). It is important to note that the South Australian data are based on children who use 
the School Dental Service and therefore may not be representative of all Indigenous children. 
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Using information from this same report, we assumed that there are negligible differentials 
by remoteness for Indigenous children’s caries experience (5–9 years RR 0.9; 10–14 years 
RR 1.1) (AIHW DSRU 2003). We assumed that the 1–4-year-old Indigenous children have the 
same decay experience as 5–9–year-old Indigenous children. 
Consistent with our findings for children, Indigenous adults also experienced higher rates of 
caries compared with their non-Indigenous counterparts. We estimated the incidence of 
caries in Indigenous adults using relative risks derived from published data on untreated 
dental decay between Indigenous and non-Indigenous adults (15–34 years RR 2.7; 35–
54 years RR 2.2; 55+ RR 2.0) from the 2004–06 National Survey of Adult Oral Health 
(Roberts-Thomson & Do 2007). Using published South Australian data, we assumed that 
Indigenous adults residing in remote areas had half the risk of dental caries compared with 
Indigenous adults residing in non-remote areas (AIHW DSRU 2003). We assumed the same 
remission and case fatality as the total Australian population. We adjusted the national 
model (Begg et al. 2007) estimate of time symptomatic using a relative risk (RR 1.3) based on 
published data of the proportion of people by Indigenous status seeking dental help for a 
problem from the 1994–96 National Dental Telephone Survey (Brennan & Carter 1998). 
Periodontal disease 
We assumed that the incidence of periodontal disease in the Indigenous population was the 
same as the national model (Begg et al. 2007). This is because of the lack of converging 
evidence of the occurrence of periodontal disease in Indigenous Australians. The 2004–06 
National Oral Health Survey found no differences in the prevalence of periodontitis. 
However, the authors state that the lack of differences ‘may be due to under-representation 
and or limited statistical power to detect differences’ (since only 75 Indigenous people were 
examined for periodontal disease) (Roberts-Thomson & Do 2007). A review of hospital data 
suggests differentials in the order of two times the total Australian population, which 
increase by remoteness. This increase of periodontal disease is consistent with the 
relationship between Type 2 diabetes and periodontal disease (Matthews 2002) and the 
increased risk of Type 2 diabetes among Indigenous people who reside in remote areas. 
However, hospital data is more likely to reflect symptomatic oral disease rather than 
asymptomatic oral health. According to expert advice, periodontal disease is asymptomatic 
the majority of the time. The 1995–96 Adult Dental Survey also showed a two-fold risk of 
periodontal disease, as indicated by pockets of 6+ mm, for Indigenous Australians (Brennan 
& Carter 1998). However, the Adult Dental Survey studied patients attending public dental 
care and therefore may not be representative of all Indigenous Australians. We assumed the 
same remission, case fatality and time symptomatic as the national model (Begg et al. 2007).  
Edentulism 
Based on findings from the 2004–06 National Oral Health Survey, we assumed that the 
incidence of edentulism in the Indigenous population is the same as the total Australian 
population. Despite reporting that Indigenous people have ‘disproportionately elevated 
rates of tooth loss’ (Slade et al. 2007:xvii), the confidence intervals for Indigenous and non-
Indigenous prevalence estimates from the national oral health survey mostly overlap (overall 
RR 1.2) (Roberts-Thomson & Do 2007). In contrast, the 1994–96 National Dental Telephone 
Survey found that Indigenous people were more likely to be edentulous than non-
Indigenous people (RR 1.5), whereas the 1995–96 Adults’ Dental Survey found that 
edentulism was lower among Indigenous than non-Indigenous patients (RR 0.4). Both of 
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these latter datasets had high associated standard errors (Brennan & Carter 1998). We 
assumed the same remission and case fatality as the national model (Begg et al. 2007). In the 
absence of more detailed information, we assumed there were no differentials by 
remoteness. 
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Appendix D Methods for attributing risk 
This study includes eleven risk factors for disease and injury (tobacco, alcohol, illicit drugs, 
high body mass index, inadequate physical activity, low intake of fruit and vegetables, high 
blood pressure, high cholesterol, unsafe sex, child sexual abuse, and intimate partner 
violence). We excluded three risk factors that were included in the National Study (Begg et 
al. 2007) (occupation, osteoporosis and air pollution) because no appropriate data existed 
upon which to estimate the prevalence of exposure and associated risk. Similarly, we did not 
include other risk factors from the Comparative quantification of health risks, global and regional 
burden of disease attributable to selected major risk factors (Ezzati et al. 2004) such as poverty 
(because of lack of available data on economic status and health outcomes in individuals), 
even though it may have considerable impact on the health of Indigenous Australians.  
We followed the methods used in the National Study (Begg et al. 2007) and used the same 
relative risks of disease due to risk factor exposure and direct population-attributable 
fractions unless otherwise specified. In this section, we describe the methods used to derive 
exposure estimates, and relative risks or direct population-attributable fractions where 
relevant. A summary of estimated exposure prevalence is provided in Table D.1, and an 
assessment of the exposure estimates is in Annex Table 3.  
D.1 High blood pressure 
High systolic blood pressure is associated with an increased risk of cardiovascular disease, 
including ischaemic heart disease and stroke. By definition, we attributed all hypertensive 
heart disease to high blood pressure.  
Mean and standard deviation systolic blood pressure for Indigenous Australians residing in 
non-remote areas was estimated using age group- and sex-specific data from the DRUID 
Study (diabetes and related conditions in urban Indigenous people in the Darwin region) 
supplied by the data custodian. This study used non-random techniques to recruit volunteer 
participants, and was based in one urban area of Australia. This may limit the study’s 
generalisability to all Indigenous Australians residing in non-remote areas; however, it is one 
of the few studies based in a non-remote area that measured systolic blood pressure and was 
available for our use. A published description of the cohort and methods used in the DRUID 
Study has been published elsewhere (Cunningham et al. 2006).  
For Indigenous Australians residing in remote areas, estimates of mean and standard 
deviation systolic blood pressure were based on a study by Wang and Hoy (2003). Data were 
collected during 1992–98, as part of a community screening program in a remote Northern 
Territory Aboriginal community (Tiwi Islands). Mean and standard deviation systolic blood 
pressure were reported by sex and 10-year age groups from 25 years onwards. Similar to the 
study on which the non-remote estimates are based, this study was conducted in a single 
remote Indigenous Australian community. The estimates of mean blood pressure may 
therefore not be representative of the entire Indigenous Australian population that live in 
remote areas. 
The mean blood pressure and standard deviations for both the DRUID and Wang and Hoy 
studies were presented for age groups that do not match the available relative risk. 
Therefore, we estimated the mean and standard deviation blood pressure for the required 
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age groups by fitting a linear equation to the supplied means, and a power equation to the 
standard deviations. 
D.2 High blood cholesterol  
High total cholesterol is associated with ischaemic heart disease and stroke. Mean and 
standard deviation total cholesterol estimates are based on the same studies used to estimate 
mean blood pressure. For Indigenous Australians residing in non-remote areas, we 
estimated the mean and SD cholesterol for the required age groups by fitting polynomial 
equations to the supplied DRUID data. For Indigenous Australians residing in remote areas, 
we estimated the mean cholesterol for males by fitting a linear equation, and for females by 
fitting a power equation to the Wang and Hoy data (2003). To estimate SD for both male and 
female Indigenous Australians residing in remote areas we fit power equations. 
D.3 High body mass index 
High body mass index (BMI) is associated with an increased risk of cardiovascular disease, 
Type 2 diabetes, osteoarthritis, and cancers of the breast, bowel, and uterus.  
We estimated mean and standard deviation of BMI from NATSIHS 2004–05 (Source: ABS 
2006. ABS data available on request). The NATSIHS 2004–05 collected self-reported height 
and weight information for Indigenous Australians residing in non-remote areas, while in 
remote areas participants were offered to have their height and weight measured (ABS 
2006a). The ABS provided tables of mean self-reported and measured BMI and SDs by age 
and sex for Indigenous Australians residing in remote areas, and also mean self-reported 
BMI and SD by age group for Indigenous Australians residing in non-remote areas. We 
estimated the sex-specific self-reported mean BMI and SD for Indigenous Australians 
residing in non-remote areas by assuming the same sex ratios as those residing in remote 
areas. Tables provided by the ABS indicated that for Indigenous Australians residing in 
remote areas, mean BMI based on self-report data was higher than that based on measured 
data (i.e. remote residing Indigenous Australians tend to overestimate weight, and/or 
underestimate height). We assumed that these sex- and age-specific self-reported to 
measured ratios are the same for Indigenous Australians in non-remote areas and adjusted 
the non-remote self-reported estimates accordingly. To interpolate from the ABS data to the 
required age groups, we fitted polynomial equations to the sex- and geographic-specific BMI 
estimates. 
Since BMI is not normally distributed, we assumed that it follows a log-normal distribution 
and derived parameters of a log-normal distribution that has the same mean as generated 
above.  
D.4 Insufficient intake of fruit and vegetables 
Insufficient consumption of fruit and vegetables is related to an increased risk of ischaemic 
heart disease, stroke, and cancers of the lung, stomach, bowel, and oesophagus.  
The National Study (Begg et al. 2007) assumed a normal distribution of grams of fruit and 
vegetable intake, and therefore used mean and standard deviation of fruit and vegetable 
intake. In this study, however, we used grams of fruit and vegetable intake as a categorical 
variable, while the theoretical minimum was still a distribution with a mean of 600 g and 
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standard deviation of 50 g. Categories of daily fruit and vegetable consumption for 
Indigenous Australians residing in non-remote areas were derived from the NATSIHS 2004–
05 survey (ABS 2006b). In the NATSISH 2004–05 survey, one serve of vegetables was defined 
as 75 g, while a serve of fruit was defined as 150 g fresh or 50 g dried fruit (ABS 2006a). 
Given that there was no breakdown of fruit into fresh or dried, and that the inherent 
assumption from the ABS definition is that 50 g dried fruit is of equivalent value to 150 g 
fresh fruit, we applied the conversion of 150 g to each serve of fruit (whether fresh or dried). 
The questions relating to fruit and vegetable consumption in the remote component of the 
survey did not allow for direct estimation of the number of grams consumed. Therefore, we 
estimated the proportion of Indigenous people in remote areas who do not usually consume 
fruit or vegetables, and distributed those that usually eat fruit and/or vegetables each day as 
per the estimates for Indigenous Australians residing in non-remote areas.  
D.5 Physical inactivity 
Insufficient level of physical activity was associated with an increased risk of ischaemic heart 
disease, stroke, Type 2 diabetes, breast cancer, and bowel cancer.  
Physical activity data were derived for Indigenous Australians in non-remote areas from the 
NATSIHS 2004–05 survey (Source: ABS 2006. ABS data available on request). The questions 
regarding physical activity in the remote component of the survey did not allow for the 
classification of individuals into the required categories. We therefore estimated the 
proportion of Indigenous Australians residing in remote areas who are classified as inactive 
(i.e. did not walk or do moderate or vigorous activity) from the items relating to number of 
times walked, or participated in moderate or vigorous activity, and distributed the 
remaining ‘active’ population to the other three categories as per the non-remote 
distribution. The exercise-related questions in this survey related to physical exercise 
undertaken for recreation, sport or health/fitness purposes, conceptually excluding physical 
activity undertaken as a part of work or for other purposes. This may result in an 
underestimate of the amount of physical activity undertaken, and therefore overestimate the 
burden of disease attributable to physical inactivity.  
Since the relative risks for conditions due to exercise level apply to different age groupings 
from those supplied in the tables by the ABS, we estimated the prevalence for relevant age 
groups by fitting a polynomial equation.  
D.6 Tobacco smoking 
Tobacco smoking is associated with cardiovascular disease, a range of cancers, chronic 
respiratory disease, fire injuries, inflammatory bowel disease, age-related vision disorders, 
low birth weight, sudden infant death syndrome, and otitis media. Tobacco smoking also has 
a small protective effect on Parkinson’s disease. 
Given the long lag time between exposure to tobacco smoke and the occurrence of cancers 
and COPD, the attributable burden cannot be estimated from the current prevalence of 
smoking. We therefore used the method of Peto and colleagues, who proposed an artificial 
compound prevalence measure of the relevant past exposure to tobacco (Peto et al. 1992). 
This ‘smoking impact ratio’ was derived from a comparison of lung cancer mortality rates in 
the population of interest and lung cancer mortality rates among non-smokers and smokers 
observed in a large, long-term follow-up study in the United States. Due to the small number 
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of lung cancer deaths, we calculated a smoking impact ratio for Indigenous Australians by 
age group, with no sex- or remoteness-specific estimates, with the reference population being 
adult males from the CPS-II. Compared with cancers and COPD, the mean time between 
exposure to tobacco and all other adverse health outcomes was considerably shorter. 
Therefore, for these conditions, we used the prevalence of daily smoking among adults from 
the NATSIHS 2004–05 survey (ABS 2006b).  
We base adult passive smoking estimates on those used by Ridolfo & Stevenson (2001), and 
therefore assume the proportion of people who are non-smokers and are exposed to spousal 
tobacco smoke is the same in the Indigenous Australian and total Australian population. 
Comparisons of proportions of those that have never smoked but live with a smoker in the 
1994 NDSHS Urban Indigenous Supplement (Department of Human Services and Health 
1995) are very similar to those estimates used for the total population in Ridolfo & Stevenson 
and therefore has negligible impact on the tobacco smoking results. 
Prevalence of smoking during pregnancy (52%) was taken from the Australia’s Mothers and 
Babies 2003 report (Laws & Sullivan 2005). Data from the Western Australian Aboriginal 
Child Health Survey suggest a relationship between remoteness and prevalence of smoking 
during pregnancy, with a non-remote to remote RR of 1.33 (Zubrick et al. 2004). For 2003, we 
estimated that 32% of Indigenous women aged 15–49 years lived in remote areas of the five 
states and territories that provided data to the NPSU for Australia’s Mothers and Babies 2003 
(Laws & Sullivan 2005). This distribution and the RR from the Western Australian study 
were used to estimate the prevalence of smoking during pregnancy for Indigenous 
Australians residing in remote and non-remote areas. Based on the Bibbulung Gnarneep 
Solid Kid Study (Eades et al. 1999), we assumed that the same proportion of Indigenous 
Australian women continue to smoke post-partum, and applied the prevalence of smoking 
during pregnancy to infants exposed to maternal smoking. 
D.7 Alcohol 
Alcohol abuse and harmful use is associated with stroke, hypertensive heart disease, cancers 
of the mouth, oesophagus, liver, larynx, and breast, pancreatitis, inflammatory heart disease, 
and injuries. Alcohol also has some beneficial effect on ischaemic heart disease and 
cholelithiasis.  
To estimate prevalence of alcohol consumption, we used self-report data from the ABS 
NATSIHS 2004–05 survey (ABS 2006b). These data suggest that a higher proportion of 
Indigenous Australians in non-remote areas fall into the harmful/hazardous category than 
remote residing Indigenous Australians (remote 9.0% males, 8.6% females; non-remote 10.7% 
males, 8.8% females). This relationship is in the opposite direction of that suggested by 
hospital and mortality data for alcohol dependence, where the rate of hospitalisation and 
mortality for this cause is higher in remote compared with non-remote areas (NHMD RR 1.5 
males, 2.1 females; mortality RR 1.9 males, 3.3 females).  
While we recognised that alcohol consumption occurs at ages younger than 18 years, we did 
not estimate the risk of disease or injury (excluding RTAs and fire/burns/scalds) from 
alcohol for this age group due to lack of exposure data comparable to that used for adults. 
Prevalence of alcohol consumption among adults was categorised into the four levels used in 
English et al.’s analysis of the risks of alcohol consumption (1995). The prevalence of each 
level of alcohol intake was estimated by age group and sex, from the average weekly 
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consumption of alcohol. The data was combined to give each day of the week of interview 
equal weighting. 
Based on data from English et al. (1995), the National Study (Begg et al. 2007) attributed 24% 
of acute pancreatitis to alcohol use. According to a study on admissions to Alice Springs 
Hospital, 70% of Indigenous and 43% of non-Indigenous admissions for pancreatitis were 
associated with alcohol (Ah-Tye 2001). We applied this Indigenous to non-Indigenous 
relativity to the PAF used in the National Study and estimated that 38% of acute pancreatitis 
in Indigenous Australians was attributable to alcohol.  
D.8 Illicit drugs 
We estimated the proportion of HIV/AIDS, hepatitis B and C, antepartum haemorrhage, low 
birth weight, schizophrenia, inflammatory heart disease, suicide, and RTA injuries due to 
use of illicit drugs. 
We used 2003 data from the HIV/AIDS, viral hepatitis and sexually transmissible infections 
in the HIV/AIDS, Viral Hepatitis and Sexually Transmissible Infections in Australia Annual 
Surveillance Report 2005 (National Centre in HIV Epidemiology and Clinical Research 2005) to 
estimate the proportion of HIV and AIDS cases among Indigenous Australians that are 
attributable to illicit drug use. We assumed that all cases with exposure category ‘male 
homosexual contact and injecting drug use’ were attributable to male homosexual contact. 
Given a lack of information regarding HIV exposure categories for Indigenous Australian 
deaths following AIDS, we assumed that the exposure category for death following AIDS 
was the same as for all AIDS cases over the period 1995–2004.  
We had no information regarding hepatitis B and C in Indigenous Australians that is 
attributable to illicit drugs or sexual transmission. We therefore applied the same 
proportions as the total Australian population estimates. 
Antepartum haemorrhage is a potential outcome of heroin or cocaine use during pregnancy. 
We estimated the Indigenous Australian to total Australian rate ratio of heroin or cocaine use 
in past 12 months for females aged 15–49 years from the NATSIHS 2004–05 survey (Source: 
ABS 2006. ABS data available on request), and the NDSHS 2004 (AIHW & Australian 
Government Department of Health and Ageing 2005). We applied this rate ratio to the age-
specific prevalence estimates for the total Australian population. Given a lack of information, 
we assumed the same prevalence for Indigenous Australians residing in remote and non-
remote areas. For low birth weight, we used prevalence of cannabis and opioid diagnosis 
during pregnancy in New South Wales and relative risks from Burns et al. (2006). 
To estimate the proportion of schizophrenia attributable to cannabis use, we estimated the 
prevalence of daily cannabis use for Indigenous Australians. According the Chikritzhs and 
Brady (Chikritzhs & Brady 2006), the National Drug Strategy Household Survey: Urban 
Aboriginal and Torres Strait Islander Supplement, 1994 is the most reliable Indigenous 
substance-use survey published so far, although it is now quite dated. A comparison of 
prevalence from the 1995 and 2004 NDSHS data indicates that the self-reported prevalence of 
daily cannabis use in all Australians has risen (AIHW & Australian Government Department 
of Health and Ageing 2005, Vuksa & Kelly 1996). We assumed a similar increase in 
prevalence among Indigenous Australians residing in remote and non-remote areas.  
The method used to derive Indigenous Australian prevalence of daily cannabis use assumes 
that the non-remote Indigenous-to-total-Australian differential that existed in 1994–95 was 
the same as in 2004. We applied the age-standardised ratio of urban Indigenous prevalence 
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(Department of Human Services and Health 1995) to total Australian prevalence (Vuksa & 
Kelly 1996), to the total Australian prevalence in 2004 (AIHW & Australian Government 
Department of Health and Ageing 2005). This gave us a recent estimate of daily cannabis use 
for Indigenous Australians residing in non-remote areas. In the absence of other information, 
we resorted to using the rate ratio of hospitalisation for cannabis dependence & harmful use 
between non-remote and remote residing Indigenous Australians to derive the estimated 
prevalence of daily cannabis use for remote residing Indigenous Australians.  
D.9 Unsafe sex 
For HIV, AIDS, AIDS deaths and hepatitis, we calculated the proportion attributable to 
unsafe sex in the same way as for illicit drug use (described above). We assumed that all 
sexually transmitted disease, abortion and cervical cancer resulted from unsafe sex. 
D.10 Childhood sexual abuse  
Sexual abuse in childhood is associated with anxiety & depression, alcohol and illicit drug 
dependence & harmful use and associated risks, and suicide as an adult.  
Studies have suggested that child protection statistics underestimate the actual occurrence of 
child sexual abuse more so in the Indigenous community than the non-Indigenous 
community (Stanley et al. 2003). Despite this, child protection statistics are still believed to be 
the most reliable source of data on child abuse and neglect (Richardson 2005), and therefore 
probably the best source of information regarding the relative differences in the prevalence 
of child sexual abuse in Indigenous and non-Indigenous Australians.  
We estimated the rate ratio of Indigenous child sexual abuse substantiations to total 
Australian child sexual abuse substantiations from child protection data for 2002–03 (AIHW 
2004a). For non-contact child sexual abuse, we assume the same prevalence among 
Indigenous Australians as the national model (Begg et al. 2007); for contact-only child sexual 
abuse, we applied half the rate ratio; and for intercourse child sexual abuse, we applied the 
whole rate ratio. This gradient of risk was based on the assumption that child sexual abuse 
substantiations reflect more severe abuse, and if this rate ratio were applied to all categories, 
the overall prevalence of child sexual abuse would be implausibly high. Due to the lack of 
empirical data on the prevalence of child sexual abuse in remote versus non-remote 
communities, we assumed the same prevalence applies to both areas.  
Our method assumed that the observed rate ratio of child sexual abuse between Indigenous 
and non-Indigenous Australian children in 2002–03 has been constant over time. This was 
necessary as we attributed disease outcomes in adulthood to child sexual abuse in the past.  
D.11 Intimate partner violence 
Intimate partner violence is associated with anxiety & depression, eating disorders, tobacco, 
alcohol and other drug use and associated risks, sexually transmitted disease, cervical 
cancer, fall injuries, suicide, and homicide & violence.  
We estimated the prevalence of Indigenous women that had experienced intimate partner 
violence by applying the Indigenous-to-non-Indigenous ratio of the proportion of women 
who reported experiencing any violence in the past 12 months, and over their lifetime from 
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the Australian component of the International Violence Against Women Survey (Mouzos & 
Makkai 2004) to the national model estimates of 12-month or lifetime prevalence (Begg et al. 
2007). The application of these rate ratios assumed that the same proportion of any violence 
experienced by Indigenous and non-Indigenous women was perpetrated by the intimate 
partner. Australian hospital data (AIHW 2003b) on assaults suggest that a similar proportion 
of assaults in all Australian women, and Indigenous Australian women residing in non-
remote and remote areas, are perpetrated by a spouse (including ex and defacto) (40%, 44%, 
and 40% respectively). However, the proportion of female hospital separations for assault 
that have no perpetrator specified is higher for Indigenous women (22%, 34%, and 44%). 
Also, in a study of homicide over the period 1989–98, 75.4% of Indigenous femicide victims 
were killed by their intimate partners, compared with 54% for non-Indigenous femicide 
victims (Mouzos 1999).  
The International Violence Against Women Survey was a computer-assisted telephone 
interview survey, and only included 91 respondents who identified as being Indigenous 
(1.4% of the sample). Also, the survey response rate was just 39%. This may limit the 
generalisability of the survey findings to the entire Indigenous Australian female population. 
While the hospitalisation and Supported Accommodation Assistance Program Indigenous-
to-non-Indigenous ratios are much higher than those found in the International Violence 
Against Women Survey, we assumed that the institution-based data represented the severe 
end of the spectrum, and since Indigenous women experience more severe injury as a result 
of violence (Ferrante et al. cited in Blagg 2000), use of service data could lead to 
overestimation of total intimate partner violence experienced.  
Remote-to-non-remote ratios based on the Supported Accommodation Assistance Program 
data for closed support periods were used to adjust the total Indigenous prevalence of 
intimate partner violence. We attempted to adjust support periods to represent people by 
dividing the non-Indigenous and Indigenous periods by the mean number of support 
periods per client (1.5 and 1.8 respectively) (AIHW 2005c). While the mean number of 
support periods per client may differ between Indigenous women residing in remote and 
non-remote areas, we have no information regarding this.  
The population-attributable fraction for homicide & violence due to intimate partner was 
derived from a study that found that over the period 1989–98, 75.4% of Indigenous women 
who were victims of homicide were killed by an intimate partner (Mouzos 1999). We 
adjusted this figure for Indigenous Australian women residing in remote and non-remote 
areas by applying the remote/non-remote to total Indigenous ratios derived from the 
proportion of assault hospital separations, where the relationship of the victim of assault to 
the perpetrator was recorded as spouse or domestic partner.  
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Annex table 1: Principal data sources for epidemiological modelling 
Primary data source 
Reference
period Disease and injury categories 
A. Disease registers, surveillance, notification and 
vital registration systems 
 
  
National Notifiable Diseases Surveillance System     
Age- and sex-specific rate ratios 2001–03 1A02b Chlamydia (E) 
  1A02c Gonorrhoea (E) 
  1A05b Whooping cough 
  1A05g Haemophilus influenzae type b 
  1A08c Dengue 
  1A08d Other arbovirus infection 
  1A09a Hepatitis A 
  1A10 Malaria 
Age-standardised rate ratios 2001–03 1A08a Ross River virus 
  1A08b Barmah Forest virus 
  1A09b Hepatitis B (E) 
Annual report 2003 1A01 Tuberculosis (E) 
  1A05e Measles (E) 
National HIV Database and National AIDS Registry 2003 1A03 HIV/AIDS (E) 
Australia and New Zealand Dialysis and Transplant 
Registry 
2001–03 
2O01 Nephritis & nephrosis (E) 
Australian mortality data    
Age-standardised mortality rate ratios 2003 2F Malignant neoplasms(a) 
 2003 2O01 Nephritis & nephrosis (E) 
National Perinatal Data Collection 2003 1D02 Low birth weight (E) 
B. Health service utilisation data    
Australian hospital data     
Age- and sex-specific rate ratios 2001–03 1A02a Syphilis 
  1A02d Other STD 
  1A04 Diarrhoeal diseases 
  1A06 Meningitis 
  1A07 Septicaemia (E) 
  1C01 Maternal haemorrhage (E) 
  1C02 Maternal sepsis (E) 
  1C03 Hypertensive disorders of pregnancy (E) 
  1C04 Obstructed labour (E) 
  1C05 Abortion (E) 
(continued) 
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Annex table 1 (continued): Principal data sources for epidemiological modelling 
Primary data source 
Reference
period Disease and injury categories 
  1Coth Other maternal conditions (E) 
  1E02 Deficiency anaemia 
  2K08b Cataract-related blindness (E, P) 
  2L02 Ischaemic heart disease (E) 
  2L06 Non-rheumatic valvular disease (E) (c) 
  2L08 Peripheral vascular disease (E) 
  2Lhfa Heart failure(c)  
  2M01 Chronic obstructive pulmonary disease (E) 
  2N07 Pancreatitis 
Age-standardised rate ratios  1A01 Tuberculosis (E) 
  1B01 Lower respiratory tract infections 
  1B02 Upper respiratory tract infections 
  1B01 Lower respiratory tract infections 
  1B02 Upper respiratory tract infections 
  1D01 Birth trauma & asphyxia (E) 
  1D02 Low birth weight (E) 
  1D03 Neonatal infections (E) 
  2G01 Uterine myomas 
  2G02 Benign neoplasms of meninges and brain 
  2H02 Type 2 diabetes (E) 
  2J01d Cannabis 
  2J01e Other drug dependence 
  2J02 Schizophrenia 
  2I01a Haemolytic anaemia 
  2I01b  Other non-deficiency anaemia 
  2I02 Cystic fibrosis 
  2I03 Haemophilia 
  2J01b Heroin or polydrug dependence  
  2J04 Bipolar disorder 
  2J06a Anorexia nervosa 
  2J06b Bulimia nervosa 
  2J06c Other eating disorders 
  2K04 Multiple sclerosis 
  2K08a Glaucoma-related blindness (E, P) 
  2K08b Cataract-related blindness (E) 
  2K08e Refractive errors 
(continued) 
 Annex table 1 (continued): Principal data sources for epidemiological modelling 
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Primary data source 
Reference
period Disease and injury categories 
  2L03 Stroke (E) 
  2L05 Hypertensive heart disease (E) 
  2L07 Aortic aneurysm 
  2N01 Peptic ulcer disease 
  2N02 Cirrhosis of the liver (E, U) 
  2N03 Appendicitis 
  2N04 Intestinal obstruction 
  2N05 Diverticulitis 
  2N06 Gallbladder and bile duct disease 
  2N09 Vascular insufficiency bowel 
  2O02 Benign prostatic hypertrophy 
  2Ooth Other genitourinary diseases 
  2P03 Psoriasis 
  2P04 Ulcers 
  2Q02 Osteoarthritis 
  2Q04 Slipped disc 
  2Q06 Systemic lupus erythematosus  
  2Q07 Gout 
  2Qoth Other musculoskeletal diseases 
  2R01 Anencephaly 
  2R02 Spina bifida 
  2R03 Congenital heart disease 
  2R04 Cleft lip and/or palate 
  2R05a Anorectal atresia 
  2R05b Oesophageal atresia 
  2R05c Other digestive system malformations 
  2R06a Renal agenesis  
  2R06b Other urogenital tract malformations 
  2R07 Abdominal wall defect 
  2S04 Pulpitis 
  2Z02 Chronic fatigue syndrome 
  3T Unintentional injuries 
  3U Intentional injuries 
Bettering the Evaluation And Care of Health 2000–01 1B03 Otitis media (E) 
Western Australian Data Linkage System 1990–03 2L03 Stroke (E) 
(continued) 
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Annex table 1 (continued): Principal data sources for epidemiological modelling 
Primary data source 
Reference
period Disease and injury categories 
C. Population health surveys    
National Trachoma Eye Health Program 1976–78 1A11 Trachoma (E) 
  1B03 Otitis media (E) 
National Health Survey    
Customised table 2004–05 
and 2001 2M02 Asthma (E) 
Main report 2004–05 2J01a Alcohol dependence (E) 
Main report 2004–05 2J03 Anxiety & depression (E) 
CURF 2001 1B03 Otitis media 
NSW Health Survey 1997–98 2J03 Anxiety & depression (E) 
Western Australian Aboriginal Child Health Survey 2001–02 2J03 Anxiety & depression (E) 
2004–06 National Oral Health Survey  2004–06 2S01 Dental caries (E) 
 2004–06 2S02 Periodontal disease (E) 
 2004–06 2S03 Edentulism (E) 
South Australian Child and Adult Dental Health Surveys 1999–01 2S01 Dental caries (E) 
D. Epidemiological studies     
Menzies et al. (2004) 2000–02 1A05e Measles (E)  
Menzies et al. (2004) 2000–02 1A05c Tetanus (E)  
National Trachoma and Eye Health Program Report 
(1980) 
1998–99 
1A11 Trachoma (E)  
Kaldor et al. (1996) 1996(b)  1A09b Hepatitis B (E)  
Mott (2005)  2H02 Type 2 diabetes  
Leonard et al. (2003) 1983–92 2K9 Intellectual disability  
Glasson et al. (2005) 1953–2000 2K9 Intellectual disability (U)  
Archer and Bunby (2006) 2001–05 2K02 Epilepsy (E)  
Leonard et al. (2005) 1983–92 2J07b Autism and Asperger’s (E)  
E. Indirect estimation    
YLD to YLL ratio from rest of category  1Aoth Other infectious and parasitic diseases 
  2Foth Other malignant neoplasms 
  2Goth Other benign neoplasms 
  2Ioth Other endocrine and metabolic disorders 
  
2Koth 
Other nervous system and sense organ 
disorders 
  2Loth Other cardiovascular disease 
  2Moth Other chronic respiratory diseases 
  2Noth Other digestive system diseases 
  2Roth Other congenital anomalies 
(continued) 
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Primary data source 
Reference
period Disease and injury categories 
F. Assume same incidence as the total Australian population   
  1A09d Other hepatitis 
  2H01 Type 1 diabetes 
  2J01c Benzodiazepine dependence 
  2J05 Personality disorders (isolated) 
  2J07a Attention-deficit hyperactivity disorder 
  2K01 Alzheimer and other dementias 
  2K03 Parkinson’s disease 
  2K05 Motor-neuron disease 
  2K06 Huntington’s chorea 
  2K07 Muscular dystrophy 
  2K08c Macular degeneration 
  2K08d Adult-onset hearing loss 
  2K08f Other vision loss 
  2K10 Migraine 
  2N08 Inflammatory bowel disease 
  2O03 Urinary incontinence 
  2O04 Infertility 
  2P01 Eczema 
  2P02 Acne 
  2Q01 Rheumatoid arthritis 
  2Q03 Back pain (acute and chronic) 
G. Condition assumed absent in Indigenous population   
  1A11 Trachoma (for the non-remote population) 
  1A05a Diphtheria 
  1A05d Poliomyelitis 
  1A05f Rubella 
  
1Doth 
Other conditions arising in the perinatal 
period 
  2Q05 Occupational overuse syndrome 
(a) Liver cancer is the only explicit model (as it has different assumptions re: survival) 
(b) Review published in 1996 — year of primary data collection is uncertain 
(c) Four broad age groups 
(U) Proportion by underlying cause 
(E) Explicit model 
(P) Uses procedures as basis of estimates instead of diagnosis mentions  
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l d
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l d
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D
is
ea
se
 
co
nd
iti
on
  
M
ai
n 
da
ta
 s
ou
rc
e 
an
d 
ap
pl
ic
at
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at
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l d
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l d
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at
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l d
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l d
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 d
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at
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at
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at
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l c
as
es
 
us
in
g 
a 
ra
tio
 fr
om
 th
e 
19
80
 s
ur
ve
y.
 A
pp
ly
 e
st
im
at
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m
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os
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 d
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l d
at
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at
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at
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os
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l d
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 d
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 p
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at
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l p
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 d
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ho
d 
 
W
e 
us
e 
ag
e-
sp
ec
ifi
c 
lu
ng
 c
an
ce
r m
or
ta
lit
y 
ra
te
s 
fo
r m
al
es
 a
nd
 fe
m
al
es
 c
om
bi
ne
d 
to
 e
st
im
at
e 
pr
op
or
tio
ns
 o
f l
on
g 
la
g-
tim
e 
co
nd
iti
on
s 
du
e 
to
 to
ba
cc
o 
sm
ok
in
g.
 W
e 
as
su
m
e 
th
at
 ra
te
s 
of
 lu
ng
 
ca
nc
er
 m
or
ta
lit
y 
ar
e 
th
e 
sa
m
e 
in
 In
di
ge
no
us
 m
al
es
 a
nd
 fe
m
al
es
 re
si
di
ng
 in
 re
m
ot
e 
an
d 
no
n-
re
m
ot
e 
ar
ea
s,
 a
nd
 b
y 
im
pl
ic
at
io
n 
th
at
 le
ve
ls
 o
f s
m
ok
in
g 
w
er
e 
si
m
ila
r i
n 
th
es
e 
po
pu
la
tio
n 
gr
ou
ps
 o
ve
r t
he
 
pa
st
 2
0–
30
 y
ea
rs
. 
4 
C
ur
re
nt
 d
ai
ly
 s
m
ok
er
s 
N
A
TS
IH
S
 (A
B
S
 2
00
6b
) 
P
re
va
le
nc
e 
of
 c
ur
re
nt
 s
m
ok
er
s 
is
 b
as
ed
 o
n 
se
lf-
re
po
rt 
da
ta
 a
nd
 th
e 
as
su
m
pt
io
n 
is
 th
at
 th
at
 re
fle
ct
s 
tru
e 
pr
ev
al
en
ce
. 
4 
P
as
si
ve
 s
m
ok
in
g 
N
at
io
na
l H
ea
lth
 S
ur
ve
y 
19
95
 (c
ite
d 
in
 R
id
ol
fo
 &
 S
te
ve
ns
on
 2
00
1)
 
W
e 
ba
se
 p
as
si
ve
 s
m
ok
in
g 
es
tim
at
es
 o
n 
th
os
e 
us
ed
 b
y 
R
id
ol
fo
 &
 S
te
ve
ns
on
, a
nd
 th
er
ef
or
e 
as
su
m
e 
th
e 
pr
op
or
tio
n 
of
 p
eo
pl
e 
w
ho
 a
re
 n
on
-s
m
ok
er
s 
an
d 
ar
e 
ex
po
se
d 
to
 s
po
us
al
 to
ba
cc
o 
sm
ok
e 
is
 th
e 
sa
m
e 
in
 th
e 
In
di
ge
no
us
 A
us
tra
lia
n 
an
d 
to
ta
l A
us
tra
lia
n 
po
pu
la
tio
n.
  
2 
M
at
er
na
l s
m
ok
in
g 
an
d 
sm
ok
in
g 
w
hi
le
 p
re
gn
an
t  
A
us
tra
lia
’s
 M
ot
he
rs
 a
nd
 B
ab
ie
s 
20
03
 (L
aw
s 
&
 S
ul
liv
an
 2
00
5)
; 
W
A
A
C
H
S
 (Z
ub
ric
k 
et
 a
l. 
20
04
); 
B
ib
bu
lu
ng
 G
na
rn
ee
p 
(‘S
ol
id
 K
id
’) 
st
ud
y 
(E
ad
es
 e
t a
l. 
19
99
) 
Th
e 
es
tim
at
e 
of
 p
re
va
le
nc
e 
of
 s
m
ok
in
g 
du
rin
g 
pr
eg
na
nc
y 
is
 b
as
ed
 o
n 
se
lf-
re
po
rte
d 
sm
ok
in
g,
 a
nd
 
th
e 
as
su
m
pt
io
n 
is
 th
at
 s
el
f-r
ep
or
t d
at
a 
re
fle
ct
s 
tru
e 
pr
ev
al
en
ce
. 
3 
A
lc
oh
ol
 
N
A
TS
IH
S
 2
00
4–
05
 (A
B
S
 2
00
6b
) 
Th
e 
N
A
TS
IH
S
 2
00
4–
05
 c
ol
le
ct
ed
 s
el
f-r
ep
or
t d
at
a 
on
 a
lc
oh
ol
 c
on
su
m
pt
io
n.
 W
e 
as
su
m
e 
th
at
 s
el
f-
re
po
rte
d 
al
co
ho
l c
on
su
m
pt
io
n 
re
fle
ct
s 
tru
e 
pr
ev
al
en
ce
. 
4 
Ill
ic
it 
dr
ug
s 
 
 
 
D
ru
g 
us
e 
an
d 
de
pe
nd
en
ce
 
D
ru
g 
us
e 
an
d 
de
pe
nd
en
ce
 m
od
el
s 
 
 
U
se
 o
f i
lli
ci
t d
ru
gs
 
H
IV
/A
ID
S
, h
ep
at
iti
s 
B
, h
ep
at
iti
s 
C
, 
in
fla
m
m
at
or
y 
he
ar
t d
is
ea
se
, 
pa
nc
re
at
iti
s,
 s
ui
ci
de
, a
nd
 R
TA
s 
po
pu
la
tio
n 
at
tri
bu
ta
bl
e 
fra
ct
io
ns
 
di
re
ct
 fr
om
 th
e 
lit
er
at
ur
e 
W
e 
as
su
m
e 
th
at
 h
ep
at
iti
s 
B
 a
nd
 C
, R
TA
, a
nd
 s
ui
ci
de
 a
ttr
ib
ut
ab
le
 fr
ac
tio
ns
 a
re
 th
e 
sa
m
e 
in
 
In
di
ge
no
us
 a
nd
 to
ta
l A
us
tra
lia
n 
po
pu
la
tio
ns
. 
3 
(c
on
tin
ue
d)
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ss
es
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en
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f q
ua
lit
y 
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 ri
sk
 fa
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or
 e
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ur
e 
es
tim
at
es
 in
 th
e 
In
di
ge
no
us
 p
op
ul
at
io
n 
 
R
is
k 
fa
ct
or
 
D
at
a 
so
ur
ce
 
A
ss
um
pt
io
ns
 
C
on
fid
en
ce
 in
 
pr
ev
al
en
ce
 
es
tim
at
es
(a
)  
D
ai
ly
 c
an
na
bi
s 
us
e 
N
D
S
H
S
: A
bo
rig
in
al
 a
nd
 T
or
re
s 
S
tra
it 
Is
la
nd
er
 S
up
pl
em
en
t 1
99
4 
(D
ep
ar
tm
en
t o
f H
um
an
 S
er
vi
ce
s 
an
d 
H
ea
lth
 1
99
5)
; N
D
S
H
S
 1
99
5 
(V
uk
sa
 &
 K
el
ly
 1
99
6)
; N
D
S
H
S
 
20
04
 (A
IH
W
 &
 A
us
tra
lia
n 
G
ov
er
nm
en
t D
ep
ar
tm
en
t o
f H
ea
lth
 
an
d 
A
ge
in
g 
20
05
); 
ho
sp
ita
lis
at
io
n 
da
ta
 2
00
1–
03
 
W
e 
ap
pl
y 
th
e 
ra
tio
 o
f 2
00
4 
to
 1
99
5 
es
tim
at
ed
 p
re
va
le
nc
e 
of
 d
ai
ly
 c
an
na
bi
s 
us
e 
in
 th
e 
to
ta
l 
A
us
tra
lia
n 
po
pu
la
tio
n 
to
 th
e 
19
94
 e
st
im
at
e 
of
 p
re
va
le
nc
e 
in
 th
e 
no
n-
re
m
ot
e 
re
si
di
ng
 In
di
ge
no
us
 
A
us
tra
lia
n 
po
pu
la
tio
n.
 W
e 
th
er
ef
or
e 
as
su
m
e 
th
at
 th
e 
in
cr
ea
se
 s
ee
n 
in
 d
ai
ly
 c
an
na
bi
s 
us
e 
in
 th
e 
N
at
io
na
l D
ru
g 
S
tra
te
gy
 H
ou
se
ho
ld
 S
ur
ve
y 
ov
er
 th
e 
pe
rio
d 
19
95
 –
20
04
 a
ls
o 
oc
cu
rr
ed
 in
 th
e 
In
di
ge
no
us
 A
us
tra
lia
n 
po
pu
la
tio
n 
re
si
di
ng
 in
 n
on
-r
em
ot
e 
ar
ea
s.
  
W
e 
us
e 
th
e 
ra
te
 ra
tio
 o
f h
os
pi
ta
l s
ep
ar
at
io
ns
 fo
r c
an
na
bi
s 
de
pe
nd
en
ce
 b
et
w
ee
n 
In
di
ge
no
us
 
A
us
tra
lia
ns
 re
si
di
ng
 in
 n
on
-r
em
ot
e 
an
d 
re
m
ot
e 
ar
ea
s 
to
 d
er
iv
e 
th
e 
es
tim
at
es
 o
f p
re
va
le
nc
e 
of
 d
ai
ly
 
ca
nn
ab
is
 u
se
 fo
r r
em
ot
e 
re
si
di
ng
 In
di
ge
no
us
 A
us
tra
lia
ns
. T
he
 p
ro
po
rti
on
 o
f d
ai
ly
 c
an
na
bi
s 
us
er
s 
ho
sp
ita
lis
ed
 fo
r r
ea
so
ns
 re
la
tin
g 
to
 h
ar
m
fu
l o
r d
ep
en
da
nt
 c
an
na
bi
s 
us
e 
ar
e 
th
er
ef
or
e 
as
su
m
ed
 to
 b
e 
th
e 
sa
m
e 
fo
r I
nd
ig
en
ou
s 
A
us
tra
lia
ns
 re
si
di
ng
 in
 re
m
ot
e 
an
d 
no
n-
re
m
ot
e 
ar
ea
s.
 
3 
P
re
na
ta
l e
xp
os
ur
e 
ca
nn
ab
is
 
an
d 
co
ca
in
e 
B
ur
ns
 a
nd
 c
ol
le
ag
ue
s 
(B
ur
ns
 e
t a
l. 
20
06
)  
B
ur
ns
 a
nd
 c
ol
le
ag
ue
s 
us
ed
 re
co
rd
 li
nk
ag
e 
to
 e
xa
m
in
e 
ill
ic
it 
dr
ug
 u
se
 in
 p
re
gn
an
cy
 in
 N
ew
 S
ou
th
 
W
al
es
. W
e 
as
su
m
e 
th
at
 p
re
va
le
nc
e 
of
 d
ru
g 
us
e 
du
rin
g 
pr
eg
na
nc
y 
am
on
g 
In
di
ge
no
us
 w
om
en
 in
 
N
ew
 S
ou
th
 W
al
es
 c
an
 b
e 
ge
ne
ra
lis
ed
 to
 a
ll 
In
di
ge
no
us
 A
us
tra
lia
n 
w
om
en
. 
3 
U
se
 h
er
oi
n 
an
d 
co
ca
in
e 
w
hi
le
 p
re
gn
an
t 
N
A
TS
IH
S
 2
00
4–
05
 (S
ou
rc
e:
 A
B
S
 
20
06
. A
B
S
 d
at
a 
av
ai
la
bl
e 
on
 
re
qu
es
t) 
Th
e 
N
A
TS
IH
S
 2
00
4-
05
 c
ol
le
ct
ed
 s
el
f r
ep
or
te
d 
da
ta
 o
n 
ill
ic
it 
dr
ug
 u
se
. W
e 
as
su
m
e 
se
lf-
re
po
rte
d 
us
e 
of
 h
er
oi
n 
an
d 
co
ca
in
e 
re
fle
ct
s 
tru
e 
pr
ev
al
en
ce
. 
3 
U
ns
af
e 
se
x 
S
ex
ua
lly
 tr
an
sm
is
si
bl
e 
di
se
as
es
, 
ab
or
tio
n,
 a
nd
 c
er
vi
ca
l c
an
ce
r 
m
od
el
s;
 P
A
F 
di
re
ct
 fr
om
 th
e 
lit
er
at
ur
e 
(N
at
io
na
l C
en
tre
 in
 H
IV
 
E
pi
de
m
io
lo
gy
 a
nd
 C
lin
ic
al
 
R
es
ea
rc
h 
20
05
) 
 
4 
C
hi
ld
 s
ex
ua
l a
bu
se
 
G
lo
ba
l B
ur
de
n 
of
 D
is
ea
se
 
C
om
pa
ra
tiv
e 
R
is
k 
as
se
ss
m
en
t 
pr
ev
al
en
ce
 e
st
im
at
es
 fo
r A
us
tra
lia
; 
C
hi
ld
 P
ro
te
ct
io
n 
da
ta
 2
00
2–
03
 
(A
IH
W
 2
00
4a
) 
W
e 
us
e 
ch
ild
 p
ro
te
ct
io
n 
da
ta
 to
 e
st
im
at
e 
th
e 
re
la
tiv
e 
di
ffe
re
nc
e 
in
 p
re
va
le
nc
e 
of
 c
hi
ld
 s
ex
ua
l a
bu
se
 
be
tw
ee
n 
In
di
ge
no
us
 a
nd
 th
e 
to
ta
l A
us
tra
lia
n 
po
pu
la
tio
n.
 T
hi
s 
ca
rie
s 
th
e 
as
su
m
pt
io
n 
th
at
 c
hi
ld
 
pr
ot
ec
tio
n 
st
at
is
tic
s 
co
ve
r t
he
 s
am
e 
pr
op
or
tio
n 
of
 a
bu
se
 c
as
es
 in
 th
e 
In
di
ge
no
us
 a
nd
 n
on
-
In
di
ge
no
us
 A
us
tra
lia
n 
po
pu
la
tio
n.
 
O
ur
 m
et
ho
d 
as
su
m
es
 th
at
 th
e 
ob
se
rv
ed
 ra
te
 ra
tio
 o
f c
hi
ld
 s
ex
ua
l a
bu
se
 b
et
w
ee
n 
In
di
ge
no
us
 a
nd
 
no
n-
In
di
ge
no
us
 A
us
tra
lia
n 
ch
ild
re
n 
in
 2
00
2–
03
 h
as
 b
ee
n 
co
ns
ta
nt
 o
ve
r t
im
e.
 T
hi
s 
is
 n
ec
es
sa
ry
 a
s 
w
e 
at
tri
bu
te
 d
is
ea
se
 o
ut
co
m
es
 in
 a
du
lth
oo
d 
th
at
 a
re
 d
ue
 to
 c
hi
ld
 s
ex
ua
l a
bu
se
 in
 th
e 
pa
st
.  
Fo
r n
on
-c
on
ta
ct
 c
hi
ld
 s
ex
ua
l a
bu
se
 w
e 
as
su
m
e 
th
e 
sa
m
e 
pr
ev
al
en
ce
 a
m
on
g 
In
di
ge
no
us
 A
us
tra
lia
ns
 
as
 th
e 
na
tio
na
l m
od
el
; f
or
 c
on
ta
ct
-o
nl
y 
ch
ild
 s
ex
ua
l a
bu
se
 w
e 
ap
pl
y 
ha
lf 
of
 th
e 
ra
te
 ra
tio
; a
nd
 fo
r 
in
te
rc
ou
rs
e 
ch
ild
 s
ex
ua
l a
bu
se
 w
e 
ap
pl
y 
th
e 
w
ho
le
 ra
te
 ra
tio
. T
hi
s 
gr
ad
ie
nt
 o
f r
is
k 
is
 b
as
ed
 o
n 
th
e 
as
su
m
pt
io
n 
th
at
 c
hi
ld
 s
ex
ua
l a
bu
se
 s
ub
st
an
tia
tio
ns
 re
fle
ct
 m
or
e 
se
ve
re
 a
bu
se
, a
nd
 if
 th
is
 ra
te
 ra
tio
 
w
er
e 
ap
pl
ie
d 
to
 a
ll 
ca
te
go
rie
s,
 th
e 
ov
er
al
l p
re
va
le
nc
e 
of
 c
hi
ld
 s
ex
ua
l a
bu
se
 w
ou
ld
 b
e 
ex
tre
m
el
y 
hi
gh
 
an
d 
fo
r s
om
e 
ag
e 
gr
ou
ps
 re
ac
h 
10
0%
.  
G
iv
en
 n
o 
da
ta
 re
la
te
d 
to
 re
la
tiv
e 
di
ffe
re
nc
e 
in
 p
re
va
le
nc
e 
of
 c
hi
ld
 s
ex
ua
l a
bu
se
 in
 re
m
ot
e 
an
d 
no
n-
re
m
ot
e 
ar
ea
s,
 w
e 
as
su
m
e 
th
at
 p
re
va
le
nc
e 
of
 c
hi
ld
 s
ex
ua
l a
bu
se
 is
 th
e 
sa
m
e 
in
 In
di
ge
no
us
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(n
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ot
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tin
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ur
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es
tim
at
es
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 th
e 
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di
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us
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op
ul
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io
n 
 
R
is
k 
fa
ct
or
 
D
at
a 
so
ur
ce
 
A
ss
um
pt
io
ns
 
C
on
fid
en
ce
 in
 
pr
ev
al
en
ce
 
es
tim
at
es
(a
)  
A
us
tra
lia
ns
 re
si
di
ng
 in
 re
m
ot
e 
ar
ea
s 
as
 th
os
e 
in
 n
on
-r
em
ot
e 
ar
ea
s.
 
In
tim
at
e 
pa
rtn
er
 v
io
le
nc
e 
W
om
en
’s
 S
af
et
y 
S
ur
ve
y 
19
96
 
(A
B
S
 1
99
6)
; I
nt
er
na
tio
na
l V
io
le
nc
e 
A
ga
in
st
 W
om
en
 S
ur
ve
y 
(M
ou
zo
s 
&
 
M
ak
ka
i 2
00
4)
; S
up
po
rte
d 
A
cc
om
m
od
at
io
n 
A
ss
is
ta
nc
e 
P
ro
gr
am
 (A
IH
W
 2
00
5c
)  
W
e 
es
tim
at
e 
th
e 
re
la
tiv
e 
di
ffe
re
nc
e 
in
 e
xp
er
ie
nc
e 
of
 in
tim
at
e 
pa
rtn
er
 v
io
le
nc
e 
ba
se
d 
on
 p
re
va
le
nc
e 
of
 a
ny
 v
io
le
nc
e 
fro
m
 th
e 
A
us
tra
lia
n 
co
m
po
ne
nt
 o
f t
he
 In
te
rn
at
io
na
l V
io
le
nc
e 
A
ga
in
st
 W
om
en
 S
ur
ve
y.
 
It 
is
 th
er
ef
or
e 
as
su
m
ed
 th
at
 th
e 
es
tim
at
es
 o
f p
ro
po
rti
on
 o
f w
om
en
 th
at
 h
av
e 
ex
pe
rie
nc
ed
 v
io
le
nc
e 
fro
m
 th
e 
IV
A
W
S
 is
 re
pr
es
en
ta
tiv
e 
of
 a
ll 
A
us
tra
lia
n 
w
om
en
, a
nd
 n
on
-r
em
ot
e 
re
si
di
ng
 In
di
ge
no
us
 
A
us
tra
lia
ns
.  
S
in
ce
 w
e 
ap
pl
y 
ra
tio
s 
of
 a
ny
 v
io
le
nc
e 
to
 in
tim
at
e 
pa
rtn
er
 v
io
le
nc
e,
 w
e 
as
su
m
e 
th
e 
sa
m
e 
pr
op
or
tio
n 
of
 a
ny
 v
io
le
nc
e 
ex
pe
rie
nc
ed
 b
y 
In
di
ge
no
us
 a
nd
 a
ll 
A
us
tra
lia
n 
w
om
en
 is
 p
er
pe
tra
te
d 
by
 a
n 
in
tim
at
e 
pa
rtn
er
. 
W
e 
us
e 
S
up
po
rte
d 
A
cc
om
m
od
at
io
n 
A
ss
is
ta
nc
e 
P
ro
gr
am
 d
at
a 
to
 d
er
iv
e 
re
m
ot
e 
es
tim
at
es
. W
e 
th
er
ef
or
e 
as
su
m
e 
In
di
ge
no
us
 w
om
en
 re
si
di
ng
 in
 re
m
ot
e 
an
d 
no
n-
re
m
ot
e 
ar
ea
s 
th
at
 e
xp
er
ie
nc
e 
in
tim
at
e 
pa
rtn
er
 v
io
le
nc
e 
us
e 
su
pp
or
te
d 
ac
co
m
m
od
at
io
n 
at
 th
e 
sa
m
e 
ra
te
. 
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The Burden of Disease and Injury in Aboriginal and 
Torres Strait Islander peoples 2003 provides the first 
comprehensive assessment of the burden of disease 
of Indigenous Australians. 
Burden of disease analysis gives a unique 
perspective on health. Fatal and non-fatal outcomes 
are combined, but can be examined separately as 
well. This report provides details of the extent of 
premature mortality and disability estimated for 
over 170 disease and injury categories and for 
Indigenous people living in remote and non-remote 
areas of Australia. It also presents estimates of the 
amount of disease and injury caused by 11 major 
risk factors. More importantly, it measures the 
Indigenous Health Gap, which is the difference 
between the observed burden of disease in 
Indigenous Australians and what it would have been 
if the same rates of burden of disease as in the total 
Australian population would have applied. This is of 
major policy interest. The diseases and risk factors 
that contribute most to the Indigenous Health Gap 
are identified as health areas where appropriately 
resourced health services, combined with 
interventions to address the social and economic 
disadvantages faced by Indigenous Australians, are 
likely to have the greatest impact on reducing the 
burden of disease in Aboriginal and Torres Strait 
Islander peoples.
